microRNA information: hsa-miR-29b-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-29b-3p | miRbase |
Accession: | MIMAT0000100 | miRbase |
Precursor name: | hsa-mir-29b-1 | miRbase |
Precursor accession: | MI0000105 | miRbase |
Symbol: | MIR29B1 | HGNC |
RefSeq ID: | NR_029517 | GenBank |
Sequence: | UAGCACCAUUUGAAAUCAGUGUU |
Reported expression in cancers: hsa-miR-29b-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-29b-3p | acute myeloid leukemia | downregulation | "Higher miR-29b pretreatment expression is associat ......" | 23493348 | qPCR |
hsa-miR-29b-3p | bladder cancer | deregulation | "Fresh normal 5 samples and BUC 30 samples tissues ......" | 21223810 | Reverse transcription PCR; Microarray |
hsa-miR-29b-3p | breast cancer | downregulation | "Here we aimed to identify the mRNAs targeted by mi ......" | 22864815 | Microarray |
hsa-miR-29b-3p | breast cancer | downregulation | "miR 29b is an indicator of prognosis in breast can ......" | 26171207 | |
hsa-miR-29b-3p | colon cancer | downregulation | "To present proof-of-principle application for empl ......" | 23741026 | qPCR; Microarray |
hsa-miR-29b-3p | colorectal cancer | downregulation | "Recently the role of miR-29b in colorectal carcino ......" | 25032858 | |
hsa-miR-29b-3p | colorectal cancer | upregulation | "The aim of this study was to detect the expression ......" | 27346400 | qPCR |
hsa-miR-29b-3p | esophageal cancer | deregulation | "Our results indicated that MiR-29b expression was ......" | 25866219 | |
hsa-miR-29b-3p | glioblastoma | deregulation | "A number of changes in the levels of microRNAs wer ......" | 24155920 | |
hsa-miR-29b-3p | liver cancer | downregulation | "Based on microarray data we have previously shown ......" | 20041405 | Microarray; Northern blot; Reverse transcription PCR |
hsa-miR-29b-3p | liver cancer | downregulation | "Modulation of miR 29 expression by α fetoprotein ......" | 24798303 | Microarray |
hsa-miR-29b-3p | lung cancer | downregulation | "miR-29b was significantly downregulated in primary ......" | 22249264 | |
hsa-miR-29b-3p | lung squamous cell cancer | deregulation | "Furthermore miR-29 overexpression downregulated β ......" | 23939044 | |
hsa-miR-29b-3p | lymphoma | downregulation | "Notably expression levels of miR-29 family are ass ......" | 20086245 | |
hsa-miR-29b-3p | lymphoma | upregulation | "The up-regulation of miR-155 miR-27b miR-30c and m ......" | 22776000 | Microarray |
hsa-miR-29b-3p | ovarian cancer | downregulation | "miR 29b expression is associated with disease free ......" | 19509563 | |
hsa-miR-29b-3p | prostate cancer | downregulation | "We also observed a significant downregulation of m ......" | 22402125 | |
hsa-miR-29b-3p | prostate cancer | upregulation | "Loss of 18 miRNAs e.g.miR-34c miR-29b miR-212 and ......" | 23781281 | |
hsa-miR-29b-3p | sarcoma | downregulation | "The signature includes high expression of miR-181a ......" | 22350417 | |
hsa-miR-29b-3p | sarcoma | upregulation | "Furthermore the upregulated miRNAs included miR-9/ ......" | 23133552 | |
hsa-miR-29b-3p | sarcoma | upregulation | "Previous studies have reported the antineoplastic ......" | 25337211 | |
hsa-miR-29b-3p | sarcoma | downregulation | "In this study the expression levels of miRNAs were ......" | 26423405 | qPCR |
Reported cancer pathway affected by hsa-miR-29b-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-29b-3p | acute myeloid leukemia | Apoptosis pathway; cell cycle pathway | "We have previously shown that miR-29b expression i ......" | 19850741 | |
hsa-miR-29b-3p | acute myeloid leukemia | Apoptosis pathway | "Previous studies showed that miR-29a and miR-29b c ......" | 24076586 | |
hsa-miR-29b-3p | breast cancer | Apoptosis pathway | "miR 29b regulates migration of human breast cancer ......" | 21359530 | Cell migration assay; Western blot |
hsa-miR-29b-3p | breast cancer | Apoptosis pathway | "Special suppressive role of miR 29b in HER2 positi ......" | 26175849 | |
hsa-miR-29b-3p | colorectal cancer | Wnt signaling pathway | "MiR 29b downregulates canonical Wnt signaling by s ......" | 24913975 | Western blot |
hsa-miR-29b-3p | colorectal cancer | Epithelial mesenchymal transition pathway | "miR 29b suppresses tumor growth and metastasis in ......" | 25032858 | |
hsa-miR-29b-3p | colorectal cancer | Apoptosis pathway; cell cycle pathway | "Recent studies have suggested that microRNA-29 miR ......" | 25472644 | Western blot; Flow cytometry |
hsa-miR-29b-3p | colorectal cancer | PI3K/Akt signaling pathway; Apoptosis pathway | "To investigate the clinicopathological significanc ......" | 25592039 | Luciferase |
hsa-miR-29b-3p | glioblastoma | Apoptosis pathway | "miR 29b and miR 125a regulate podoplanin and suppr ......" | 20665731 | |
hsa-miR-29b-3p | glioblastoma | Apoptosis pathway | "Using this in vitro system a microarray-based high ......" | 24155920 | |
hsa-miR-29b-3p | liver cancer | Apoptosis pathway | "Based on microarray data we have previously shown ......" | 20041405 | |
hsa-miR-29b-3p | lung squamous cell cancer | Wnt signaling pathway; Apoptosis pathway | "Suppression of Wnt signaling by the miR 29 family ......" | 23939044 | Western blot |
hsa-miR-29b-3p | lung squamous cell cancer | Apoptosis pathway | "miR 29b Mediates NF κB Signaling in KRAS Induced ......" | 27199349 | |
hsa-miR-29b-3p | ovarian cancer | Apoptosis pathway | "Anticancer role of MUC1 aptamer miR 29b chimera in ......" | 23179556 | |
hsa-miR-29b-3p | ovarian cancer | Epithelial mesenchymal transition pathway | "Id 1 a protein repressed by miR 29b facilitates th ......" | 24662327 | Western blot; Luciferase |
hsa-miR-29b-3p | retinoblastoma | cell cycle pathway | "To investigate differential expression of microRNA ......" | 21941147 | |
hsa-miR-29b-3p | sarcoma | cell cycle pathway | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 | |
hsa-miR-29b-3p | sarcoma | Apoptosis pathway | "MicroRNA 29b 1 impairs in vitro cell proliferation ......" | 25174983 | Western blot |
hsa-miR-29b-3p | sarcoma | Apoptosis pathway | "Previous studies have reported the antineoplastic ......" | 25337211 | |
hsa-miR-29b-3p | sarcoma | cell cycle pathway | "c Myc Represses Tumor Suppressive microRNAs let 7a ......" | 26393798 |
Reported cancer prognosis affected by hsa-miR-29b-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-29b-3p | acute myeloid leukemia | drug resistance | "We have previously shown that miR-29b expression i ......" | 19850741 | |
hsa-miR-29b-3p | acute myeloid leukemia | drug resistance | "Therefore an increase in miR-29b expression preced ......" | 23178755 | |
hsa-miR-29b-3p | acute myeloid leukemia | drug resistance; poor survival | "miR-29b directly or indirectly targets genes invol ......" | 23493348 | Flow cytometry; Colony formation |
hsa-miR-29b-3p | acute myeloid leukemia | differentiation | "Previous studies showed that miR-29a and miR-29b c ......" | 24076586 | |
hsa-miR-29b-3p | acute myeloid leukemia | drug resistance | "microRNA-29 miR-29 family of non-coding small RNAs ......" | 26862847 | |
hsa-miR-29b-3p | breast cancer | poor survival | "To investigate the global expression profile of mi ......" | 18812439 | |
hsa-miR-29b-3p | breast cancer | cell migration | "miR 29b regulates migration of human breast cancer ......" | 21359530 | Cell migration assay; Western blot |
hsa-miR-29b-3p | breast cancer | differentiation; drug resistance | "Progestin suppression of miR 29 potentiates dediff ......" | 22751119 | |
hsa-miR-29b-3p | breast cancer | tumorigenesis | "The inhibitory role of Mir 29 in growth of breast ......" | 24289849 | |
hsa-miR-29b-3p | breast cancer | metastasis | "The expression of miRNAs in patients with primary ......" | 24846313 | |
hsa-miR-29b-3p | breast cancer | progression | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 | Western blot; Luciferase |
hsa-miR-29b-3p | breast cancer | worse prognosis; tumorigenesis; poor survival; metastasis; recurrence | "miR 29b is an indicator of prognosis in breast can ......" | 26171207 | |
hsa-miR-29b-3p | breast cancer | malignant trasformation | "Special suppressive role of miR 29b in HER2 positi ......" | 26175849 | |
hsa-miR-29b-3p | colon cancer | staging | "To present proof-of-principle application for empl ......" | 23741026 | |
hsa-miR-29b-3p | colon cancer | staging | "The associations of expressions of tissue and plas ......" | 26466603 | |
hsa-miR-29b-3p | colorectal cancer | metastasis; staging; progression | "miR 29b suppresses tumor growth and metastasis in ......" | 25032858 | |
hsa-miR-29b-3p | colorectal cancer | differentiation; poor survival; metastasis | "Recent studies have suggested that microRNA-29 miR ......" | 25472644 | Western blot; Flow cytometry |
hsa-miR-29b-3p | colorectal cancer | metastasis | "To investigate the clinicopathological significanc ......" | 25592039 | Luciferase |
hsa-miR-29b-3p | colorectal cancer | progression | "Downloading from GEO Gene Expression Omnibus datab ......" | 25755742 | |
hsa-miR-29b-3p | colorectal cancer | worse prognosis | "Circulating levels of the miRNAs miR 194 and miR 2 ......" | 26318304 | |
hsa-miR-29b-3p | colorectal cancer | worse prognosis; metastasis; staging; malignant trasformation; progression | "The aim of this study was to detect the expression ......" | 27346400 | |
hsa-miR-29b-3p | esophageal cancer | progression | "miR 29b inhibits the progression of esophageal squ ......" | 25866219 | Transwell assay; Western blot |
hsa-miR-29b-3p | gastric cancer | metastasis | "The de-regulation of the miR-29 family and DNA met ......" | 25874772 | Transwell assay; Luciferase |
hsa-miR-29b-3p | gastric cancer | drug resistance | "miR 29b Reduces Cisplatin Resistance of Gastric Ca ......" | 26564501 | Western blot |
hsa-miR-29b-3p | gastric cancer | metastasis | "RUNX3 mediated up regulation of miR 29b suppresses ......" | 27497248 | |
hsa-miR-29b-3p | glioblastoma | differentiation | "Using this in vitro system a microarray-based high ......" | 24155920 | |
hsa-miR-29b-3p | glioblastoma | cell migration | "miR 29b attenuates tumorigenicity and stemness mai ......" | 26155940 | |
hsa-miR-29b-3p | glioblastoma | poor survival | "Feedback Loop Regulation of SCAP/SREBP 1 by miR 29 ......" | 27477273 | |
hsa-miR-29b-3p | kidney renal cell cancer | poor survival | "miR 29b and miR 198 overexpression in CD8+ T cells ......" | 27063186 | |
hsa-miR-29b-3p | liver cancer | malignant trasformation; tumorigenesis; poor survival; worse prognosis | "Based on microarray data we have previously shown ......" | 20041405 | |
hsa-miR-29b-3p | liver cancer | malignant trasformation | "Microarray analysis of >23000 lncRNAs revealed dow ......" | 21625215 | |
hsa-miR-29b-3p | liver cancer | worse prognosis | "Modulation of miR 29 expression by α fetoprotein ......" | 24798303 | |
hsa-miR-29b-3p | liver cancer | metastasis; progression; tumorigenesis | "Negative feedback of miR 29 family TET1 involves i ......" | 25367851 | |
hsa-miR-29b-3p | liver cancer | metastasis; progression; tumorigenesis | "Erratum to: Negative feedback of miR 29 family TET ......" | 25616722 | |
hsa-miR-29b-3p | lung cancer | worse prognosis | "Among the reported down-regulated miRNAs in lung c ......" | 17890317 | |
hsa-miR-29b-3p | lung cancer | recurrence; staging | "miRNA screening was done using qRT-PCR based low-d ......" | 23410826 | |
hsa-miR-29b-3p | lung cancer | progression | "MicroRNA-29b miR-29b expression has been shown to ......" | 23591808 | |
hsa-miR-29b-3p | lung cancer | metastasis | "MicroRNA microarrays were performed on 26 primary ......" | 24778034 | |
hsa-miR-29b-3p | lung squamous cell cancer | metastasis; progression; poor survival | "The dual role of the microRNA-29 miR-29 family in ......" | 24909176 | Colony formation |
hsa-miR-29b-3p | lung squamous cell cancer | metastasis; motility | "Our pilot study using miRNA PCR array found that m ......" | 26063204 | Transwell assay; Western blot; Luciferase |
hsa-miR-29b-3p | lung squamous cell cancer | drug resistance | "miR 29b Mediates NF κB Signaling in KRAS Induced ......" | 27199349 | |
hsa-miR-29b-3p | lung squamous cell cancer | tumorigenesis | "Expression analysis of three miRNAs miR 26a miR 29 ......" | 27447710 | |
hsa-miR-29b-3p | lymphoma | worse prognosis; poor survival | "microRNA expression profile and identification of ......" | 20086245 | |
hsa-miR-29b-3p | lymphoma | staging | "The miRNA expression profiles of skin biopsies fro ......" | 22776000 | |
hsa-miR-29b-3p | melanoma | staging; metastasis | "We hypothesized that the expression level of miR-2 ......" | 21081840 | |
hsa-miR-29b-3p | ovarian cancer | poor survival | "miR 29b expression is associated with disease free ......" | 19509563 | |
hsa-miR-29b-3p | ovarian cancer | drug resistance | "Downregulation of miR 29 contributes to cisplatin ......" | 23904094 | |
hsa-miR-29b-3p | ovarian cancer | poor survival; staging; progression | "Involvement of miR 29b signaling in the sensitivit ......" | 24767251 | |
hsa-miR-29b-3p | ovarian cancer | drug resistance; progression; poor survival | "BAG3 upregulates Mcl 1 through downregulation of m ......" | 24992675 | |
hsa-miR-29b-3p | ovarian cancer | progression | "MicroRNA 29B mir 29b regulates the Warburg effect ......" | 26512921 | Luciferase |
hsa-miR-29b-3p | pancreatic cancer | progression; tumorigenesis | "The microRNA miR 29 family has been studied extens ......" | 26356262 | |
hsa-miR-29b-3p | prostate cancer | metastasis | "MBP 1 upregulates miR 29b that represses Mcl 1 col ......" | 20657750 | |
hsa-miR-29b-3p | prostate cancer | metastasis | "Here we have shown that miRNA-29b miR-29b expressi ......" | 22402125 | |
hsa-miR-29b-3p | prostate cancer | metastasis | "Herein we aimed to investigate the functional sign ......" | 24820027 | Luciferase |
hsa-miR-29b-3p | sarcoma | differentiation | "NF kappaB YY1 miR 29 regulatory circuitry in skele ......" | 18977326 | |
hsa-miR-29b-3p | sarcoma | differentiation; tumorigenesis | "miR 29 acts as a decoy in sarcomas to protect the ......" | 23901138 | |
hsa-miR-29b-3p | sarcoma | progression; differentiation | "Therefore in this review we focus on the regulatio ......" | 24831881 | |
hsa-miR-29b-3p | sarcoma | progression; worse prognosis; metastasis; recurrence | "The aim of this study was to facilitate and deepen ......" | 25015394 | |
hsa-miR-29b-3p | sarcoma | drug resistance | "MicroRNA 29b 1 impairs in vitro cell proliferation ......" | 25174983 | Western blot |
hsa-miR-29b-3p | sarcoma | progression | "Previous studies have reported the antineoplastic ......" | 25337211 | |
hsa-miR-29b-3p | sarcoma | progression | "c Myc Represses Tumor Suppressive microRNAs let 7a ......" | 26393798 | |
hsa-miR-29b-3p | sarcoma | worse prognosis; staging; metastasis; tumor size; poor survival | "Tissue expression levels of miR 29b and miR 422a i ......" | 26423405 |
Reported gene related to hsa-miR-29b-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-29b-3p | bladder cancer | DNMT3A | "Mechanistically ATDC exerted its oncogenic effects ......" | 26471361 |
hsa-miR-29b-3p | breast cancer | DNMT3A | "In addition a significant inverse correlation was ......" | 26171207 |
hsa-miR-29b-3p | gastric cancer | DNMT3A | "The de-regulation of the miR-29 family and DNA met ......" | 25874772 |
hsa-miR-29b-3p | liver cancer | DNMT3A | "Consistent with miR-29's role in targeting DNA met ......" | 24798303 |
hsa-miR-29b-3p | lung cancer | DNMT3A | "Among the reported down-regulated miRNAs in lung c ......" | 17890317 |
hsa-miR-29b-3p | lung squamous cell cancer | DNMT3A | "The miR-29 family miR-29a -29b and -29c which nega ......" | 23939044 |
hsa-miR-29b-3p | lymphoma | DNMT3A | "DNMT3A and 3B genes can be regulated post-transcri ......" | 25746661 |
hsa-miR-29b-3p | ovarian cancer | DNMT3A | "The miR-29 family and predicted target genes were ......" | 22479643 |
hsa-miR-29b-3p | colorectal cancer | CDK6 | "Moreover miR-29b inhibited the expression of MCL1 ......" | 25472644 |
hsa-miR-29b-3p | glioblastoma | CDK6 | "Knockdown of NTSR1 increased the expression of miR ......" | 26180082 |
hsa-miR-29b-3p | lung cancer | CDK6 | "Here we have identified the oncogene cyclin-depend ......" | 23591808 |
hsa-miR-29b-3p | lymphoma | CDK6 | "microRNA expression profile and identification of ......" | 20086245 |
hsa-miR-29b-3p | melanoma | CDK6 | "The IFN-γ-induced G1-arrest of melanoma cells inv ......" | 23245396 |
hsa-miR-29b-3p | sarcoma | CDK6 | "MiR 29b suppresses the proliferation and migration ......" | 27230400 |
hsa-miR-29b-3p | acute myeloid leukemia | MCL1 | "A significant enrichment for apoptosis genes inclu ......" | 19850741 |
hsa-miR-29b-3p | colorectal cancer | MCL1 | "Moreover miR-29b inhibited the expression of MCL1 ......" | 25472644 |
hsa-miR-29b-3p | glioblastoma | MCL1 | "Finally miR-29a and miR-29b targeted MCL1 mRNA in ......" | 24155920 |
hsa-miR-29b-3p | kidney renal cell cancer | MCL1 | "miR 29b and miR 198 overexpression in CD8+ T cells ......" | 27063186 |
hsa-miR-29b-3p | liver cancer | MCL1 | "Subsequent investigation characterized two antiapo ......" | 20041405 |
hsa-miR-29b-3p | ovarian cancer | MCL1 | "BAG3 upregulates Mcl 1 through downregulation of m ......" | 24992675 |
hsa-miR-29b-3p | colon cancer | MMP2 | "Since miR-29b plays a role in regulating the migra ......" | 24130681 |
hsa-miR-29b-3p | esophageal cancer | MMP2 | "miR 29b inhibits the progression of esophageal squ ......" | 25866219 |
hsa-miR-29b-3p | gastric cancer | MMP2 | "We further demonstrated that miR-29 family acted a ......" | 24130168 |
hsa-miR-29b-3p | glioblastoma | MMP2 | "In this study we found that only miR-29b inhibited ......" | 26155940 |
hsa-miR-29b-3p | lung squamous cell cancer | MMP2 | "Furthermore the dual-luciferase reporter assay dem ......" | 26063204 |
hsa-miR-29b-3p | prostate cancer | MMP2 | "Further a novel target with potential implications ......" | 20657750 |
hsa-miR-29b-3p | acute myeloid leukemia | MYC | "Furthermore a feed-back loop comprising of c-Myc m ......" | 24076586 |
hsa-miR-29b-3p | glioblastoma | MYC | "The c-Myc binding sites in the miR-29b-1 and cycli ......" | 26180082 |
hsa-miR-29b-3p | lung cancer | MYC | "In agreement we showed direct recruitment of c-Myc ......" | 22249264 |
hsa-miR-29b-3p | lung squamous cell cancer | MYC | "Mechanistic studies presented herein demonstrated ......" | 24909176 |
hsa-miR-29b-3p | bladder cancer | PTEN | "Mechanistically ATDC exerted its oncogenic effects ......" | 26471361 |
hsa-miR-29b-3p | breast cancer | PTEN | "In contrast enhanced miR-29b expression by transfe ......" | 21359530 |
hsa-miR-29b-3p | lung squamous cell cancer | PTEN | "Furthermore the dual-luciferase reporter assay dem ......" | 26063204 |
hsa-miR-29b-3p | ovarian cancer | PTEN | "Anticancer role of MUC1 aptamer miR 29b chimera in ......" | 23179556 |
hsa-miR-29b-3p | acute myeloid leukemia | AKT2 | "Furthermore a feed-back loop comprising of c-Myc m ......" | 24076586 |
hsa-miR-29b-3p | gastric cancer | AKT2 | "The expression of miR-29b was significantly upregu ......" | 26564501 |
hsa-miR-29b-3p | ovarian cancer | AKT2 | "MicroRNA 29B mir 29b regulates the Warburg effect ......" | 26512921 |
hsa-miR-29b-3p | liver cancer | DNMT3B | "The induction of miR-29b was accompanied with supp ......" | 26404322 |
hsa-miR-29b-3p | lung squamous cell cancer | DNMT3B | "The miR-29 family miR-29a -29b and -29c which nega ......" | 23939044 |
hsa-miR-29b-3p | ovarian cancer | DNMT3B | "The miR-29 family and predicted target genes were ......" | 22479643 |
hsa-miR-29b-3p | gastric cancer | CCND2 | "We further demonstrated that miR-29 family acted a ......" | 24130168 |
hsa-miR-29b-3p | sarcoma | CCND2 | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 |
hsa-miR-29b-3p | glioblastoma | EGFR | "Feedback Loop Regulation of SCAP/SREBP 1 by miR 29 ......" | 27477273 |
hsa-miR-29b-3p | lung squamous cell cancer | EGFR | "Cell biologic analyses showed that pharmacologic i ......" | 27199349 |
hsa-miR-29b-3p | lung cancer | ID1 | "Incubation of lung cancer cells with the Src inhib ......" | 22249264 |
hsa-miR-29b-3p | ovarian cancer | ID1 | "Id 1 a protein repressed by miR 29b facilitates th ......" | 24662327 |
hsa-miR-29b-3p | ovarian cancer | MUC1 | "Anticancer role of MUC1 aptamer miR 29b chimera in ......" | 23179556 |
hsa-miR-29b-3p | ovarian cancer | MUC1 | "The anti chemoresistant effect and mechanism of MU ......" | 23933187 |
hsa-miR-29b-3p | gastric cancer | SMAD3 | "We used qRT-PCR to confirm the miRNA microarray re ......" | 27497248 |
hsa-miR-29b-3p | pancreatic cancer | SMAD3 | "Furthermore the loss of miR-29 in TGF-β1 activate ......" | 26095125 |
hsa-miR-29b-3p | liver cancer | TET1 | "Negative feedback of miR 29 family TET1 involves i ......" | 25367851 |
hsa-miR-29b-3p | liver cancer | TET1 | "Erratum to: Negative feedback of miR 29 family TET ......" | 25616722 |
hsa-miR-29b-3p | glioblastoma | VEGFA | "Moreover miR-29b inhibits angiogenesis by attenuat ......" | 26155940 |
hsa-miR-29b-3p | prostate cancer | VEGFA | "Additionally for two genes that are deregulated in ......" | 22815235 |
hsa-miR-29b-3p | breast cancer | ADAM12 | "ADAM12 L is a direct target of the miR 29 and miR ......" | 25886595 |
hsa-miR-29b-3p | liver cancer | AFP | "Tumor biology differs considerably between AFP+ HC ......" | 24798303 |
hsa-miR-29b-3p | ovarian cancer | AKT3 | "MicroRNA 29B mir 29b regulates the Warburg effect ......" | 26512921 |
hsa-miR-29b-3p | glioblastoma | ANGPT2 | "Moreover miR-29b inhibits angiogenesis by attenuat ......" | 26155940 |
hsa-miR-29b-3p | colorectal cancer | ANXA5 | "An Annexin V apoptosis assay and flow cytometric a ......" | 25472644 |
hsa-miR-29b-3p | ovarian cancer | ATG9A | "miR-29b mRNA and ATG9A gene mRNA levels were measu ......" | 24767251 |
hsa-miR-29b-3p | breast cancer | ATP1B1 | "Many progestin-responsive genes are putative targe ......" | 22330642 |
hsa-miR-29b-3p | ovarian cancer | BAG3 | "BAG3 upregulates Mcl 1 through downregulation of m ......" | 24992675 |
hsa-miR-29b-3p | liver cancer | BCL2 | "Subsequent investigation characterized two antiapo ......" | 20041405 |
hsa-miR-29b-3p | glioblastoma | BCL2L2 | "miR 29b attenuates tumorigenicity and stemness mai ......" | 26155940 |
hsa-miR-29b-3p | colorectal cancer | BCL9L | "miR-29b targeted the 3'UTR of BCL9L and decreased ......" | 24913975 |
hsa-miR-29b-3p | ovarian cancer | CASP3 | "When combined with cisplatin treatment knockdown o ......" | 23904094 |
hsa-miR-29b-3p | ovarian cancer | CASP9 | "When combined with cisplatin treatment knockdown o ......" | 23904094 |
hsa-miR-29b-3p | prostate cancer | CDH1 | "Epithelial cell marker E-cadherin expression was e ......" | 22402125 |
hsa-miR-29b-3p | glioblastoma | CDK4 | "The c-Myc binding sites in the miR-29b-1 and cycli ......" | 26180082 |
hsa-miR-29b-3p | lung squamous cell cancer | CDKN2A | "Finally the association of p16 and miR-29b express ......" | 20978195 |
hsa-miR-29b-3p | ovarian cancer | DGCR14 | "Upregulation of miR-29b also reduced levels of Mcl ......" | 24992675 |
hsa-miR-29b-3p | ovarian cancer | DICER1 | "Dicer efficiently cleaved the Chi-29b chimera to r ......" | 23179556 |
hsa-miR-29b-3p | liver cancer | DNMT1 | "MiRNA-dependent regulation of MEG3 expression was ......" | 21625215 |
hsa-miR-29b-3p | sarcoma | E2F7 | "In addition to CCND2 miR-29 also targets E2F7 anot ......" | 22330340 |
hsa-miR-29b-3p | sarcoma | ELAVL1 | "miR 29 acts as a decoy in sarcomas to protect the ......" | 23901138 |
hsa-miR-29b-3p | breast cancer | ERBB2 | "Special suppressive role of miR 29b in HER2 positi ......" | 26175849 |
hsa-miR-29b-3p | breast cancer | ESR1 | "In the present study we show that S100A7 significa ......" | 25622979 |
hsa-miR-29b-3p | B cell lymphoma | EZH2 | "Combined inhibition of HDAC3 and EZH2 cooperativel ......" | 23079660 |
hsa-miR-29b-3p | lung squamous cell cancer | FHIT | "Interestingly the decrease in the expression of mi ......" | 24909176 |
hsa-miR-29b-3p | lung squamous cell cancer | FRTS1 | "Evidence for the role of miR-29 in tumor malignanc ......" | 24909176 |
hsa-miR-29b-3p | acute myeloid leukemia | GLI2 | "Overexpression of each miR-29 member in THP1 and N ......" | 24076586 |
hsa-miR-29b-3p | B cell lymphoma | HDAC3 | "Combined inhibition of HDAC3 and EZH2 cooperativel ......" | 23079660 |
hsa-miR-29b-3p | acute myeloid leukemia | HDAC9 | "Thus HDAC inhibition may increase miR-29b expressi ......" | 23178755 |
hsa-miR-29b-3p | ovarian cancer | HK2 | "A luciferase reporter assay confirmed the direct b ......" | 26512921 |
hsa-miR-29b-3p | prostate cancer | HNRNPK | "Additionally for two genes that are deregulated in ......" | 22815235 |
hsa-miR-29b-3p | colorectal cancer | IGF1 | "Luciferase reporter assays were conducted to deter ......" | 25592039 |
hsa-miR-29b-3p | colorectal cancer | IL6 | "IL6 Mediates Immune and Colorectal Cancer Cell Cro ......" | 26184038 |
hsa-miR-29b-3p | colorectal cancer | IRF1 | "Chromatin immunoprecipitation ChIP assays were emp ......" | 25592039 |
hsa-miR-29b-3p | kidney renal cell cancer | JAK3 | "miR 29b and miR 198 overexpression in CD8+ T cells ......" | 27063186 |
hsa-miR-29b-3p | gastric cancer | KDM2A | "RUNX3 mediated up regulation of miR 29b suppresses ......" | 27497248 |
hsa-miR-29b-3p | breast cancer | KLF4 | "Progestin suppression of miR 29 potentiates dediff ......" | 22751119 |
hsa-miR-29b-3p | lung squamous cell cancer | KRAS | "miR 29b Mediates NF κB Signaling in KRAS Induced ......" | 27199349 |
hsa-miR-29b-3p | colorectal cancer | MAP2K6 | "In addition miR-29b mediated the inhibition of epi ......" | 25032858 |
hsa-miR-29b-3p | ovarian cancer | MAPK10 | "The percentage of positive myeloid cell leukemia s ......" | 24767251 |
hsa-miR-29b-3p | liver cancer | MEG3 | "MiRNA-dependent regulation of MEG3 expression was ......" | 21625215 |
hsa-miR-29b-3p | pancreatic cancer | MMRN1 | "Loss of miR-29 is correlated with a significant in ......" | 26095125 |
hsa-miR-29b-3p | lung squamous cell cancer | NFASC | "miR 29b Mediates NF κB Signaling in KRAS Induced ......" | 27199349 |
hsa-miR-29b-3p | sarcoma | NFKB1 | "Results demonstrate that in myoblasts miR-29 is re ......" | 18977326 |
hsa-miR-29b-3p | breast cancer | NMI | "Luciferase reporter assays and western blot analys ......" | 25174825 |
hsa-miR-29b-3p | glioblastoma | NTSR1 | "Knockdown of NTSR1 increased the expression of miR ......" | 26180082 |
hsa-miR-29b-3p | glioblastoma | PDPN | "miR 29b and miR 125a regulate podoplanin and suppr ......" | 20665731 |
hsa-miR-29b-3p | ovarian cancer | PKM | "A luciferase reporter assay confirmed the direct b ......" | 26512921 |
hsa-miR-29b-3p | gastric cancer | RUNX3 | "RUNX3 mediated up regulation of miR 29b suppresses ......" | 27497248 |
hsa-miR-29b-3p | breast cancer | S100A7 | "miR 29b defines the pro /anti proliferative effect ......" | 25622979 |
hsa-miR-29b-3p | glioblastoma | SCAP | "Here we unraveled a link between miR-29 and the SC ......" | 27477273 |
hsa-miR-29b-3p | breast cancer | SLC10A4 | "We demonstrate that P4 rapidly downregulates miR-2 ......" | 22751119 |
hsa-miR-29b-3p | lung cancer | SRC | "Incubation of lung cancer cells with the Src inhib ......" | 22249264 |
hsa-miR-29b-3p | breast cancer | STAT3 | "Special suppressive role of miR 29b in HER2 positi ......" | 26175849 |
hsa-miR-29b-3p | colorectal cancer | TIAM1 | "miR 29b suppresses tumor growth and metastasis in ......" | 25032858 |
hsa-miR-29b-3p | lung squamous cell cancer | TNFAIP3 | "Accordingly overexpression of an miR-29b-refractor ......" | 27199349 |
hsa-miR-29b-3p | breast cancer | TP53 | "The distinct modulations of the NF-κB - miR-29b - ......" | 25622979 |
hsa-miR-29b-3p | melanoma | TRG | "We hypothesized that the expression level of miR-2 ......" | 21081840 |
hsa-miR-29b-3p | lung squamous cell cancer | WIF1 | "Suppression of Wnt signaling by the miR 29 family ......" | 23939044 |
hsa-miR-29b-3p | glioblastoma | YBX1 | "Furthermore we show that down-regulation of miR-29 ......" | 26240386 |
hsa-miR-29b-3p | sarcoma | YY1 | "Results demonstrate that in myoblasts miR-29 is re ......" | 18977326 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-29b-3p | BACE1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.238; TCGA BRCA -0.153; TCGA CESC -0.089; TCGA COAD -0.281; TCGA ESCA -0.251; TCGA HNSC -0.199; TCGA KIRC -0.062; TCGA KIRP -0.159; TCGA LIHC -0.074; TCGA LUAD -0.178; TCGA LUSC -0.101; TCGA PRAD -0.094; TCGA SARC -0.095; TCGA STAD -0.387 |
hsa-miR-29b-3p | BCL2 | 10 cancers: BLCA; COAD; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.297; TCGA COAD -0.27; TCGA KIRC -0.33; TCGA KIRP -0.388; TCGA LUAD -0.097; TCGA PAAD -0.214; TCGA PRAD -0.127; TCGA SARC -0.237; TCGA THCA -0.484; TCGA STAD -0.199 |
hsa-miR-29b-3p | CALU | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNAWalker2 validate; MirTarget | TCGA BLCA -0.166; TCGA BRCA -0.068; TCGA COAD -0.238; TCGA HNSC -0.215; TCGA KIRP -0.179; TCGA LGG -0.059; TCGA LUSC -0.13; TCGA OV -0.063; TCGA PAAD -0.445; TCGA PRAD -0.203; TCGA THCA -0.183; TCGA STAD -0.151; TCGA UCEC -0.067 |
hsa-miR-29b-3p | CDK6 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate; miRTarBase; miRNATAP; RAID | TCGA BLCA -0.224; TCGA BRCA -0.108; TCGA HNSC -0.231; TCGA KIRP -0.275; TCGA LGG -0.269; TCGA LUAD -0.178; TCGA LUSC -0.15; TCGA OV -0.139; TCGA PAAD -0.278; TCGA THCA -0.397 |
hsa-miR-29b-3p | COL1A1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.347; TCGA BRCA -0.425; TCGA CESC -0.232; TCGA COAD -0.677; TCGA ESCA -0.577; TCGA HNSC -0.694; TCGA KIRC -0.334; TCGA LGG -0.241; TCGA LUSC -0.29; TCGA PAAD -0.9 |
hsa-miR-29b-3p | COL3A1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.396; TCGA BRCA -0.501; TCGA CESC -0.311; TCGA COAD -0.783; TCGA ESCA -0.562; TCGA HNSC -0.662; TCGA KIRC -0.264; TCGA LGG -0.442; TCGA LUSC -0.239; TCGA PAAD -1.027; TCGA PRAD -0.237; TCGA SARC -0.298; TCGA STAD -0.299; TCGA UCEC -0.139 |
hsa-miR-29b-3p | COL4A1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.26; TCGA BRCA -0.11; TCGA CESC -0.163; TCGA COAD -0.37; TCGA ESCA -0.226; TCGA HNSC -0.393; TCGA KIRC -0.467; TCGA LGG -0.351; TCGA LUAD -0.17; TCGA LUSC -0.205; TCGA PAAD -0.478; TCGA PRAD -0.291; TCGA SARC -0.253; TCGA THCA -0.262; TCGA STAD -0.318; TCGA UCEC -0.129 |
hsa-miR-29b-3p | COL5A3 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; THCA | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.209; TCGA BRCA -0.348; TCGA COAD -0.329; TCGA ESCA -0.564; TCGA HNSC -0.427; TCGA KIRC -0.567; TCGA LUSC -0.345; TCGA PAAD -0.278; TCGA THCA -0.145 |
hsa-miR-29b-3p | HDAC4 | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.235; TCGA BRCA -0.142; TCGA CESC -0.094; TCGA ESCA -0.249; TCGA HNSC -0.137; TCGA KIRC -0.086; TCGA LGG -0.185; TCGA LUSC -0.096; TCGA OV -0.072; TCGA PRAD -0.176; TCGA SARC -0.206; TCGA THCA -0.306; TCGA STAD -0.339; TCGA UCEC -0.142 |
hsa-miR-29b-3p | HP1BP3 | 10 cancers: BLCA; CESC; KIRC; KIRP; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.1; TCGA CESC -0.077; TCGA KIRC -0.061; TCGA KIRP -0.118; TCGA PAAD -0.071; TCGA PRAD -0.064; TCGA SARC -0.064; TCGA THCA -0.06; TCGA STAD -0.094; TCGA UCEC -0.055 |
hsa-miR-29b-3p | KIAA1671 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; THCA | miRNAWalker2 validate | TCGA BLCA -0.209; TCGA CESC -0.115; TCGA ESCA -0.155; TCGA HNSC -0.168; TCGA KIRC -0.137; TCGA KIRP -0.176; TCGA LUAD -0.076; TCGA LUSC -0.147; TCGA PRAD -0.154; TCGA SARC -0.146; TCGA THCA -0.277 |
hsa-miR-29b-3p | MMP2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; PAAD; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BLCA -0.251; TCGA BRCA -0.457; TCGA CESC -0.191; TCGA COAD -0.806; TCGA ESCA -0.479; TCGA HNSC -0.422; TCGA KIRC -0.212; TCGA LGG -0.279; TCGA PAAD -1.115; TCGA STAD -0.199; TCGA UCEC -0.176 |
hsa-miR-29b-3p | NID1 | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; miRTarBase; MirTarget | TCGA BLCA -0.357; TCGA BRCA -0.354; TCGA CESC -0.309; TCGA COAD -0.374; TCGA HNSC -0.616; TCGA KIRC -0.457; TCGA LGG -0.426; TCGA LIHC -0.319; TCGA LUAD -0.216; TCGA LUSC -0.288; TCGA OV -0.143; TCGA PAAD -0.534; TCGA PRAD -0.379; TCGA SARC -0.355; TCGA THCA -0.156; TCGA STAD -0.371 |
hsa-miR-29b-3p | NNT | 9 cancers: BLCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.172; TCGA HNSC -0.136; TCGA KIRP -0.112; TCGA LUAD -0.101; TCGA LUSC -0.204; TCGA PRAD -0.36; TCGA SARC -0.123; TCGA THCA -0.444; TCGA STAD -0.108 |
hsa-miR-29b-3p | SMARCC1 | 14 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.103; TCGA CESC -0.14; TCGA HNSC -0.116; TCGA KIRP -0.101; TCGA LGG -0.242; TCGA LIHC -0.145; TCGA LUAD -0.074; TCGA LUSC -0.175; TCGA OV -0.084; TCGA PAAD -0.084; TCGA PRAD -0.158; TCGA SARC -0.151; TCGA THCA -0.068; TCGA UCEC -0.192 |
hsa-miR-29b-3p | SP1 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.072; TCGA HNSC -0.084; TCGA KIRC -0.074; TCGA KIRP -0.232; TCGA LGG -0.13; TCGA LIHC -0.119; TCGA LUSC -0.083; TCGA PAAD -0.131; TCGA PRAD -0.156; TCGA SARC -0.074 |
hsa-miR-29b-3p | TET1 | 19 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.262; TCGA BRCA -0.161; TCGA CESC -0.396; TCGA COAD -0.195; TCGA ESCA -0.375; TCGA HNSC -0.334; TCGA KIRC -0.292; TCGA KIRP -0.295; TCGA LGG -0.433; TCGA LIHC -0.714; TCGA LUAD -0.113; TCGA LUSC -0.381; TCGA OV -0.26; TCGA PAAD -0.225; TCGA PRAD -0.272; TCGA SARC -0.464; TCGA THCA -0.145; TCGA STAD -0.405; TCGA UCEC -0.381 |
hsa-miR-29b-3p | TGFB3 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; SARC; STAD | miRTarBase | TCGA BLCA -0.4; TCGA BRCA -0.301; TCGA COAD -0.778; TCGA ESCA -0.38; TCGA HNSC -0.233; TCGA KIRC -0.215; TCGA LUAD -0.068; TCGA PAAD -0.698; TCGA SARC -0.36; TCGA STAD -0.38 |
hsa-miR-29b-3p | COL4A2 | 17 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.247; TCGA BRCA -0.135; TCGA COAD -0.377; TCGA ESCA -0.277; TCGA HNSC -0.297; TCGA KIRC -0.384; TCGA KIRP -0.107; TCGA LGG -0.242; TCGA LUAD -0.162; TCGA LUSC -0.191; TCGA OV -0.075; TCGA PAAD -0.42; TCGA PRAD -0.249; TCGA SARC -0.243; TCGA THCA -0.271; TCGA STAD -0.374; TCGA UCEC -0.167 |
hsa-miR-29b-3p | TGFB2 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD | miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.232; TCGA BRCA -0.436; TCGA COAD -0.52; TCGA ESCA -0.265; TCGA HNSC -0.16; TCGA KIRC -0.289; TCGA KIRP -0.199; TCGA LUAD -0.323; TCGA OV -0.132; TCGA PAAD -0.524; TCGA PRAD -0.242; TCGA SARC -0.458; TCGA STAD -0.395 |
hsa-miR-29b-3p | GSK3B | 15 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | miRTarBase; miRNATAP | TCGA BLCA -0.09; TCGA CESC -0.079; TCGA ESCA -0.14; TCGA HNSC -0.156; TCGA KIRP -0.163; TCGA LGG -0.103; TCGA LIHC -0.107; TCGA LUAD -0.121; TCGA LUSC -0.157; TCGA OV -0.059; TCGA PAAD -0.099; TCGA PRAD -0.204; TCGA SARC -0.069; TCGA THCA -0.065; TCGA UCEC -0.056 |
hsa-miR-29b-3p | CEP68 | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.148; TCGA BRCA -0.112; TCGA CESC -0.106; TCGA ESCA -0.239; TCGA HNSC -0.063; TCGA KIRC -0.275; TCGA LGG -0.081; TCGA LUAD -0.059; TCGA LUSC -0.088; TCGA PAAD -0.104; TCGA PRAD -0.184; TCGA SARC -0.138; TCGA THCA -0.181; TCGA STAD -0.242; TCGA UCEC -0.08 |
hsa-miR-29b-3p | MLF1 | 10 cancers: BLCA; CESC; ESCA; KIRP; LUAD; LUSC; OV; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.132; TCGA CESC -0.228; TCGA ESCA -0.721; TCGA KIRP -0.179; TCGA LUAD -0.093; TCGA LUSC -0.127; TCGA OV -0.172; TCGA PRAD -0.119; TCGA THCA -0.164; TCGA STAD -0.555 |
hsa-miR-29b-3p | UBTD2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.139; TCGA BRCA -0.112; TCGA CESC -0.177; TCGA COAD -0.08; TCGA ESCA -0.086; TCGA HNSC -0.109; TCGA KIRP -0.093; TCGA LGG -0.173; TCGA LIHC -0.127; TCGA LUAD -0.105; TCGA LUSC -0.141; TCGA OV -0.111; TCGA PAAD -0.266; TCGA PRAD -0.136; TCGA SARC -0.177; TCGA THCA -0.141; TCGA UCEC -0.177 |
hsa-miR-29b-3p | MORF4L1 | 11 cancers: BLCA; CESC; COAD; ESCA; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.112; TCGA CESC -0.079; TCGA COAD -0.179; TCGA ESCA -0.072; TCGA LUAD -0.106; TCGA LUSC -0.057; TCGA OV -0.055; TCGA PAAD -0.166; TCGA PRAD -0.094; TCGA STAD -0.077; TCGA UCEC -0.06 |
hsa-miR-29b-3p | FOXJ2 | 12 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.152; TCGA ESCA -0.152; TCGA HNSC -0.188; TCGA KIRC -0.145; TCGA KIRP -0.096; TCGA LGG -0.09; TCGA LUAD -0.084; TCGA LUSC -0.124; TCGA PRAD -0.105; TCGA SARC -0.111; TCGA THCA -0.065; TCGA STAD -0.085 |
hsa-miR-29b-3p | AHNAK | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.209; TCGA BRCA -0.182; TCGA COAD -0.226; TCGA HNSC -0.309; TCGA KIRC -0.151; TCGA KIRP -0.296; TCGA LIHC -0.129; TCGA LUAD -0.177; TCGA PAAD -0.374; TCGA PRAD -0.283; TCGA STAD -0.295 |
hsa-miR-29b-3p | CDC42BPA | 9 cancers: BLCA; BRCA; HNSC; KIRC; LUSC; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.266; TCGA BRCA -0.082; TCGA HNSC -0.214; TCGA KIRC -0.171; TCGA LUSC -0.083; TCGA PRAD -0.183; TCGA SARC -0.26; TCGA THCA -0.103; TCGA STAD -0.177 |
hsa-miR-29b-3p | MLXIP | 9 cancers: BLCA; BRCA; HNSC; LGG; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.232; TCGA BRCA -0.096; TCGA HNSC -0.201; TCGA LGG -0.134; TCGA LUSC -0.078; TCGA PRAD -0.311; TCGA SARC -0.096; TCGA THCA -0.287; TCGA STAD -0.147 |
hsa-miR-29b-3p | ROBO1 | 17 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.384; TCGA BRCA -0.222; TCGA COAD -0.556; TCGA ESCA -0.389; TCGA HNSC -0.133; TCGA KIRC -0.354; TCGA KIRP -0.267; TCGA LGG -0.308; TCGA LUAD -0.193; TCGA LUSC -0.265; TCGA OV -0.129; TCGA PAAD -0.571; TCGA PRAD -0.365; TCGA SARC -0.199; TCGA THCA -0.129; TCGA STAD -0.348; TCGA UCEC -0.203 |
hsa-miR-29b-3p | CGGBP1 | 9 cancers: BLCA; CESC; KIRP; LGG; LIHC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.06; TCGA CESC -0.063; TCGA KIRP -0.11; TCGA LGG -0.066; TCGA LIHC -0.096; TCGA PAAD -0.073; TCGA PRAD -0.139; TCGA STAD -0.078; TCGA UCEC -0.089 |
hsa-miR-29b-3p | KLF11 | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.229; TCGA BRCA -0.125; TCGA CESC -0.145; TCGA COAD -0.085; TCGA HNSC -0.074; TCGA KIRC -0.128; TCGA KIRP -0.1; TCGA LIHC -0.13; TCGA LUAD -0.134; TCGA LUSC -0.148; TCGA OV -0.06; TCGA PRAD -0.199; TCGA SARC -0.128; TCGA THCA -0.146; TCGA STAD -0.259; TCGA UCEC -0.079 |
hsa-miR-29b-3p | FAM168B | 15 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.18; TCGA BRCA -0.081; TCGA CESC -0.11; TCGA ESCA -0.117; TCGA HNSC -0.105; TCGA LIHC -0.142; TCGA LUAD -0.07; TCGA LUSC -0.191; TCGA OV -0.086; TCGA PAAD -0.13; TCGA PRAD -0.19; TCGA SARC -0.179; TCGA THCA -0.141; TCGA STAD -0.228; TCGA UCEC -0.1 |
hsa-miR-29b-3p | PIK3R1 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.227; TCGA BRCA -0.213; TCGA CESC -0.229; TCGA HNSC -0.122; TCGA KIRP -0.201; TCGA LGG -0.146; TCGA LUAD -0.169; TCGA PAAD -0.302; TCGA PRAD -0.31; TCGA SARC -0.259; TCGA THCA -0.124; TCGA STAD -0.268 |
hsa-miR-29b-3p | RAB30 | 9 cancers: BLCA; COAD; HNSC; LGG; OV; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.181; TCGA COAD -0.308; TCGA HNSC -0.228; TCGA LGG -0.087; TCGA OV -0.084; TCGA PAAD -0.234; TCGA PRAD -0.421; TCGA SARC -0.188; TCGA THCA -0.186 |
hsa-miR-29b-3p | KIAA1644 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; OV; PAAD; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.629; TCGA BRCA -0.364; TCGA COAD -0.98; TCGA ESCA -0.47; TCGA HNSC -0.4; TCGA OV -0.177; TCGA PAAD -0.398; TCGA PRAD -0.501; TCGA THCA -0.314; TCGA STAD -0.689 |
hsa-miR-29b-3p | CRISPLD1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.516; TCGA BRCA -0.424; TCGA CESC -0.493; TCGA COAD -0.917; TCGA ESCA -0.73; TCGA HNSC -0.284; TCGA KIRC -0.271; TCGA LGG -0.23; TCGA LUAD -0.259; TCGA LUSC -0.29; TCGA OV -0.404; TCGA PAAD -0.714; TCGA PRAD -0.537; TCGA SARC -0.582; TCGA THCA -0.214; TCGA STAD -0.754; TCGA UCEC -0.382 |
hsa-miR-29b-3p | CYBRD1 | 9 cancers: BLCA; COAD; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.371; TCGA COAD -0.75; TCGA HNSC -0.337; TCGA LUAD -0.191; TCGA PAAD -0.66; TCGA PRAD -0.325; TCGA SARC -0.101; TCGA THCA -0.152; TCGA STAD -0.384 |
hsa-miR-29b-3p | WDFY1 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC | MirTarget; miRNATAP | TCGA BLCA -0.057; TCGA HNSC -0.073; TCGA KIRC -0.102; TCGA KIRP -0.142; TCGA LGG -0.069; TCGA LIHC -0.154; TCGA LUAD -0.07; TCGA PAAD -0.217; TCGA PRAD -0.273; TCGA SARC -0.072 |
hsa-miR-29b-3p | ISG20L2 | 10 cancers: BLCA; HNSC; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.077; TCGA HNSC -0.103; TCGA LGG -0.136; TCGA LIHC -0.149; TCGA LUSC -0.154; TCGA OV -0.061; TCGA PRAD -0.199; TCGA SARC -0.106; TCGA THCA -0.172; TCGA UCEC -0.075 |
hsa-miR-29b-3p | HBP1 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.114; TCGA COAD -0.087; TCGA ESCA -0.096; TCGA HNSC -0.1; TCGA KIRC -0.073; TCGA KIRP -0.094; TCGA LGG -0.056; TCGA LUAD -0.062; TCGA LUSC -0.056; TCGA PRAD -0.103; TCGA SARC -0.083; TCGA STAD -0.099 |
hsa-miR-29b-3p | MFAP3 | 17 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.101; TCGA BRCA -0.079; TCGA CESC -0.074; TCGA COAD -0.128; TCGA HNSC -0.158; TCGA KIRC -0.124; TCGA KIRP -0.18; TCGA LGG -0.098; TCGA LIHC -0.082; TCGA LUAD -0.108; TCGA LUSC -0.093; TCGA OV -0.051; TCGA PAAD -0.246; TCGA PRAD -0.196; TCGA SARC -0.101; TCGA THCA -0.178; TCGA STAD -0.057 |
hsa-miR-29b-3p | KDM5B | 16 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.089; TCGA CESC -0.166; TCGA COAD -0.124; TCGA ESCA -0.315; TCGA HNSC -0.268; TCGA KIRC -0.094; TCGA KIRP -0.128; TCGA LGG -0.233; TCGA LIHC -0.148; TCGA LUSC -0.232; TCGA OV -0.146; TCGA PAAD -0.166; TCGA PRAD -0.204; TCGA SARC -0.23; TCGA STAD -0.152; TCGA UCEC -0.216 |
hsa-miR-29b-3p | ZBTB10 | 15 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.227; TCGA BRCA -0.092; TCGA CESC -0.355; TCGA HNSC -0.331; TCGA KIRC -0.212; TCGA KIRP -0.203; TCGA LGG -0.237; TCGA LUAD -0.102; TCGA LUSC -0.123; TCGA PAAD -0.216; TCGA PRAD -0.26; TCGA SARC -0.325; TCGA THCA -0.228; TCGA STAD -0.482; TCGA UCEC -0.147 |
hsa-miR-29b-3p | COL6A3 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.376; TCGA BRCA -0.457; TCGA COAD -0.752; TCGA ESCA -0.449; TCGA HNSC -0.575; TCGA KIRC -0.216; TCGA LUSC -0.183; TCGA PAAD -1.002; TCGA PRAD -0.317; TCGA STAD -0.38 |
hsa-miR-29b-3p | STARD8 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.228; TCGA BRCA -0.238; TCGA COAD -0.488; TCGA HNSC -0.163; TCGA KIRC -0.37; TCGA LUAD -0.18; TCGA PAAD -0.267; TCGA PRAD -0.272; TCGA SARC -0.092; TCGA THCA -0.264; TCGA STAD -0.165 |
hsa-miR-29b-3p | FERMT2 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.471; TCGA BRCA -0.31; TCGA CESC -0.378; TCGA COAD -0.839; TCGA ESCA -0.305; TCGA HNSC -0.292; TCGA KIRC -0.198; TCGA KIRP -0.223; TCGA LGG -0.082; TCGA LUAD -0.25; TCGA OV -0.077; TCGA PAAD -0.53; TCGA PRAD -0.236; TCGA SARC -0.22; TCGA THCA -0.132; TCGA STAD -0.682; TCGA UCEC -0.132 |
hsa-miR-29b-3p | MAPKBP1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LIHC; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.111; TCGA BRCA -0.096; TCGA ESCA -0.39; TCGA HNSC -0.065; TCGA KIRC -0.142; TCGA LIHC -0.091; TCGA PRAD -0.099; TCGA SARC -0.176; TCGA STAD -0.179 |
hsa-miR-29b-3p | ELF2 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.103; TCGA CESC -0.134; TCGA COAD -0.064; TCGA HNSC -0.055; TCGA KIRC -0.111; TCGA KIRP -0.149; TCGA LGG -0.118; TCGA LUAD -0.055; TCGA LUSC -0.054; TCGA SARC -0.204; TCGA STAD -0.154 |
hsa-miR-29b-3p | MLLT11 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.199; TCGA CESC -0.394; TCGA COAD -0.473; TCGA ESCA -0.751; TCGA HNSC -0.283; TCGA LIHC -0.23; TCGA LUAD -0.145; TCGA LUSC -0.42; TCGA OV -0.311; TCGA PAAD -0.259; TCGA SARC -0.188; TCGA STAD -0.62; TCGA UCEC -0.369 |
hsa-miR-29b-3p | ZBTB5 | 14 cancers: BLCA; BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.062; TCGA BRCA -0.05; TCGA CESC -0.067; TCGA ESCA -0.157; TCGA KIRC -0.117; TCGA KIRP -0.196; TCGA LGG -0.216; TCGA LIHC -0.178; TCGA LUSC -0.138; TCGA OV -0.052; TCGA PRAD -0.079; TCGA SARC -0.181; TCGA THCA -0.16; TCGA UCEC -0.1 |
hsa-miR-29b-3p | VASH2 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.421; TCGA BRCA -0.264; TCGA CESC -0.471; TCGA COAD -0.253; TCGA HNSC -0.214; TCGA LGG -0.289; TCGA LUAD -0.186; TCGA LUSC -0.273; TCGA OV -0.263; TCGA PAAD -0.503; TCGA PRAD -0.275; TCGA SARC -0.486; TCGA STAD -0.262; TCGA UCEC -0.386 |
hsa-miR-29b-3p | CCDC117 | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.118; TCGA CESC -0.091; TCGA ESCA -0.095; TCGA HNSC -0.074; TCGA KIRP -0.124; TCGA LGG -0.111; TCGA LIHC -0.208; TCGA LUAD -0.065; TCGA LUSC -0.143; TCGA OV -0.062; TCGA PAAD -0.137; TCGA PRAD -0.072; TCGA SARC -0.078; TCGA THCA -0.148 |
hsa-miR-29b-3p | IREB2 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.151; TCGA BRCA -0.055; TCGA CESC -0.139; TCGA COAD -0.071; TCGA HNSC -0.133; TCGA KIRP -0.085; TCGA LGG -0.093; TCGA LIHC -0.15; TCGA LUAD -0.115; TCGA LUSC -0.117; TCGA PAAD -0.139; TCGA PRAD -0.274; TCGA SARC -0.164; TCGA THCA -0.173 |
hsa-miR-29b-3p | PARG | 10 cancers: BLCA; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.067; TCGA HNSC -0.061; TCGA KIRP -0.176; TCGA LGG -0.084; TCGA LIHC -0.155; TCGA LUSC -0.058; TCGA PRAD -0.216; TCGA SARC -0.072; TCGA THCA -0.081; TCGA UCEC -0.094 |
hsa-miR-29b-3p | PRICKLE2 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.295; TCGA BRCA -0.23; TCGA COAD -0.56; TCGA HNSC -0.135; TCGA KIRC -0.235; TCGA KIRP -0.198; TCGA LUAD -0.093; TCGA PAAD -0.385; TCGA PRAD -0.346; TCGA SARC -0.224; TCGA THCA -0.296; TCGA STAD -0.728; TCGA UCEC -0.151 |
hsa-miR-29b-3p | PPIC | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LIHC; PAAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.073; TCGA BRCA -0.186; TCGA COAD -0.147; TCGA ESCA -0.199; TCGA HNSC -0.095; TCGA KIRP -0.212; TCGA LIHC -0.185; TCGA PAAD -0.524; TCGA SARC -0.115; TCGA THCA -0.219 |
hsa-miR-29b-3p | STX17 | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.075; TCGA KIRC -0.071; TCGA KIRP -0.122; TCGA LGG -0.055; TCGA LIHC -0.094; TCGA PRAD -0.076; TCGA SARC -0.094; TCGA THCA -0.093; TCGA STAD -0.098 |
hsa-miR-29b-3p | PHF14 | 13 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.105; TCGA CESC -0.07; TCGA HNSC -0.055; TCGA KIRP -0.139; TCGA LIHC -0.053; TCGA LUAD -0.068; TCGA LUSC -0.161; TCGA OV -0.097; TCGA PAAD -0.073; TCGA PRAD -0.074; TCGA SARC -0.072; TCGA THCA -0.08; TCGA UCEC -0.114 |
hsa-miR-29b-3p | OSBPL11 | 11 cancers: BLCA; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.142; TCGA ESCA -0.147; TCGA HNSC -0.155; TCGA LGG -0.104; TCGA LUAD -0.172; TCGA LUSC -0.086; TCGA PAAD -0.187; TCGA PRAD -0.15; TCGA SARC -0.078; TCGA THCA -0.218; TCGA STAD -0.084 |
hsa-miR-29b-3p | ANKRD13B | 10 cancers: BLCA; ESCA; KIRC; KIRP; LGG; LUSC; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.163; TCGA ESCA -0.317; TCGA KIRC -0.174; TCGA KIRP -0.348; TCGA LGG -0.198; TCGA LUSC -0.262; TCGA OV -0.097; TCGA SARC -0.218; TCGA STAD -0.128; TCGA UCEC -0.176 |
hsa-miR-29b-3p | DBT | 11 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.098; TCGA CESC -0.127; TCGA COAD -0.062; TCGA HNSC -0.111; TCGA LUAD -0.11; TCGA LUSC -0.105; TCGA PAAD -0.159; TCGA PRAD -0.153; TCGA SARC -0.114; TCGA THCA -0.255; TCGA STAD -0.12 |
hsa-miR-29b-3p | NFIA | 11 cancers: BLCA; BRCA; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.318; TCGA BRCA -0.116; TCGA KIRC -0.237; TCGA KIRP -0.146; TCGA LUAD -0.123; TCGA PAAD -0.31; TCGA PRAD -0.072; TCGA SARC -0.307; TCGA THCA -0.137; TCGA STAD -0.339; TCGA UCEC -0.133 |
hsa-miR-29b-3p | SHPRH | 15 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.362; TCGA BRCA -0.138; TCGA CESC -0.35; TCGA HNSC -0.296; TCGA KIRC -0.227; TCGA KIRP -0.417; TCGA LGG -0.213; TCGA LIHC -0.255; TCGA LUAD -0.19; TCGA LUSC -0.21; TCGA OV -0.091; TCGA PRAD -0.448; TCGA SARC -0.355; TCGA THCA -0.424; TCGA STAD -0.167 |
hsa-miR-29b-3p | APPL1 | 14 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.1; TCGA CESC -0.15; TCGA HNSC -0.07; TCGA KIRP -0.138; TCGA LGG -0.078; TCGA LIHC -0.11; TCGA LUAD -0.101; TCGA LUSC -0.072; TCGA PAAD -0.088; TCGA PRAD -0.147; TCGA SARC -0.071; TCGA THCA -0.185; TCGA STAD -0.089; TCGA UCEC -0.07 |
hsa-miR-29b-3p | PCDH17 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; OV; PAAD; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.238; TCGA BRCA -0.118; TCGA COAD -0.444; TCGA HNSC -0.426; TCGA KIRC -0.582; TCGA LGG -0.109; TCGA LUAD -0.235; TCGA OV -0.132; TCGA PAAD -0.255; TCGA PRAD -0.317; TCGA THCA -0.213; TCGA STAD -0.189 |
hsa-miR-29b-3p | PMP22 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.185; TCGA BRCA -0.193; TCGA CESC -0.162; TCGA COAD -0.536; TCGA HNSC -0.212; TCGA KIRC -0.25; TCGA KIRP -0.313; TCGA LUAD -0.174; TCGA PAAD -0.572; TCGA PRAD -0.135; TCGA STAD -0.292 |
hsa-miR-29b-3p | TMTC3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.132; TCGA BRCA -0.124; TCGA CESC -0.149; TCGA COAD -0.146; TCGA ESCA -0.487; TCGA HNSC -0.22; TCGA KIRP -0.131; TCGA LIHC -0.106; TCGA LUAD -0.153; TCGA LUSC -0.229; TCGA OV -0.13; TCGA PAAD -0.221; TCGA PRAD -0.287; TCGA THCA -0.139; TCGA STAD -0.168; TCGA UCEC -0.09 |
hsa-miR-29b-3p | NAV1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.198; TCGA BRCA -0.093; TCGA CESC -0.158; TCGA COAD -0.369; TCGA ESCA -0.577; TCGA HNSC -0.275; TCGA KIRC -0.211; TCGA LGG -0.249; TCGA LUSC -0.241; TCGA OV -0.14; TCGA SARC -0.087; TCGA STAD -0.231; TCGA UCEC -0.245 |
hsa-miR-29b-3p | LANCL1 | 15 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.138; TCGA CESC -0.156; TCGA ESCA -0.199; TCGA HNSC -0.12; TCGA KIRP -0.098; TCGA LIHC -0.148; TCGA LUAD -0.128; TCGA LUSC -0.188; TCGA OV -0.085; TCGA PAAD -0.092; TCGA PRAD -0.197; TCGA SARC -0.195; TCGA THCA -0.11; TCGA STAD -0.131; TCGA UCEC -0.097 |
hsa-miR-29b-3p | ARRDC3 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; OV; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.172; TCGA BRCA -0.202; TCGA CESC -0.134; TCGA COAD -0.198; TCGA HNSC -0.144; TCGA LGG -0.101; TCGA OV -0.057; TCGA PRAD -0.341; TCGA SARC -0.171; TCGA STAD -0.25 |
hsa-miR-29b-3p | PCDHAC2 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; LUAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.231; TCGA CESC -0.718; TCGA COAD -0.312; TCGA HNSC -0.326; TCGA KIRC -0.41; TCGA LUAD -0.255; TCGA PRAD -0.452; TCGA SARC -0.615; TCGA STAD -0.502 |
hsa-miR-29b-3p | LRCH1 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.138; TCGA BRCA -0.134; TCGA CESC -0.083; TCGA HNSC -0.132; TCGA KIRC -0.082; TCGA KIRP -0.107; TCGA LUAD -0.157; TCGA PAAD -0.155; TCGA PRAD -0.267; TCGA SARC -0.085; TCGA THCA -0.097; TCGA STAD -0.158 |
hsa-miR-29b-3p | REST | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.314; TCGA BRCA -0.157; TCGA CESC -0.289; TCGA COAD -0.147; TCGA HNSC -0.492; TCGA KIRP -0.273; TCGA LUAD -0.177; TCGA LUSC -0.194; TCGA PAAD -0.533; TCGA PRAD -0.55; TCGA SARC -0.364; TCGA THCA -0.419 |
hsa-miR-29b-3p | CTDSPL2 | 16 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.149; TCGA CESC -0.206; TCGA COAD -0.12; TCGA HNSC -0.147; TCGA KIRC -0.113; TCGA KIRP -0.185; TCGA LGG -0.153; TCGA LIHC -0.227; TCGA LUAD -0.164; TCGA LUSC -0.175; TCGA PAAD -0.183; TCGA PRAD -0.277; TCGA SARC -0.192; TCGA THCA -0.13; TCGA STAD -0.133; TCGA UCEC -0.105 |
hsa-miR-29b-3p | DDX46 | 10 cancers: BLCA; CESC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.065; TCGA CESC -0.087; TCGA KIRP -0.064; TCGA LGG -0.119; TCGA LIHC -0.114; TCGA LUSC -0.071; TCGA PRAD -0.111; TCGA SARC -0.085; TCGA THCA -0.125; TCGA UCEC -0.059 |
hsa-miR-29b-3p | GNA13 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; THCA | MirTarget | TCGA BLCA -0.085; TCGA CESC -0.091; TCGA COAD -0.063; TCGA HNSC -0.133; TCGA KIRP -0.091; TCGA LGG -0.106; TCGA LIHC -0.06; TCGA LUAD -0.12; TCGA PAAD -0.143; TCGA PRAD -0.214; TCGA THCA -0.143 |
hsa-miR-29b-3p | PPARGC1A | 9 cancers: BLCA; BRCA; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.671; TCGA BRCA -0.259; TCGA KIRP -0.48; TCGA LUAD -0.188; TCGA OV -0.492; TCGA PRAD -0.386; TCGA SARC -0.428; TCGA THCA -1.059; TCGA STAD -0.431 |
hsa-miR-29b-3p | PPIP5K2 | 10 cancers: BLCA; CESC; KIRP; LGG; LIHC; LUAD; OV; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.062; TCGA CESC -0.112; TCGA KIRP -0.108; TCGA LGG -0.096; TCGA LIHC -0.11; TCGA LUAD -0.063; TCGA OV -0.052; TCGA PRAD -0.199; TCGA SARC -0.077; TCGA THCA -0.126 |
hsa-miR-29b-3p | PI15 | 9 cancers: BLCA; COAD; ESCA; HNSC; LIHC; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.484; TCGA COAD -0.728; TCGA ESCA -0.344; TCGA HNSC -0.241; TCGA LIHC -0.329; TCGA PAAD -0.425; TCGA PRAD -0.45; TCGA SARC -0.706; TCGA STAD -0.657 |
hsa-miR-29b-3p | RLF | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.135; TCGA BRCA -0.075; TCGA CESC -0.16; TCGA HNSC -0.142; TCGA KIRC -0.202; TCGA KIRP -0.171; TCGA LUAD -0.072; TCGA LUSC -0.13; TCGA PAAD -0.106; TCGA PRAD -0.174; TCGA SARC -0.093; TCGA THCA -0.097; TCGA STAD -0.118; TCGA UCEC -0.075 |
hsa-miR-29b-3p | DTWD2 | 10 cancers: BLCA; BRCA; CESC; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.155; TCGA BRCA -0.103; TCGA CESC -0.146; TCGA HNSC -0.186; TCGA LIHC -0.126; TCGA LUAD -0.082; TCGA PAAD -0.169; TCGA PRAD -0.323; TCGA SARC -0.145; TCGA THCA -0.387 |
hsa-miR-29b-3p | RFX7 | 12 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget | TCGA BLCA -0.068; TCGA CESC -0.124; TCGA ESCA -0.109; TCGA HNSC -0.143; TCGA LGG -0.266; TCGA LIHC -0.15; TCGA LUAD -0.074; TCGA LUSC -0.149; TCGA PAAD -0.083; TCGA PRAD -0.219; TCGA SARC -0.101; TCGA THCA -0.099 |
hsa-miR-29b-3p | MED12L | 9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.335; TCGA CESC -0.232; TCGA ESCA -1.04; TCGA HNSC -0.25; TCGA LUAD -0.214; TCGA LUSC -0.311; TCGA PRAD -0.432; TCGA SARC -0.314; TCGA STAD -0.465 |
hsa-miR-29b-3p | ATP2B4 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.291; TCGA BRCA -0.103; TCGA COAD -0.479; TCGA ESCA -0.328; TCGA HNSC -0.177; TCGA KIRP -0.222; TCGA LUSC -0.097; TCGA PAAD -0.181; TCGA PRAD -0.456; TCGA SARC -0.19; TCGA STAD -0.537; TCGA UCEC -0.107 |
hsa-miR-29b-3p | CHSY1 | 17 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.156; TCGA BRCA -0.117; TCGA CESC -0.115; TCGA COAD -0.21; TCGA HNSC -0.186; TCGA KIRC -0.199; TCGA KIRP -0.289; TCGA LGG -0.058; TCGA LUAD -0.153; TCGA LUSC -0.118; TCGA OV -0.079; TCGA PAAD -0.402; TCGA PRAD -0.142; TCGA SARC -0.082; TCGA THCA -0.084; TCGA STAD -0.132; TCGA UCEC -0.131 |
hsa-miR-29b-3p | REV3L | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.285; TCGA BRCA -0.068; TCGA CESC -0.267; TCGA COAD -0.122; TCGA HNSC -0.167; TCGA KIRC -0.172; TCGA KIRP -0.262; TCGA LGG -0.238; TCGA LUAD -0.171; TCGA LUSC -0.12; TCGA PAAD -0.161; TCGA PRAD -0.342; TCGA SARC -0.269; TCGA THCA -0.201; TCGA STAD -0.21; TCGA UCEC -0.163 |
hsa-miR-29b-3p | LAMC1 | 19 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.22; TCGA BRCA -0.26; TCGA CESC -0.125; TCGA COAD -0.29; TCGA ESCA -0.216; TCGA HNSC -0.29; TCGA KIRC -0.201; TCGA KIRP -0.247; TCGA LGG -0.147; TCGA LIHC -0.102; TCGA LUAD -0.145; TCGA LUSC -0.227; TCGA OV -0.104; TCGA PAAD -0.488; TCGA PRAD -0.344; TCGA SARC -0.153; TCGA THCA -0.089; TCGA STAD -0.46; TCGA UCEC -0.148 |
hsa-miR-29b-3p | ADAMTS10 | 9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; PAAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.164; TCGA BRCA -0.221; TCGA COAD -0.611; TCGA ESCA -0.214; TCGA KIRC -0.43; TCGA LGG -0.129; TCGA PAAD -0.294; TCGA SARC -0.366; TCGA STAD -0.325 |
hsa-miR-29b-3p | ISLR2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; OV; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.487; TCGA BRCA -0.361; TCGA CESC -0.345; TCGA COAD -0.627; TCGA ESCA -0.429; TCGA HNSC -0.28; TCGA OV -0.286; TCGA PAAD -0.409; TCGA SARC -0.323; TCGA STAD -0.454; TCGA UCEC -0.509 |
hsa-miR-29b-3p | YTHDF3 | 11 cancers: BLCA; COAD; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.062; TCGA COAD -0.07; TCGA HNSC -0.124; TCGA LGG -0.059; TCGA LUAD -0.063; TCGA PAAD -0.138; TCGA PRAD -0.16; TCGA SARC -0.052; TCGA THCA -0.111; TCGA STAD -0.056; TCGA UCEC -0.065 |
hsa-miR-29b-3p | ARPP19 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.104; TCGA CESC -0.115; TCGA COAD -0.071; TCGA ESCA -0.142; TCGA HNSC -0.104; TCGA KIRP -0.078; TCGA LUAD -0.106; TCGA LUSC -0.09; TCGA PAAD -0.08; TCGA PRAD -0.152; TCGA THCA -0.072; TCGA STAD -0.131 |
hsa-miR-29b-3p | COL5A2 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.312; TCGA BRCA -0.402; TCGA COAD -0.671; TCGA ESCA -0.483; TCGA HNSC -0.601; TCGA KIRC -0.352; TCGA LIHC -0.23; TCGA LUSC -0.324; TCGA PAAD -0.9; TCGA PRAD -0.152; TCGA SARC -0.213; TCGA THCA -0.208; TCGA STAD -0.241; TCGA UCEC -0.11 |
hsa-miR-29b-3p | HELZ | 12 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.125; TCGA CESC -0.078; TCGA HNSC -0.17; TCGA KIRC -0.089; TCGA KIRP -0.264; TCGA LGG -0.129; TCGA LIHC -0.221; TCGA LUSC -0.102; TCGA PRAD -0.232; TCGA SARC -0.15; TCGA THCA -0.203; TCGA STAD -0.101 |
hsa-miR-29b-3p | NOTCH2 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.181; TCGA BRCA -0.098; TCGA CESC -0.13; TCGA COAD -0.209; TCGA ESCA -0.19; TCGA HNSC -0.248; TCGA KIRP -0.304; TCGA LGG -0.1; TCGA LIHC -0.175; TCGA LUAD -0.098; TCGA LUSC -0.154; TCGA PAAD -0.544; TCGA PRAD -0.286; TCGA SARC -0.074; TCGA STAD -0.278 |
hsa-miR-29b-3p | NAP1L3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.6; TCGA BRCA -0.39; TCGA CESC -0.203; TCGA COAD -0.894; TCGA ESCA -0.327; TCGA HNSC -0.38; TCGA LUAD -0.166; TCGA LUSC -0.159; TCGA OV -0.227; TCGA PRAD -0.132; TCGA SARC -0.438; TCGA STAD -0.581; TCGA UCEC -0.222 |
hsa-miR-29b-3p | SH3PXD2A | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.156; TCGA BRCA -0.25; TCGA COAD -0.267; TCGA ESCA -0.364; TCGA HNSC -0.212; TCGA KIRC -0.305; TCGA LIHC -0.242; TCGA LUAD -0.061; TCGA LUSC -0.12; TCGA PAAD -0.455; TCGA PRAD -0.342; TCGA SARC -0.167; TCGA STAD -0.313 |
hsa-miR-29b-3p | LYSMD1 | 10 cancers: BLCA; CESC; ESCA; KIRP; LGG; LIHC; LUSC; OV; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.079; TCGA CESC -0.107; TCGA ESCA -0.157; TCGA KIRP -0.077; TCGA LGG -0.063; TCGA LIHC -0.198; TCGA LUSC -0.149; TCGA OV -0.093; TCGA SARC -0.195; TCGA STAD -0.133 |
hsa-miR-29b-3p | TMEM65 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.175; TCGA CESC -0.111; TCGA COAD -0.112; TCGA ESCA -0.266; TCGA HNSC -0.124; TCGA KIRP -0.128; TCGA LIHC -0.127; TCGA LUAD -0.103; TCGA PRAD -0.077; TCGA THCA -0.167; TCGA STAD -0.135; TCGA UCEC -0.168 |
hsa-miR-29b-3p | AKAP13 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; SARC | MirTarget; miRNATAP | TCGA BLCA -0.182; TCGA BRCA -0.123; TCGA CESC -0.139; TCGA COAD -0.209; TCGA HNSC -0.208; TCGA KIRC -0.18; TCGA KIRP -0.087; TCGA LGG -0.125; TCGA LUAD -0.066; TCGA PAAD -0.296; TCGA PRAD -0.209; TCGA SARC -0.089 |
hsa-miR-29b-3p | NAV2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.281; TCGA BRCA -0.164; TCGA CESC -0.277; TCGA COAD -0.104; TCGA ESCA -0.244; TCGA HNSC -0.139; TCGA KIRP -0.164; TCGA LGG -0.186; TCGA LUSC -0.192; TCGA PAAD -0.16; TCGA PRAD -0.391; TCGA SARC -0.154; TCGA STAD -0.367; TCGA UCEC -0.131 |
hsa-miR-29b-3p | PPM1D | 17 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.065; TCGA CESC -0.197; TCGA COAD -0.112; TCGA HNSC -0.085; TCGA KIRC -0.202; TCGA KIRP -0.175; TCGA LGG -0.175; TCGA LIHC -0.185; TCGA LUAD -0.185; TCGA LUSC -0.155; TCGA OV -0.098; TCGA PAAD -0.092; TCGA PRAD -0.181; TCGA SARC -0.204; TCGA THCA -0.166; TCGA UCEC -0.075 |
hsa-miR-29b-3p | BACH2 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.437; TCGA BRCA -0.353; TCGA CESC -0.344; TCGA COAD -0.667; TCGA HNSC -0.2; TCGA LGG -0.195; TCGA LUAD -0.241; TCGA OV -0.166; TCGA SARC -0.334; TCGA STAD -0.245; TCGA UCEC -0.201 |
hsa-miR-29b-3p | GAB1 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.15; TCGA BRCA -0.125; TCGA CESC -0.114; TCGA HNSC -0.203; TCGA KIRC -0.208; TCGA KIRP -0.151; TCGA LGG -0.13; TCGA LIHC -0.176; TCGA LUAD -0.199; TCGA PAAD -0.216; TCGA PRAD -0.269; TCGA SARC -0.286; TCGA STAD -0.301 |
hsa-miR-29b-3p | DPYSL3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.594; TCGA BRCA -0.422; TCGA CESC -0.51; TCGA COAD -0.849; TCGA ESCA -0.567; TCGA HNSC -0.193; TCGA LGG -0.258; TCGA LUAD -0.16; TCGA LUSC -0.147; TCGA PAAD -0.611; TCGA PRAD -0.265; TCGA SARC -0.145; TCGA STAD -0.781 |
hsa-miR-29b-3p | GPX7 | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.247; TCGA BRCA -0.207; TCGA CESC -0.266; TCGA COAD -0.465; TCGA ESCA -0.331; TCGA HNSC -0.19; TCGA KIRC -0.107; TCGA KIRP -0.356; TCGA LGG -0.097; TCGA LIHC -0.383; TCGA LUAD -0.14; TCGA LUSC -0.205; TCGA OV -0.251; TCGA PAAD -0.358; TCGA PRAD -0.266; TCGA SARC -0.193; TCGA STAD -0.247; TCGA UCEC -0.252 |
hsa-miR-29b-3p | ZNF704 | 15 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.436; TCGA BRCA -0.312; TCGA CESC -0.622; TCGA HNSC -0.42; TCGA KIRC -0.376; TCGA LGG -0.236; TCGA LIHC -0.157; TCGA LUAD -0.282; TCGA LUSC -0.302; TCGA PAAD -0.545; TCGA PRAD -0.473; TCGA SARC -0.664; TCGA THCA -0.474; TCGA STAD -0.499; TCGA UCEC -0.23 |
hsa-miR-29b-3p | CACNA1C | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; OV; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.558; TCGA BRCA -0.26; TCGA COAD -0.459; TCGA HNSC -0.392; TCGA KIRC -0.663; TCGA OV -0.185; TCGA PRAD -0.397; TCGA SARC -0.469; TCGA STAD -0.699 |
hsa-miR-29b-3p | BRWD3 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.184; TCGA BRCA -0.076; TCGA CESC -0.298; TCGA HNSC -0.297; TCGA KIRC -0.186; TCGA KIRP -0.165; TCGA LGG -0.359; TCGA LIHC -0.23; TCGA LUAD -0.075; TCGA LUSC -0.289; TCGA PAAD -0.195; TCGA PRAD -0.319; TCGA SARC -0.182; TCGA THCA -0.279 |
hsa-miR-29b-3p | DLG2 | 9 cancers: BLCA; BRCA; CESC; COAD; LUAD; OV; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.451; TCGA BRCA -0.276; TCGA CESC -0.491; TCGA COAD -0.953; TCGA LUAD -0.132; TCGA OV -0.145; TCGA SARC -0.677; TCGA THCA -1.015; TCGA STAD -0.866 |
hsa-miR-29b-3p | DAAM1 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.345; TCGA BRCA -0.15; TCGA CESC -0.193; TCGA COAD -0.211; TCGA ESCA -0.235; TCGA HNSC -0.272; TCGA KIRC -0.167; TCGA KIRP -0.173; TCGA LUAD -0.198; TCGA LUSC -0.146; TCGA PAAD -0.19; TCGA PRAD -0.423; TCGA SARC -0.258; TCGA THCA -0.373; TCGA STAD -0.247; TCGA UCEC -0.142 |
hsa-miR-29b-3p | CD93 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA BLCA -0.175; TCGA BRCA -0.223; TCGA COAD -0.477; TCGA HNSC -0.24; TCGA KIRC -0.491; TCGA LGG -0.252; TCGA LUAD -0.236; TCGA PAAD -0.425; TCGA PRAD -0.17; TCGA THCA -0.177; TCGA STAD -0.228 |
hsa-miR-29b-3p | SIRT1 | 13 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.164; TCGA CESC -0.138; TCGA HNSC -0.104; TCGA KIRC -0.113; TCGA KIRP -0.101; TCGA LGG -0.132; TCGA LIHC -0.096; TCGA LUAD -0.089; TCGA PRAD -0.217; TCGA SARC -0.15; TCGA THCA -0.053; TCGA STAD -0.122; TCGA UCEC -0.102 |
hsa-miR-29b-3p | STRN3 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.178; TCGA CESC -0.122; TCGA COAD -0.071; TCGA ESCA -0.136; TCGA HNSC -0.116; TCGA KIRP -0.096; TCGA PAAD -0.1; TCGA PRAD -0.178; TCGA SARC -0.125; TCGA THCA -0.117; TCGA STAD -0.185 |
hsa-miR-29b-3p | ELN | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.478; TCGA BRCA -0.602; TCGA CESC -0.584; TCGA COAD -0.767; TCGA HNSC -0.314; TCGA KIRC -0.54; TCGA LGG -0.201; TCGA LUAD -0.141; TCGA OV -0.279; TCGA PAAD -0.821; TCGA SARC -0.437; TCGA THCA -0.276; TCGA STAD -0.615; TCGA UCEC -0.315 |
hsa-miR-29b-3p | ADAMTS2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; THCA | MirTarget; miRNATAP | TCGA BLCA -0.38; TCGA BRCA -0.466; TCGA COAD -0.783; TCGA ESCA -0.345; TCGA HNSC -0.589; TCGA LUAD -0.163; TCGA LUSC -0.344; TCGA PAAD -0.48; TCGA PRAD -0.223; TCGA THCA -0.499 |
hsa-miR-29b-3p | PPM1E | 10 cancers: BLCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.185; TCGA KIRP -0.793; TCGA LGG -0.067; TCGA LIHC -0.443; TCGA LUAD -0.129; TCGA LUSC -0.185; TCGA OV -0.146; TCGA PRAD -0.19; TCGA SARC -0.421; TCGA STAD -0.368 |
hsa-miR-29b-3p | NLGN3 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.245; TCGA BRCA -0.253; TCGA CESC -0.161; TCGA COAD -0.275; TCGA KIRP -0.155; TCGA LGG -0.128; TCGA OV -0.112; TCGA PAAD -0.315; TCGA PRAD -0.304; TCGA SARC -0.466; TCGA STAD -0.321; TCGA UCEC -0.137 |
hsa-miR-29b-3p | ITGB1 | 15 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.11; TCGA BRCA -0.152; TCGA COAD -0.18; TCGA HNSC -0.135; TCGA KIRC -0.142; TCGA KIRP -0.121; TCGA LUAD -0.117; TCGA LUSC -0.1; TCGA OV -0.071; TCGA PAAD -0.4; TCGA PRAD -0.2; TCGA SARC -0.103; TCGA THCA -0.092; TCGA STAD -0.314; TCGA UCEC -0.102 |
hsa-miR-29b-3p | COMMD2 | 17 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.103; TCGA BRCA -0.054; TCGA CESC -0.15; TCGA ESCA -0.165; TCGA HNSC -0.065; TCGA KIRC -0.064; TCGA KIRP -0.256; TCGA LGG -0.144; TCGA LIHC -0.202; TCGA LUAD -0.166; TCGA LUSC -0.133; TCGA OV -0.124; TCGA PAAD -0.159; TCGA PRAD -0.132; TCGA SARC -0.075; TCGA THCA -0.08; TCGA UCEC -0.122 |
hsa-miR-29b-3p | ZNF518B | 13 cancers: BLCA; BRCA; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.175; TCGA BRCA -0.159; TCGA ESCA -0.444; TCGA HNSC -0.172; TCGA LUAD -0.124; TCGA LUSC -0.155; TCGA OV -0.161; TCGA PAAD -0.361; TCGA PRAD -0.309; TCGA SARC -0.407; TCGA THCA -0.224; TCGA STAD -0.324; TCGA UCEC -0.187 |
hsa-miR-29b-3p | USP37 | 13 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.133; TCGA CESC -0.201; TCGA HNSC -0.095; TCGA KIRC -0.125; TCGA KIRP -0.138; TCGA LGG -0.111; TCGA LIHC -0.274; TCGA LUAD -0.075; TCGA LUSC -0.132; TCGA OV -0.07; TCGA PRAD -0.186; TCGA SARC -0.154; TCGA UCEC -0.052 |
hsa-miR-29b-3p | SESTD1 | 15 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.267; TCGA CESC -0.225; TCGA COAD -0.119; TCGA HNSC -0.166; TCGA KIRC -0.184; TCGA KIRP -0.377; TCGA LUAD -0.117; TCGA LUSC -0.112; TCGA OV -0.093; TCGA PAAD -0.188; TCGA PRAD -0.214; TCGA SARC -0.261; TCGA THCA -0.166; TCGA STAD -0.275; TCGA UCEC -0.158 |
hsa-miR-29b-3p | DSC2 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD | MirTarget | TCGA BLCA -0.216; TCGA BRCA -0.223; TCGA ESCA -0.381; TCGA HNSC -0.325; TCGA KIRC -0.142; TCGA KIRP -0.284; TCGA LIHC -0.275; TCGA LUAD -0.115; TCGA LUSC -0.28; TCGA PAAD -0.303; TCGA PRAD -0.45 |
hsa-miR-29b-3p | TTC30B | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.092; TCGA CESC -0.193; TCGA ESCA -0.179; TCGA HNSC -0.172; TCGA KIRP -0.167; TCGA LIHC -0.139; TCGA LUAD -0.075; TCGA LUSC -0.202; TCGA OV -0.088; TCGA PAAD -0.129; TCGA PRAD -0.284; TCGA SARC -0.127; TCGA THCA -0.334; TCGA STAD -0.081 |
hsa-miR-29b-3p | RMND5A | 12 cancers: BLCA; CESC; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.171; TCGA CESC -0.145; TCGA HNSC -0.133; TCGA KIRC -0.144; TCGA LIHC -0.117; TCGA LUAD -0.141; TCGA LUSC -0.17; TCGA PRAD -0.17; TCGA SARC -0.149; TCGA THCA -0.119; TCGA STAD -0.138; TCGA UCEC -0.083 |
hsa-miR-29b-3p | NAV3 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.459; TCGA BRCA -0.261; TCGA CESC -0.353; TCGA COAD -0.74; TCGA ESCA -0.625; TCGA HNSC -0.346; TCGA LUAD -0.195; TCGA PAAD -0.534; TCGA THCA -0.227; TCGA STAD -0.654 |
hsa-miR-29b-3p | NUP160 | 16 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.108; TCGA BRCA -0.053; TCGA CESC -0.15; TCGA HNSC -0.164; TCGA KIRC -0.12; TCGA KIRP -0.217; TCGA LGG -0.239; TCGA LIHC -0.168; TCGA LUAD -0.155; TCGA LUSC -0.145; TCGA OV -0.074; TCGA PAAD -0.175; TCGA PRAD -0.25; TCGA SARC -0.132; TCGA THCA -0.107; TCGA UCEC -0.091 |
hsa-miR-29b-3p | SPAST | 12 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.085; TCGA CESC -0.135; TCGA ESCA -0.166; TCGA HNSC -0.099; TCGA LGG -0.081; TCGA LIHC -0.17; TCGA LUAD -0.068; TCGA LUSC -0.158; TCGA OV -0.142; TCGA PRAD -0.151; TCGA SARC -0.052; TCGA UCEC -0.146 |
hsa-miR-29b-3p | DIP2C | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.214; TCGA BRCA -0.172; TCGA CESC -0.19; TCGA COAD -0.437; TCGA HNSC -0.245; TCGA KIRC -0.301; TCGA KIRP -0.181; TCGA LUAD -0.069; TCGA LUSC -0.231; TCGA OV -0.077; TCGA PAAD -0.244; TCGA PRAD -0.197; TCGA SARC -0.181; TCGA THCA -0.438; TCGA STAD -0.421; TCGA UCEC -0.164 |
hsa-miR-29b-3p | RASAL2 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget | TCGA BLCA -0.129; TCGA BRCA -0.113; TCGA CESC -0.184; TCGA HNSC -0.193; TCGA KIRC -0.297; TCGA KIRP -0.295; TCGA LIHC -0.129; TCGA LUAD -0.111; TCGA LUSC -0.092; TCGA PAAD -0.29; TCGA SARC -0.105; TCGA STAD -0.128 |
hsa-miR-29b-3p | SPIN4 | 9 cancers: BLCA; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.12; TCGA KIRC -0.18; TCGA KIRP -0.173; TCGA LGG -0.097; TCGA LIHC -0.22; TCGA LUAD -0.18; TCGA PRAD -0.422; TCGA SARC -0.347; TCGA UCEC -0.091 |
hsa-miR-29b-3p | KIAA2022 | 9 cancers: BLCA; CESC; COAD; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.665; TCGA CESC -1.143; TCGA COAD -1.01; TCGA OV -0.287; TCGA PRAD -0.28; TCGA SARC -0.983; TCGA THCA -0.624; TCGA STAD -0.897; TCGA UCEC -0.333 |
hsa-miR-29b-3p | B3GNT5 | 11 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.096; TCGA BRCA -0.133; TCGA ESCA -0.333; TCGA HNSC -0.218; TCGA LIHC -0.215; TCGA LUAD -0.152; TCGA LUSC -0.144; TCGA OV -0.166; TCGA PAAD -0.289; TCGA PRAD -0.447; TCGA UCEC -0.176 |
hsa-miR-29b-3p | WISP1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.32; TCGA BRCA -0.288; TCGA COAD -0.787; TCGA ESCA -0.497; TCGA HNSC -0.436; TCGA KIRC -0.288; TCGA PAAD -0.88; TCGA PRAD -0.363; TCGA STAD -0.255 |
hsa-miR-29b-3p | TMEM169 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD | MirTarget; miRNATAP | TCGA BLCA -0.189; TCGA BRCA -0.114; TCGA CESC -0.186; TCGA COAD -0.445; TCGA HNSC -0.106; TCGA KIRP -0.618; TCGA LGG -0.198; TCGA LIHC -0.142; TCGA LUAD -0.137; TCGA LUSC -0.243; TCGA OV -0.155; TCGA PAAD -0.36; TCGA PRAD -0.258; TCGA STAD -0.216 |
hsa-miR-29b-3p | LIMS1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.236; TCGA BRCA -0.145; TCGA CESC -0.21; TCGA COAD -0.237; TCGA HNSC -0.444; TCGA LGG -0.161; TCGA LUAD -0.246; TCGA LUSC -0.125; TCGA PAAD -0.518; TCGA PRAD -0.437; TCGA SARC -0.142; TCGA THCA -0.492; TCGA STAD -0.119 |
hsa-miR-29b-3p | RNASEL | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRP; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.068; TCGA BRCA -0.065; TCGA COAD -0.135; TCGA HNSC -0.086; TCGA KIRP -0.131; TCGA PAAD -0.227; TCGA PRAD -0.145; TCGA SARC -0.138; TCGA STAD -0.094 |
hsa-miR-29b-3p | NSD1 | 11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.135; TCGA CESC -0.093; TCGA HNSC -0.127; TCGA KIRP -0.07; TCGA LGG -0.091; TCGA LIHC -0.134; TCGA LUSC -0.109; TCGA PAAD -0.081; TCGA PRAD -0.214; TCGA SARC -0.15; TCGA THCA -0.155 |
hsa-miR-29b-3p | RIT1 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.058; TCGA CESC -0.104; TCGA COAD -0.097; TCGA ESCA -0.212; TCGA HNSC -0.14; TCGA KIRC -0.221; TCGA KIRP -0.163; TCGA LGG -0.1; TCGA LIHC -0.1; TCGA LUSC -0.13; TCGA OV -0.059; TCGA PAAD -0.118; TCGA PRAD -0.095; TCGA SARC -0.081; TCGA STAD -0.131 |
hsa-miR-29b-3p | WASF1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.233; TCGA BRCA -0.186; TCGA CESC -0.204; TCGA COAD -0.267; TCGA ESCA -0.558; TCGA HNSC -0.107; TCGA KIRC -0.156; TCGA KIRP -0.126; TCGA LIHC -0.31; TCGA LUAD -0.109; TCGA LUSC -0.31; TCGA OV -0.24; TCGA PAAD -0.196; TCGA PRAD -0.12; TCGA SARC -0.142; TCGA STAD -0.6; TCGA UCEC -0.349 |
hsa-miR-29b-3p | RNF165 | 12 cancers: BLCA; BRCA; ESCA; KIRC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.45; TCGA BRCA -0.187; TCGA ESCA -0.836; TCGA KIRC -0.507; TCGA LGG -0.239; TCGA LUAD -0.148; TCGA LUSC -0.297; TCGA PRAD -0.46; TCGA SARC -0.751; TCGA THCA -0.295; TCGA STAD -0.728; TCGA UCEC -0.237 |
hsa-miR-29b-3p | JMY | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.229; TCGA BRCA -0.074; TCGA CESC -0.175; TCGA COAD -0.084; TCGA ESCA -0.191; TCGA HNSC -0.106; TCGA KIRP -0.157; TCGA LGG -0.078; TCGA PRAD -0.154; TCGA SARC -0.179; TCGA STAD -0.305 |
hsa-miR-29b-3p | GXYLT2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.598; TCGA BRCA -0.587; TCGA CESC -0.279; TCGA COAD -0.309; TCGA ESCA -0.64; TCGA HNSC -0.492; TCGA LUAD -0.212; TCGA LUSC -0.215; TCGA PAAD -0.815; TCGA PRAD -0.334; TCGA STAD -0.647; TCGA UCEC -0.131 |
hsa-miR-29b-3p | ZFP91 | 12 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.122; TCGA CESC -0.109; TCGA HNSC -0.146; TCGA KIRP -0.144; TCGA LGG -0.074; TCGA LIHC -0.084; TCGA LUAD -0.089; TCGA LUSC -0.077; TCGA PAAD -0.17; TCGA PRAD -0.214; TCGA SARC -0.057; TCGA THCA -0.143 |
hsa-miR-29b-3p | ZBTB41 | 9 cancers: BLCA; CESC; HNSC; KIRP; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.117; TCGA CESC -0.135; TCGA HNSC -0.207; TCGA KIRP -0.105; TCGA LUSC -0.15; TCGA PRAD -0.237; TCGA SARC -0.169; TCGA THCA -0.112; TCGA STAD -0.084 |
hsa-miR-29b-3p | HMCN1 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.364; TCGA BRCA -0.64; TCGA CESC -0.332; TCGA COAD -0.849; TCGA ESCA -0.562; TCGA HNSC -0.538; TCGA KIRC -0.513; TCGA LGG -0.304; TCGA LUAD -0.217; TCGA LUSC -0.276; TCGA OV -0.154; TCGA PAAD -0.91; TCGA PRAD -0.559; TCGA SARC -0.215; TCGA THCA -0.34; TCGA STAD -0.712; TCGA UCEC -0.224 |
hsa-miR-29b-3p | ASAP2 | 9 cancers: BLCA; CESC; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget | TCGA BLCA -0.112; TCGA CESC -0.094; TCGA HNSC -0.122; TCGA KIRC -0.233; TCGA LUAD -0.176; TCGA LUSC -0.117; TCGA PAAD -0.25; TCGA PRAD -0.19; TCGA UCEC -0.098 |
hsa-miR-29b-3p | SNX4 | 9 cancers: BLCA; CESC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.07; TCGA CESC -0.119; TCGA LIHC -0.064; TCGA LUAD -0.055; TCGA LUSC -0.058; TCGA OV -0.053; TCGA PRAD -0.108; TCGA SARC -0.055; TCGA THCA -0.224 |
hsa-miR-29b-3p | KCTD15 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.297; TCGA BRCA -0.18; TCGA COAD -0.428; TCGA ESCA -0.783; TCGA HNSC -0.101; TCGA KIRC -0.432; TCGA LGG -0.149; TCGA LUSC -0.19; TCGA OV -0.092; TCGA PRAD -0.067; TCGA SARC -0.475; TCGA THCA -0.325; TCGA STAD -0.45; TCGA UCEC -0.161 |
hsa-miR-29b-3p | PXDN | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.431; TCGA BRCA -0.309; TCGA CESC -0.343; TCGA COAD -0.586; TCGA ESCA -0.413; TCGA HNSC -0.451; TCGA KIRC -0.374; TCGA KIRP -0.39; TCGA LGG -0.469; TCGA LUAD -0.195; TCGA LUSC -0.318; TCGA OV -0.117; TCGA PAAD -0.563; TCGA PRAD -0.421; TCGA SARC -0.224; TCGA THCA -0.277; TCGA STAD -0.209; TCGA UCEC -0.202 |
hsa-miR-29b-3p | TRAK2 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.193; TCGA BRCA -0.092; TCGA CESC -0.145; TCGA COAD -0.118; TCGA HNSC -0.113; TCGA KIRC -0.09; TCGA KIRP -0.127; TCGA LIHC -0.092; TCGA LUAD -0.149; TCGA PAAD -0.229; TCGA PRAD -0.165; TCGA SARC -0.1; TCGA STAD -0.24 |
hsa-miR-29b-3p | ZHX3 | 9 cancers: BLCA; BRCA; CESC; HNSC; LUAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.228; TCGA BRCA -0.14; TCGA CESC -0.087; TCGA HNSC -0.185; TCGA LUAD -0.089; TCGA PRAD -0.129; TCGA SARC -0.147; TCGA THCA -0.329; TCGA STAD -0.314 |
hsa-miR-29b-3p | SCML2 | 10 cancers: BLCA; CESC; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.556; TCGA CESC -0.23; TCGA LGG -0.349; TCGA LIHC -0.449; TCGA LUAD -0.174; TCGA LUSC -0.273; TCGA OV -0.111; TCGA SARC -0.298; TCGA THCA -0.195; TCGA STAD -0.414 |
hsa-miR-29b-3p | ATAD2B | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.105; TCGA CESC -0.15; TCGA ESCA -0.091; TCGA HNSC -0.088; TCGA KIRC -0.077; TCGA KIRP -0.157; TCGA LGG -0.236; TCGA LIHC -0.169; TCGA LUSC -0.071; TCGA OV -0.067; TCGA PRAD -0.132; TCGA SARC -0.127; TCGA UCEC -0.104 |
hsa-miR-29b-3p | DCAF7 | 12 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.076; TCGA CESC -0.112; TCGA HNSC -0.106; TCGA KIRP -0.276; TCGA LGG -0.201; TCGA LIHC -0.151; TCGA LUAD -0.096; TCGA LUSC -0.124; TCGA PRAD -0.159; TCGA SARC -0.089; TCGA THCA -0.135; TCGA UCEC -0.063 |
hsa-miR-29b-3p | RND3 | 9 cancers: BLCA; BRCA; ESCA; KIRP; LUAD; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.103; TCGA BRCA -0.182; TCGA ESCA -0.289; TCGA KIRP -0.121; TCGA LUAD -0.168; TCGA PAAD -0.244; TCGA PRAD -0.218; TCGA STAD -0.116; TCGA UCEC -0.174 |
hsa-miR-29b-3p | PDGFRA | 9 cancers: BLCA; BRCA; COAD; HNSC; LGG; LUAD; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.201; TCGA BRCA -0.5; TCGA COAD -0.705; TCGA HNSC -0.309; TCGA LGG -0.479; TCGA LUAD -0.211; TCGA PAAD -0.811; TCGA PRAD -0.273; TCGA STAD -0.191 |
hsa-miR-29b-3p | CAND1 | 13 cancers: BLCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.103; TCGA CESC -0.066; TCGA ESCA -0.123; TCGA HNSC -0.111; TCGA LGG -0.054; TCGA LIHC -0.082; TCGA LUAD -0.09; TCGA LUSC -0.142; TCGA PAAD -0.109; TCGA PRAD -0.203; TCGA SARC -0.127; TCGA THCA -0.115; TCGA UCEC -0.066 |
hsa-miR-29b-3p | SPEN | 10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC | MirTarget; miRNATAP | TCGA BLCA -0.139; TCGA CESC -0.087; TCGA HNSC -0.163; TCGA KIRC -0.24; TCGA KIRP -0.2; TCGA LGG -0.107; TCGA LUAD -0.053; TCGA LUSC -0.071; TCGA PRAD -0.172; TCGA SARC -0.097 |
hsa-miR-29b-3p | FGD4 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUAD; PAAD; PRAD; THCA | MirTarget; miRNATAP | TCGA BLCA -0.075; TCGA BRCA -0.103; TCGA CESC -0.114; TCGA HNSC -0.14; TCGA KIRP -0.19; TCGA LUAD -0.129; TCGA PAAD -0.211; TCGA PRAD -0.102; TCGA THCA -0.223 |
hsa-miR-29b-3p | THBS2 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD | MirTarget | TCGA BLCA -0.207; TCGA BRCA -0.44; TCGA CESC -0.229; TCGA COAD -0.909; TCGA ESCA -0.626; TCGA HNSC -0.604; TCGA LUSC -0.23; TCGA PAAD -0.967; TCGA PRAD -0.235; TCGA STAD -0.502 |
hsa-miR-29b-3p | CD276 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.061; TCGA BRCA -0.159; TCGA COAD -0.175; TCGA ESCA -0.338; TCGA HNSC -0.155; TCGA KIRP -0.113; TCGA LGG -0.184; TCGA LIHC -0.183; TCGA LUSC -0.176; TCGA OV -0.077; TCGA PAAD -0.313; TCGA PRAD -0.187; TCGA UCEC -0.126 |
hsa-miR-29b-3p | KCTD20 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.194; TCGA BRCA -0.116; TCGA CESC -0.155; TCGA COAD -0.076; TCGA HNSC -0.193; TCGA KIRC -0.139; TCGA LGG -0.172; TCGA LUAD -0.144; TCGA LUSC -0.124; TCGA PAAD -0.365; TCGA PRAD -0.284; TCGA SARC -0.199; TCGA THCA -0.258; TCGA STAD -0.248 |
hsa-miR-29b-3p | TUBB2B | 12 cancers: BLCA; BRCA; CESC; COAD; KIRP; LGG; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.54; TCGA BRCA -0.605; TCGA CESC -0.473; TCGA COAD -0.604; TCGA KIRP -0.31; TCGA LGG -0.073; TCGA LUSC -0.461; TCGA OV -0.668; TCGA SARC -0.399; TCGA THCA -0.76; TCGA STAD -0.523; TCGA UCEC -0.301 |
hsa-miR-29b-3p | PER3 | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LIHC; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.391; TCGA BRCA -0.084; TCGA CESC -0.281; TCGA KIRC -0.416; TCGA KIRP -0.133; TCGA LIHC -0.19; TCGA PRAD -0.283; TCGA SARC -0.216; TCGA STAD -0.268 |
hsa-miR-29b-3p | METAP2 | 9 cancers: BLCA; ESCA; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC | MirTarget | TCGA BLCA -0.069; TCGA ESCA -0.146; TCGA LGG -0.093; TCGA LIHC -0.085; TCGA LUAD -0.112; TCGA LUSC -0.079; TCGA OV -0.059; TCGA PRAD -0.053; TCGA UCEC -0.068 |
hsa-miR-29b-3p | LEPROT | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.267; TCGA BRCA -0.165; TCGA COAD -0.287; TCGA HNSC -0.322; TCGA KIRP -0.259; TCGA LUAD -0.199; TCGA PAAD -0.461; TCGA PRAD -0.493; TCGA SARC -0.147; TCGA THCA -0.323; TCGA STAD -0.135 |
hsa-miR-29b-3p | ARMC8 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.063; TCGA CESC -0.067; TCGA ESCA -0.126; TCGA HNSC -0.059; TCGA KIRP -0.065; TCGA LUAD -0.078; TCGA LUSC -0.07; TCGA PAAD -0.064; TCGA PRAD -0.121; TCGA THCA -0.121; TCGA STAD -0.074 |
hsa-miR-29b-3p | GLIS2 | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; OV; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.255; TCGA BRCA -0.181; TCGA COAD -0.52; TCGA HNSC -0.255; TCGA KIRP -0.18; TCGA LGG -0.274; TCGA OV -0.088; TCGA PAAD -0.346; TCGA PRAD -0.152; TCGA SARC -0.093; TCGA STAD -0.338 |
hsa-miR-29b-3p | SLC16A1 | 10 cancers: BLCA; BRCA; HNSC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.319; TCGA BRCA -0.112; TCGA HNSC -0.158; TCGA LUAD -0.264; TCGA LUSC -0.162; TCGA OV -0.081; TCGA PAAD -0.324; TCGA SARC -0.103; TCGA THCA -0.223; TCGA UCEC -0.2 |
hsa-miR-29b-3p | AGPAT4 | 14 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.167; TCGA BRCA -0.339; TCGA COAD -0.577; TCGA ESCA -0.246; TCGA HNSC -0.114; TCGA KIRC -0.157; TCGA KIRP -0.363; TCGA LIHC -0.24; TCGA OV -0.154; TCGA PRAD -0.113; TCGA SARC -0.242; TCGA THCA -0.411; TCGA STAD -0.347; TCGA UCEC -0.203 |
hsa-miR-29b-3p | COL15A1 | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA BLCA -0.239; TCGA BRCA -0.235; TCGA COAD -0.517; TCGA HNSC -0.283; TCGA KIRC -0.496; TCGA LUAD -0.163; TCGA LUSC -0.208; TCGA PAAD -0.682; TCGA PRAD -0.278; TCGA SARC -0.177; TCGA THCA -0.175; TCGA STAD -0.269 |
hsa-miR-29b-3p | SH3RF3 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; OV; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA BLCA -0.189; TCGA BRCA -0.239; TCGA COAD -0.404; TCGA ESCA -0.345; TCGA HNSC -0.203; TCGA KIRC -0.278; TCGA LGG -0.1; TCGA LUAD -0.147; TCGA OV -0.106; TCGA PAAD -0.282; TCGA PRAD -0.258; TCGA SARC -0.134; TCGA STAD -0.419 |
hsa-miR-29b-3p | RNF138 | 10 cancers: BLCA; CESC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.106; TCGA CESC -0.098; TCGA KIRC -0.079; TCGA KIRP -0.121; TCGA LGG -0.141; TCGA LIHC -0.161; TCGA LUAD -0.087; TCGA LUSC -0.118; TCGA PRAD -0.155; TCGA UCEC -0.101 |
hsa-miR-29b-3p | NFATC3 | 10 cancers: BLCA; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.172; TCGA ESCA -0.093; TCGA HNSC -0.168; TCGA LGG -0.095; TCGA LUAD -0.113; TCGA LUSC -0.097; TCGA PAAD -0.128; TCGA PRAD -0.112; TCGA SARC -0.061; TCGA THCA -0.269 |
hsa-miR-29b-3p | LDOC1L | 18 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.286; TCGA BRCA -0.069; TCGA CESC -0.295; TCGA COAD -0.148; TCGA ESCA -0.125; TCGA HNSC -0.187; TCGA KIRC -0.108; TCGA KIRP -0.18; TCGA LGG -0.143; TCGA LUAD -0.105; TCGA LUSC -0.244; TCGA OV -0.08; TCGA PAAD -0.14; TCGA PRAD -0.245; TCGA SARC -0.159; TCGA THCA -0.236; TCGA STAD -0.15; TCGA UCEC -0.121 |
hsa-miR-29b-3p | SLC4A7 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.116; TCGA CESC -0.198; TCGA COAD -0.167; TCGA HNSC -0.181; TCGA KIRP -0.189; TCGA LGG -0.158; TCGA LUAD -0.06; TCGA LUSC -0.097; TCGA PAAD -0.348; TCGA PRAD -0.202; TCGA UCEC -0.11 |
hsa-miR-29b-3p | PIKFYVE | 11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.103; TCGA CESC -0.108; TCGA HNSC -0.135; TCGA KIRP -0.147; TCGA LGG -0.1; TCGA LIHC -0.099; TCGA LUSC -0.08; TCGA PRAD -0.299; TCGA SARC -0.127; TCGA THCA -0.15; TCGA STAD -0.112 |
hsa-miR-29b-3p | CREB5 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.291; TCGA BRCA -0.31; TCGA CESC -0.227; TCGA HNSC -0.21; TCGA KIRC -0.244; TCGA KIRP -0.695; TCGA LUAD -0.117; TCGA PAAD -0.427; TCGA STAD -0.389; TCGA UCEC -0.212 |
hsa-miR-29b-3p | STAG2 | 11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.134; TCGA CESC -0.114; TCGA HNSC -0.159; TCGA KIRP -0.153; TCGA LGG -0.17; TCGA LIHC -0.083; TCGA LUAD -0.104; TCGA LUSC -0.139; TCGA PRAD -0.212; TCGA SARC -0.148; TCGA THCA -0.084 |
hsa-miR-29b-3p | COL5A1 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.337; TCGA BRCA -0.385; TCGA COAD -0.59; TCGA ESCA -0.497; TCGA HNSC -0.601; TCGA KIRC -0.288; TCGA LUSC -0.272; TCGA PAAD -0.821; TCGA PRAD -0.167; TCGA STAD -0.259; TCGA UCEC -0.128 |
hsa-miR-29b-3p | MIER3 | 10 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; OV; PRAD; SARC; THCA | MirTarget; miRNATAP | TCGA BLCA -0.056; TCGA CESC -0.098; TCGA HNSC -0.071; TCGA KIRP -0.065; TCGA LGG -0.135; TCGA LIHC -0.075; TCGA OV -0.079; TCGA PRAD -0.219; TCGA SARC -0.187; TCGA THCA -0.057 |
hsa-miR-29b-3p | TSPAN9 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; OV; PAAD; SARC; STAD | mirMAP; miRNATAP | TCGA BLCA -0.073; TCGA BRCA -0.145; TCGA COAD -0.155; TCGA ESCA -0.443; TCGA HNSC -0.124; TCGA KIRC -0.173; TCGA LUAD -0.092; TCGA OV -0.09; TCGA PAAD -0.332; TCGA SARC -0.151; TCGA STAD -0.219 |
hsa-miR-29b-3p | USP13 | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.289; TCGA CESC -0.338; TCGA COAD -0.14; TCGA ESCA -0.202; TCGA HNSC -0.135; TCGA KIRC -0.144; TCGA LGG -0.143; TCGA LIHC -0.092; TCGA LUAD -0.144; TCGA LUSC -0.22; TCGA OV -0.072; TCGA PRAD -0.137; TCGA SARC -0.091; TCGA STAD -0.271; TCGA UCEC -0.134 |
hsa-miR-29b-3p | NTN1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.457; TCGA BRCA -0.109; TCGA CESC -0.258; TCGA COAD -0.666; TCGA ESCA -0.382; TCGA LGG -0.321; TCGA LUAD -0.198; TCGA LUSC -0.267; TCGA PRAD -0.402; TCGA SARC -0.54; TCGA THCA -0.505; TCGA STAD -0.654 |
hsa-miR-29b-3p | NDST1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.127; TCGA COAD -0.107; TCGA ESCA -0.326; TCGA HNSC -0.141; TCGA KIRC -0.257; TCGA LIHC -0.171; TCGA LUAD -0.185; TCGA LUSC -0.09; TCGA PRAD -0.147; TCGA THCA -0.221; TCGA STAD -0.175; TCGA UCEC -0.078 |
hsa-miR-29b-3p | ADAM11 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUSC; OV; SARC; STAD | mirMAP | TCGA BLCA -0.186; TCGA CESC -0.315; TCGA COAD -0.367; TCGA ESCA -0.364; TCGA KIRC -0.314; TCGA LIHC -0.46; TCGA LUSC -0.261; TCGA OV -0.272; TCGA SARC -0.311; TCGA STAD -0.418 |
hsa-miR-29b-3p | TNS1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.642; TCGA BRCA -0.328; TCGA COAD -0.84; TCGA ESCA -0.29; TCGA HNSC -0.284; TCGA KIRC -0.284; TCGA LIHC -0.153; TCGA LUAD -0.198; TCGA PAAD -0.504; TCGA PRAD -0.462; TCGA SARC -0.297; TCGA THCA -0.282; TCGA STAD -0.775 |
hsa-miR-29b-3p | OPHN1 | 12 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.199; TCGA CESC -0.213; TCGA HNSC -0.148; TCGA KIRP -0.172; TCGA LGG -0.333; TCGA LIHC -0.162; TCGA LUSC -0.198; TCGA PAAD -0.196; TCGA PRAD -0.19; TCGA SARC -0.302; TCGA THCA -0.346; TCGA STAD -0.182 |
hsa-miR-29b-3p | PITPNM3 | 9 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; PRAD; SARC; STAD | mirMAP; miRNATAP | TCGA BLCA -0.244; TCGA BRCA -0.12; TCGA ESCA -0.581; TCGA HNSC -0.113; TCGA KIRC -0.175; TCGA KIRP -0.175; TCGA PRAD -0.163; TCGA SARC -0.326; TCGA STAD -0.44 |
hsa-miR-29b-3p | YPEL1 | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; OV; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.119; TCGA BRCA -0.074; TCGA CESC -0.284; TCGA KIRC -0.227; TCGA KIRP -0.256; TCGA OV -0.063; TCGA SARC -0.252; TCGA STAD -0.115; TCGA UCEC -0.186 |
hsa-miR-29b-3p | MAPK1 | 12 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.095; TCGA CESC -0.1; TCGA HNSC -0.156; TCGA KIRC -0.093; TCGA KIRP -0.059; TCGA LUAD -0.122; TCGA LUSC -0.11; TCGA PAAD -0.113; TCGA PRAD -0.166; TCGA SARC -0.052; TCGA THCA -0.104; TCGA STAD -0.064 |
hsa-miR-29b-3p | PACSIN2 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.063; TCGA CESC -0.167; TCGA HNSC -0.136; TCGA KIRP -0.126; TCGA LGG -0.065; TCGA LUAD -0.051; TCGA PAAD -0.193; TCGA PRAD -0.204; TCGA SARC -0.072; TCGA THCA -0.302; TCGA STAD -0.056 |
hsa-miR-29b-3p | NCS1 | 10 cancers: BLCA; BRCA; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.204; TCGA BRCA -0.164; TCGA COAD -0.171; TCGA ESCA -0.687; TCGA LUSC -0.13; TCGA PAAD -0.182; TCGA PRAD -0.172; TCGA SARC -0.102; TCGA THCA -0.191; TCGA STAD -0.639 |
hsa-miR-29b-3p | CBL | 9 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LUAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.091; TCGA HNSC -0.165; TCGA KIRC -0.105; TCGA KIRP -0.112; TCGA LGG -0.098; TCGA LUAD -0.091; TCGA PRAD -0.176; TCGA THCA -0.094; TCGA STAD -0.143 |
hsa-miR-29b-3p | SOX6 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.286; TCGA BRCA -0.189; TCGA CESC -0.328; TCGA COAD -0.317; TCGA HNSC -0.314; TCGA KIRP -0.18; TCGA LGG -0.412; TCGA LUAD -0.161; TCGA LUSC -0.431; TCGA PAAD -0.478; TCGA PRAD -0.141; TCGA SARC -0.425; TCGA THCA -0.113; TCGA STAD -0.26; TCGA UCEC -0.272 |
hsa-miR-29b-3p | KLF7 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP; miRNATAP | TCGA BLCA -0.217; TCGA BRCA -0.31; TCGA COAD -0.182; TCGA ESCA -0.461; TCGA HNSC -0.36; TCGA KIRC -0.348; TCGA KIRP -0.223; TCGA LUAD -0.118; TCGA PAAD -0.278; TCGA PRAD -0.384; TCGA SARC -0.208; TCGA THCA -0.206; TCGA STAD -0.322 |
hsa-miR-29b-3p | KIF1A | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.587; TCGA BRCA -0.357; TCGA CESC -0.663; TCGA COAD -0.924; TCGA ESCA -0.681; TCGA HNSC -0.326; TCGA LUAD -0.344; TCGA LUSC -0.668; TCGA OV -0.44; TCGA PRAD -0.45; TCGA SARC -1.058; TCGA THCA -1.159; TCGA STAD -0.921; TCGA UCEC -0.541 |
hsa-miR-29b-3p | IL6ST | 11 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.575; TCGA BRCA -0.179; TCGA COAD -0.487; TCGA HNSC -0.583; TCGA KIRP -0.279; TCGA LUAD -0.303; TCGA PAAD -0.463; TCGA PRAD -0.782; TCGA SARC -0.403; TCGA THCA -0.663; TCGA STAD -0.248 |
hsa-miR-29b-3p | KIAA1614 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.389; TCGA BRCA -0.365; TCGA CESC -0.153; TCGA COAD -0.344; TCGA ESCA -0.544; TCGA HNSC -0.158; TCGA KIRC -0.33; TCGA KIRP -0.171; TCGA LIHC -0.181; TCGA LUAD -0.178; TCGA LUSC -0.251; TCGA PAAD -0.354; TCGA PRAD -0.35; TCGA SARC -0.243; TCGA THCA -0.445; TCGA STAD -0.449 |
hsa-miR-29b-3p | ENTPD1 | 10 cancers: BLCA; BRCA; COAD; KIRC; LGG; LUAD; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.182; TCGA BRCA -0.09; TCGA COAD -0.344; TCGA KIRC -0.141; TCGA LGG -0.059; TCGA LUAD -0.064; TCGA PAAD -0.326; TCGA PRAD -0.063; TCGA SARC -0.079; TCGA STAD -0.239 |
hsa-miR-29b-3p | ABL2 | 12 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.099; TCGA ESCA -0.112; TCGA HNSC -0.181; TCGA KIRC -0.114; TCGA KIRP -0.077; TCGA LGG -0.126; TCGA LIHC -0.105; TCGA LUSC -0.072; TCGA PAAD -0.185; TCGA PRAD -0.064; TCGA THCA -0.055; TCGA STAD -0.159 |
hsa-miR-29b-3p | TMEM108 | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.761; TCGA BRCA -0.422; TCGA COAD -0.417; TCGA HNSC -0.206; TCGA LGG -0.167; TCGA OV -0.257; TCGA PRAD -0.193; TCGA SARC -0.556; TCGA STAD -0.417; TCGA UCEC -0.469 |
hsa-miR-29b-3p | SNX30 | 9 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.076; TCGA HNSC -0.131; TCGA KIRC -0.125; TCGA KIRP -0.116; TCGA LIHC -0.181; TCGA LUAD -0.101; TCGA PAAD -0.136; TCGA PRAD -0.076; TCGA STAD -0.14 |
hsa-miR-29b-3p | FZD1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.263; TCGA BRCA -0.142; TCGA CESC -0.224; TCGA COAD -0.39; TCGA ESCA -0.51; TCGA HNSC -0.344; TCGA KIRC -0.345; TCGA KIRP -0.484; TCGA LUAD -0.125; TCGA LUSC -0.265; TCGA PAAD -0.455; TCGA PRAD -0.174; TCGA SARC -0.234; TCGA STAD -0.254 |
hsa-miR-29b-3p | MRAS | 9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.304; TCGA BRCA -0.175; TCGA COAD -0.67; TCGA HNSC -0.167; TCGA LUAD -0.107; TCGA PAAD -0.393; TCGA PRAD -0.207; TCGA THCA -0.073; TCGA STAD -0.346 |
hsa-miR-29b-3p | TAL1 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.176; TCGA BRCA -0.278; TCGA COAD -0.434; TCGA HNSC -0.101; TCGA KIRC -0.683; TCGA LUAD -0.192; TCGA SARC -0.142; TCGA THCA -0.185; TCGA STAD -0.306 |
hsa-miR-29b-3p | GRIK3 | 9 cancers: BLCA; BRCA; COAD; KIRC; LGG; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.379; TCGA BRCA -0.216; TCGA COAD -0.496; TCGA KIRC -1.243; TCGA LGG -0.289; TCGA PAAD -0.365; TCGA PRAD -0.214; TCGA SARC -0.361; TCGA STAD -0.877 |
hsa-miR-29b-3p | ADCY1 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.168; TCGA COAD -0.382; TCGA ESCA -0.283; TCGA HNSC -0.285; TCGA KIRC -0.373; TCGA LUSC -0.247; TCGA OV -0.311; TCGA PRAD -0.499; TCGA SARC -0.387; TCGA THCA -0.502; TCGA STAD -0.292; TCGA UCEC -0.189 |
hsa-miR-29b-3p | TBC1D16 | 10 cancers: BLCA; BRCA; HNSC; LGG; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.087; TCGA BRCA -0.083; TCGA HNSC -0.264; TCGA LGG -0.054; TCGA LUSC -0.199; TCGA OV -0.067; TCGA PAAD -0.215; TCGA PRAD -0.086; TCGA THCA -0.358; TCGA STAD -0.152 |
hsa-miR-29b-3p | IRF2BP2 | 9 cancers: BLCA; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; STAD | mirMAP | TCGA BLCA -0.103; TCGA ESCA -0.075; TCGA KIRC -0.161; TCGA KIRP -0.078; TCGA LGG -0.094; TCGA LIHC -0.095; TCGA LUSC -0.098; TCGA PRAD -0.129; TCGA STAD -0.132 |
hsa-miR-29b-3p | SIK2 | 10 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.138; TCGA BRCA -0.132; TCGA COAD -0.052; TCGA HNSC -0.152; TCGA LIHC -0.144; TCGA LUAD -0.163; TCGA PRAD -0.171; TCGA SARC -0.123; TCGA THCA -0.202; TCGA STAD -0.117 |
hsa-miR-29b-3p | DIRAS1 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUSC; SARC; STAD | mirMAP | TCGA BLCA -0.638; TCGA BRCA -0.141; TCGA COAD -0.714; TCGA ESCA -0.48; TCGA HNSC -0.339; TCGA LIHC -0.329; TCGA LUSC -0.25; TCGA SARC -0.512; TCGA STAD -0.491 |
hsa-miR-29b-3p | SCN4B | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.325; TCGA BRCA -0.491; TCGA COAD -0.712; TCGA HNSC -0.241; TCGA KIRC -0.647; TCGA LUAD -0.299; TCGA OV -0.137; TCGA PAAD -0.419; TCGA PRAD -0.182; TCGA SARC -0.457; TCGA THCA -0.421; TCGA STAD -0.511 |
hsa-miR-29b-3p | WBSCR17 | 10 cancers: BLCA; BRCA; CESC; COAD; LUAD; PAAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.602; TCGA BRCA -0.297; TCGA CESC -0.406; TCGA COAD -0.761; TCGA LUAD -0.132; TCGA PAAD -0.524; TCGA SARC -0.863; TCGA THCA -0.617; TCGA STAD -0.484; TCGA UCEC -0.377 |
hsa-miR-29b-3p | LRCH3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.145; TCGA BRCA -0.058; TCGA CESC -0.182; TCGA COAD -0.114; TCGA ESCA -0.151; TCGA HNSC -0.141; TCGA KIRP -0.108; TCGA LGG -0.221; TCGA LUAD -0.109; TCGA LUSC -0.152; TCGA PAAD -0.156; TCGA PRAD -0.241; TCGA SARC -0.093; TCGA THCA -0.193; TCGA STAD -0.197; TCGA UCEC -0.108 |
hsa-miR-29b-3p | MKL2 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.156; TCGA BRCA -0.073; TCGA CESC -0.165; TCGA COAD -0.075; TCGA HNSC -0.164; TCGA KIRC -0.151; TCGA KIRP -0.26; TCGA LUAD -0.077; TCGA LUSC -0.08; TCGA PAAD -0.254; TCGA PRAD -0.231; TCGA SARC -0.162; TCGA THCA -0.177; TCGA STAD -0.169 |
hsa-miR-29b-3p | TEAD1 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.261; TCGA BRCA -0.184; TCGA CESC -0.091; TCGA COAD -0.1; TCGA HNSC -0.161; TCGA KIRP -0.112; TCGA LGG -0.218; TCGA LIHC -0.098; TCGA LUAD -0.13; TCGA LUSC -0.109; TCGA PAAD -0.275; TCGA PRAD -0.36; TCGA SARC -0.143; TCGA THCA -0.074; TCGA STAD -0.514 |
hsa-miR-29b-3p | MYO5A | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BLCA -0.149; TCGA COAD -0.569; TCGA ESCA -0.531; TCGA HNSC -0.284; TCGA LUAD -0.088; TCGA PAAD -0.181; TCGA PRAD -0.207; TCGA THCA -0.151; TCGA STAD -0.248 |
hsa-miR-29b-3p | ITSN1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.187; TCGA CESC -0.102; TCGA COAD -0.136; TCGA HNSC -0.104; TCGA LUAD -0.138; TCGA LUSC -0.089; TCGA PAAD -0.317; TCGA PRAD -0.191; TCGA SARC -0.072; TCGA THCA -0.122; TCGA STAD -0.158; TCGA UCEC -0.092 |
hsa-miR-29b-3p | C17orf51 | 10 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.175; TCGA BRCA -0.296; TCGA HNSC -0.116; TCGA KIRP -0.107; TCGA LUAD -0.065; TCGA OV -0.085; TCGA PRAD -0.152; TCGA SARC -0.135; TCGA THCA -0.266; TCGA STAD -0.201 |
hsa-miR-29b-3p | NEURL1B | 10 cancers: BLCA; ESCA; KIRC; LGG; LIHC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.369; TCGA ESCA -0.327; TCGA KIRC -0.332; TCGA LGG -0.091; TCGA LIHC -0.154; TCGA PAAD -0.176; TCGA PRAD -0.187; TCGA SARC -0.315; TCGA STAD -0.354; TCGA UCEC -0.094 |
hsa-miR-29b-3p | TET2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC | miRNATAP | TCGA BLCA -0.092; TCGA BRCA -0.059; TCGA CESC -0.252; TCGA COAD -0.156; TCGA ESCA -0.171; TCGA HNSC -0.17; TCGA KIRC -0.205; TCGA KIRP -0.188; TCGA LGG -0.228; TCGA LUSC -0.131; TCGA PRAD -0.21; TCGA SARC -0.184 |
hsa-miR-29b-3p | POU2F1 | 9 cancers: BLCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD | miRNATAP | TCGA BLCA -0.241; TCGA HNSC -0.119; TCGA KIRP -0.178; TCGA LGG -0.121; TCGA LIHC -0.181; TCGA LUAD -0.101; TCGA LUSC -0.225; TCGA PRAD -0.221; TCGA STAD -0.082 |
hsa-miR-29b-3p | LOX | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.364; TCGA BRCA -0.457; TCGA COAD -0.659; TCGA ESCA -0.398; TCGA HNSC -0.417; TCGA LUAD -0.238; TCGA LUSC -0.163; TCGA PAAD -0.893; TCGA PRAD -0.316; TCGA STAD -0.167 |
hsa-miR-29b-3p | CLCN5 | 11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; OV; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.077; TCGA CESC -0.152; TCGA HNSC -0.124; TCGA KIRP -0.179; TCGA LGG -0.136; TCGA LIHC -0.125; TCGA LUAD -0.06; TCGA OV -0.094; TCGA SARC -0.148; TCGA THCA -0.252; TCGA UCEC -0.111 |
hsa-miR-29b-3p | MAP4K4 | 16 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.153; TCGA BRCA -0.194; TCGA COAD -0.134; TCGA ESCA -0.179; TCGA HNSC -0.175; TCGA KIRC -0.214; TCGA KIRP -0.121; TCGA LGG -0.099; TCGA LIHC -0.171; TCGA LUAD -0.107; TCGA LUSC -0.106; TCGA OV -0.123; TCGA PAAD -0.186; TCGA PRAD -0.085; TCGA STAD -0.072; TCGA UCEC -0.138 |
hsa-miR-29b-3p | HIF3A | 9 cancers: BLCA; BRCA; COAD; KIRC; OV; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.489; TCGA BRCA -0.324; TCGA COAD -0.23; TCGA KIRC -0.39; TCGA OV -0.416; TCGA SARC -0.656; TCGA THCA -0.318; TCGA STAD -0.911; TCGA UCEC -0.362 |
hsa-miR-29b-3p | TNRC6B | 11 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.122; TCGA CESC -0.105; TCGA HNSC -0.182; TCGA KIRC -0.069; TCGA KIRP -0.295; TCGA LGG -0.114; TCGA LUSC -0.122; TCGA PRAD -0.215; TCGA SARC -0.118; TCGA THCA -0.17; TCGA STAD -0.107 |
hsa-miR-29b-3p | LRP6 | 17 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.223; TCGA BRCA -0.093; TCGA CESC -0.272; TCGA HNSC -0.184; TCGA KIRC -0.263; TCGA KIRP -0.139; TCGA LGG -0.152; TCGA LIHC -0.181; TCGA LUAD -0.088; TCGA LUSC -0.252; TCGA OV -0.139; TCGA PAAD -0.166; TCGA PRAD -0.234; TCGA SARC -0.322; TCGA THCA -0.252; TCGA STAD -0.148; TCGA UCEC -0.116 |
hsa-miR-29b-3p | ADAMTS9 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.268; TCGA BRCA -0.315; TCGA COAD -0.347; TCGA HNSC -0.265; TCGA KIRC -0.202; TCGA KIRP -0.473; TCGA LGG -0.255; TCGA LUAD -0.251; TCGA OV -0.263; TCGA PAAD -0.437; TCGA PRAD -0.275; TCGA SARC -0.419; TCGA STAD -0.291; TCGA UCEC -0.223 |
hsa-miR-29b-3p | COL1A2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.376; TCGA BRCA -0.461; TCGA CESC -0.251; TCGA COAD -0.731; TCGA ESCA -0.576; TCGA HNSC -0.662; TCGA KIRC -0.256; TCGA LGG -0.132; TCGA LUSC -0.311; TCGA PAAD -0.93; TCGA PRAD -0.167; TCGA STAD -0.264; TCGA UCEC -0.139 |
hsa-miR-29b-3p | RORA | 12 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.277; TCGA CESC -0.228; TCGA COAD -0.499; TCGA HNSC -0.252; TCGA KIRC -0.29; TCGA KIRP -0.35; TCGA LUAD -0.097; TCGA PAAD -0.211; TCGA PRAD -0.136; TCGA SARC -0.171; TCGA THCA -0.092; TCGA STAD -0.354 |
hsa-miR-29b-3p | NPAS3 | 9 cancers: BLCA; BRCA; COAD; KIRP; LGG; LUSC; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.397; TCGA BRCA -0.19; TCGA COAD -0.755; TCGA KIRP -0.542; TCGA LGG -0.178; TCGA LUSC -0.233; TCGA PRAD -0.132; TCGA SARC -0.231; TCGA STAD -0.564 |
hsa-miR-29b-3p | RUNX1T1 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.725; TCGA BRCA -0.577; TCGA COAD -0.907; TCGA ESCA -0.292; TCGA HNSC -0.518; TCGA KIRC -0.538; TCGA LUAD -0.295; TCGA PAAD -0.487; TCGA PRAD -0.622; TCGA SARC -0.417; TCGA THCA -0.679; TCGA STAD -0.647 |
hsa-miR-29b-3p | SLC16A7 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.366; TCGA BRCA -0.324; TCGA CESC -0.398; TCGA COAD -0.908; TCGA HNSC -0.37; TCGA PAAD -0.65; TCGA PRAD -0.581; TCGA SARC -0.175; TCGA THCA -0.526; TCGA STAD -0.37 |
hsa-miR-29b-3p | TDG | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.101; TCGA CESC -0.117; TCGA ESCA -0.166; TCGA HNSC -0.082; TCGA KIRP -0.109; TCGA LGG -0.125; TCGA LIHC -0.191; TCGA LUAD -0.094; TCGA LUSC -0.148; TCGA OV -0.15; TCGA PRAD -0.169; TCGA SARC -0.051; TCGA THCA -0.078; TCGA UCEC -0.107 |
hsa-miR-29b-3p | SPARC | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.267; TCGA BRCA -0.384; TCGA CESC -0.216; TCGA COAD -0.648; TCGA ESCA -0.448; TCGA HNSC -0.456; TCGA KIRC -0.41; TCGA LGG -0.168; TCGA LUAD -0.168; TCGA LUSC -0.194; TCGA OV -0.12; TCGA PAAD -0.687; TCGA PRAD -0.137; TCGA SARC -0.119; TCGA THCA -0.116; TCGA STAD -0.266; TCGA UCEC -0.103 |
hsa-miR-29b-3p | AFF4 | 14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.138; TCGA BRCA -0.057; TCGA CESC -0.09; TCGA COAD -0.062; TCGA HNSC -0.205; TCGA KIRP -0.129; TCGA LGG -0.11; TCGA LUAD -0.057; TCGA LUSC -0.069; TCGA PAAD -0.117; TCGA PRAD -0.227; TCGA SARC -0.18; TCGA THCA -0.169; TCGA STAD -0.15 |
hsa-miR-29b-3p | ADAMTS18 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; OV; PAAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.473; TCGA BRCA -0.441; TCGA CESC -0.606; TCGA COAD -0.839; TCGA HNSC -0.169; TCGA KIRC -0.523; TCGA LUSC -0.42; TCGA OV -0.401; TCGA PAAD -0.311; TCGA SARC -0.462; TCGA STAD -0.295; TCGA UCEC -0.385 |
hsa-miR-29b-3p | CBX5 | 16 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.158; TCGA BRCA -0.054; TCGA CESC -0.086; TCGA ESCA -0.192; TCGA HNSC -0.07; TCGA KIRP -0.189; TCGA LGG -0.146; TCGA LIHC -0.119; TCGA LUAD -0.067; TCGA LUSC -0.159; TCGA OV -0.126; TCGA PRAD -0.124; TCGA SARC -0.187; TCGA THCA -0.15; TCGA STAD -0.168; TCGA UCEC -0.111 |
hsa-miR-29b-3p | ANTXR2 | 9 cancers: BLCA; BRCA; COAD; HNSC; KIRC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.331; TCGA BRCA -0.229; TCGA COAD -0.231; TCGA HNSC -0.123; TCGA KIRC -0.117; TCGA PAAD -0.477; TCGA PRAD -0.191; TCGA THCA -0.127; TCGA STAD -0.35 |
hsa-miR-29b-3p | TLL1 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.398; TCGA BRCA -0.472; TCGA COAD -0.951; TCGA HNSC -0.305; TCGA KIRC -0.663; TCGA KIRP -0.5; TCGA LUAD -0.292; TCGA PAAD -0.816; TCGA PRAD -0.287; TCGA SARC -0.315; TCGA THCA -0.408; TCGA STAD -0.416; TCGA UCEC -0.164 |
hsa-miR-29b-3p | ACVR2A | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.203; TCGA CESC -0.185; TCGA COAD -0.074; TCGA HNSC -0.087; TCGA KIRC -0.111; TCGA KIRP -0.115; TCGA LIHC -0.079; TCGA LUSC -0.133; TCGA OV -0.109; TCGA PAAD -0.131; TCGA PRAD -0.107; TCGA SARC -0.103; TCGA STAD -0.111; TCGA UCEC -0.186 |
hsa-miR-29b-3p | MGA | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.132; TCGA BRCA -0.054; TCGA CESC -0.167; TCGA COAD -0.122; TCGA HNSC -0.133; TCGA KIRP -0.081; TCGA LGG -0.069; TCGA LIHC -0.173; TCGA LUAD -0.079; TCGA LUSC -0.112; TCGA PAAD -0.139; TCGA PRAD -0.233; TCGA SARC -0.217; TCGA THCA -0.157; TCGA STAD -0.143 |
hsa-miR-29b-3p | PCYT1B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.669; TCGA BRCA -0.603; TCGA CESC -0.591; TCGA COAD -0.84; TCGA ESCA -1.335; TCGA HNSC -0.334; TCGA KIRP -0.407; TCGA LUAD -0.315; TCGA LUSC -0.531; TCGA OV -0.311; TCGA PRAD -0.47; TCGA SARC -0.699; TCGA STAD -1.02; TCGA UCEC -0.28 |
hsa-miR-29b-3p | KLF13 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.194; TCGA BRCA -0.076; TCGA ESCA -0.168; TCGA HNSC -0.192; TCGA KIRC -0.211; TCGA KIRP -0.146; TCGA LUAD -0.131; TCGA LUSC -0.1; TCGA PAAD -0.2; TCGA PRAD -0.288; TCGA THCA -0.208 |
hsa-miR-29b-3p | NFATC4 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.216; TCGA BRCA -0.123; TCGA CESC -0.27; TCGA COAD -0.225; TCGA ESCA -0.27; TCGA KIRC -0.403; TCGA SARC -0.229; TCGA STAD -0.466; TCGA UCEC -0.097 |
hsa-miR-29b-3p | YPEL2 | 9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; SARC; STAD | miRNATAP | TCGA BLCA -0.131; TCGA COAD -0.189; TCGA HNSC -0.135; TCGA KIRC -0.261; TCGA KIRP -0.342; TCGA LIHC -0.12; TCGA LUAD -0.071; TCGA SARC -0.087; TCGA STAD -0.155 |
hsa-miR-29b-3p | PHACTR2 | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.138; TCGA BRCA -0.102; TCGA HNSC -0.202; TCGA KIRC -0.238; TCGA KIRP -0.16; TCGA LUAD -0.252; TCGA PAAD -0.296; TCGA PRAD -0.233; TCGA SARC -0.121; TCGA THCA -0.21; TCGA STAD -0.142 |
hsa-miR-29b-3p | MEX3B | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.437; TCGA BRCA -0.273; TCGA CESC -0.5; TCGA COAD -0.561; TCGA ESCA -0.55; TCGA HNSC -0.315; TCGA KIRC -0.272; TCGA KIRP -0.158; TCGA LGG -0.388; TCGA LUSC -0.409; TCGA OV -0.243; TCGA PAAD -0.35; TCGA PRAD -0.308; TCGA SARC -0.418; TCGA THCA -0.147; TCGA STAD -0.301; TCGA UCEC -0.282 |
hsa-miR-29b-3p | SYNCRIP | 12 cancers: BLCA; CESC; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.083; TCGA CESC -0.099; TCGA HNSC -0.059; TCGA KIRP -0.07; TCGA LGG -0.14; TCGA LUAD -0.079; TCGA LUSC -0.113; TCGA PAAD -0.15; TCGA PRAD -0.167; TCGA SARC -0.067; TCGA THCA -0.073; TCGA UCEC -0.097 |
hsa-miR-29b-3p | FOXO3 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.199; TCGA BRCA -0.117; TCGA CESC -0.183; TCGA HNSC -0.188; TCGA KIRC -0.201; TCGA KIRP -0.129; TCGA LGG -0.067; TCGA LIHC -0.147; TCGA LUAD -0.151; TCGA LUSC -0.116; TCGA PAAD -0.162; TCGA PRAD -0.2; TCGA SARC -0.167; TCGA STAD -0.149 |
hsa-miR-29b-3p | AKT3 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.329; TCGA BRCA -0.24; TCGA CESC -0.284; TCGA COAD -0.677; TCGA ESCA -0.338; TCGA HNSC -0.255; TCGA KIRC -0.248; TCGA KIRP -0.163; TCGA LUAD -0.267; TCGA PAAD -0.266; TCGA PRAD -0.149; TCGA SARC -0.204; TCGA STAD -0.513 |
hsa-miR-29b-3p | GRIP1 | 13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.219; TCGA BRCA -0.255; TCGA COAD -0.429; TCGA ESCA -0.629; TCGA HNSC -0.27; TCGA KIRP -0.268; TCGA LUSC -0.348; TCGA PAAD -0.319; TCGA PRAD -0.325; TCGA SARC -0.665; TCGA THCA -0.68; TCGA STAD -0.348; TCGA UCEC -0.212 |
hsa-miR-29b-3p | ZNF609 | 15 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.125; TCGA CESC -0.09; TCGA COAD -0.094; TCGA HNSC -0.183; TCGA KIRC -0.08; TCGA KIRP -0.06; TCGA LGG -0.165; TCGA LIHC -0.17; TCGA LUAD -0.087; TCGA LUSC -0.12; TCGA PAAD -0.137; TCGA PRAD -0.156; TCGA SARC -0.152; TCGA THCA -0.11; TCGA STAD -0.057 |
hsa-miR-29b-3p | LSM11 | 13 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.26; TCGA BRCA -0.113; TCGA CESC -0.1; TCGA KIRC -0.127; TCGA KIRP -0.2; TCGA LIHC -0.291; TCGA LUAD -0.077; TCGA LUSC -0.115; TCGA PAAD -0.139; TCGA PRAD -0.18; TCGA SARC -0.275; TCGA STAD -0.166; TCGA UCEC -0.096 |
hsa-miR-29b-3p | SYPL2 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.49; TCGA BRCA -0.296; TCGA CESC -0.365; TCGA COAD -0.669; TCGA HNSC -0.223; TCGA KIRP -0.237; TCGA LUAD -0.211; TCGA PAAD -0.323; TCGA PRAD -0.23; TCGA THCA -0.463; TCGA STAD -0.691 |
hsa-miR-29b-3p | KIAA0355 | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.13; TCGA BRCA -0.131; TCGA CESC -0.14; TCGA COAD -0.086; TCGA HNSC -0.171; TCGA KIRC -0.333; TCGA KIRP -0.144; TCGA LIHC -0.135; TCGA LUAD -0.143; TCGA LUSC -0.091; TCGA OV -0.054; TCGA PAAD -0.127; TCGA PRAD -0.141; TCGA SARC -0.148; TCGA THCA -0.093; TCGA STAD -0.248 |
hsa-miR-29b-3p | CSRNP2 | 11 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.076; TCGA CESC -0.079; TCGA HNSC -0.084; TCGA KIRP -0.134; TCGA LIHC -0.064; TCGA LUSC -0.074; TCGA OV -0.073; TCGA PRAD -0.096; TCGA SARC -0.103; TCGA STAD -0.145; TCGA UCEC -0.103 |
hsa-miR-29b-3p | CBX6 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.278; TCGA BRCA -0.122; TCGA CESC -0.251; TCGA COAD -0.501; TCGA ESCA -0.44; TCGA HNSC -0.222; TCGA KIRC -0.211; TCGA KIRP -0.133; TCGA LUAD -0.177; TCGA LUSC -0.147; TCGA OV -0.104; TCGA PRAD -0.465; TCGA SARC -0.247; TCGA THCA -0.276; TCGA STAD -0.535 |
hsa-miR-29b-3p | ZFX | 14 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.166; TCGA CESC -0.124; TCGA HNSC -0.178; TCGA KIRC -0.095; TCGA KIRP -0.13; TCGA LGG -0.11; TCGA LIHC -0.203; TCGA LUAD -0.103; TCGA LUSC -0.119; TCGA PAAD -0.124; TCGA PRAD -0.263; TCGA SARC -0.185; TCGA THCA -0.245; TCGA STAD -0.14 |
hsa-miR-29b-3p | PRKG1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.85; TCGA BRCA -0.514; TCGA CESC -0.375; TCGA COAD -0.747; TCGA ESCA -0.348; TCGA HNSC -0.691; TCGA KIRC -0.471; TCGA LUAD -0.414; TCGA LUSC -0.372; TCGA OV -0.155; TCGA PAAD -0.918; TCGA PRAD -0.877; TCGA SARC -0.49; TCGA THCA -0.818; TCGA STAD -0.554 |
hsa-miR-29b-3p | NFIB | 12 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.254; TCGA BRCA -0.274; TCGA COAD -0.104; TCGA KIRC -0.227; TCGA KIRP -0.21; TCGA LGG -0.244; TCGA LUAD -0.101; TCGA LUSC -0.164; TCGA PAAD -0.42; TCGA PRAD -0.156; TCGA SARC -0.368; TCGA STAD -0.114 |
hsa-miR-29b-3p | ATXN1L | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.16; TCGA BRCA -0.079; TCGA ESCA -0.1; TCGA HNSC -0.208; TCGA KIRC -0.126; TCGA KIRP -0.16; TCGA LGG -0.064; TCGA LUAD -0.104; TCGA LUSC -0.079; TCGA PAAD -0.159; TCGA PRAD -0.261; TCGA SARC -0.205; TCGA THCA -0.268; TCGA STAD -0.108 |
hsa-miR-29b-3p | ZMIZ1 | 14 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.096; TCGA COAD -0.102; TCGA ESCA -0.191; TCGA HNSC -0.229; TCGA KIRC -0.146; TCGA KIRP -0.217; TCGA LGG -0.197; TCGA LIHC -0.154; TCGA LUAD -0.133; TCGA LUSC -0.098; TCGA SARC -0.131; TCGA THCA -0.135; TCGA STAD -0.156; TCGA UCEC -0.098 |
hsa-miR-29b-3p | ERC1 | 19 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.264; TCGA BRCA -0.115; TCGA CESC -0.096; TCGA COAD -0.127; TCGA ESCA -0.238; TCGA HNSC -0.258; TCGA KIRC -0.096; TCGA KIRP -0.131; TCGA LGG -0.094; TCGA LIHC -0.132; TCGA LUAD -0.144; TCGA LUSC -0.145; TCGA OV -0.072; TCGA PAAD -0.125; TCGA PRAD -0.266; TCGA SARC -0.175; TCGA THCA -0.242; TCGA STAD -0.188; TCGA UCEC -0.093 |
hsa-miR-29b-3p | TP53INP2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.351; TCGA BRCA -0.066; TCGA CESC -0.181; TCGA COAD -0.204; TCGA ESCA -0.239; TCGA HNSC -0.139; TCGA KIRC -0.158; TCGA LIHC -0.187; TCGA LUAD -0.078; TCGA PRAD -0.099; TCGA SARC -0.147; TCGA THCA -0.458; TCGA STAD -0.314 |
hsa-miR-29b-3p | SHROOM4 | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.13; TCGA BRCA -0.237; TCGA CESC -0.307; TCGA HNSC -0.347; TCGA KIRC -0.484; TCGA KIRP -0.133; TCGA LUAD -0.218; TCGA OV -0.16; TCGA PAAD -0.417; TCGA PRAD -0.299; TCGA SARC -0.21; TCGA STAD -0.364; TCGA UCEC -0.163 |
hsa-miR-29b-3p | BCORL1 | 14 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.161; TCGA CESC -0.148; TCGA HNSC -0.311; TCGA KIRC -0.101; TCGA KIRP -0.096; TCGA LGG -0.098; TCGA LIHC -0.368; TCGA LUSC -0.235; TCGA OV -0.071; TCGA PRAD -0.196; TCGA SARC -0.176; TCGA THCA -0.157; TCGA STAD -0.161; TCGA UCEC -0.128 |
hsa-miR-29b-3p | PRKAB2 | 14 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LIHC; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.111; TCGA BRCA -0.068; TCGA COAD -0.114; TCGA HNSC -0.145; TCGA KIRP -0.091; TCGA LIHC -0.19; TCGA LUSC -0.11; TCGA OV -0.09; TCGA PAAD -0.103; TCGA PRAD -0.073; TCGA SARC -0.193; TCGA THCA -0.116; TCGA STAD -0.301; TCGA UCEC -0.068 |
hsa-miR-29b-3p | DDX3X | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.098; TCGA BRCA -0.06; TCGA CESC -0.108; TCGA COAD -0.055; TCGA HNSC -0.113; TCGA KIRC -0.085; TCGA LUAD -0.123; TCGA LUSC -0.056; TCGA PAAD -0.153; TCGA PRAD -0.16; TCGA SARC -0.057; TCGA THCA -0.172; TCGA STAD -0.067 |
hsa-miR-29b-3p | SIKE1 | 13 cancers: BLCA; CESC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.061; TCGA CESC -0.108; TCGA LGG -0.05; TCGA LIHC -0.066; TCGA LUAD -0.064; TCGA LUSC -0.073; TCGA OV -0.087; TCGA PAAD -0.126; TCGA PRAD -0.16; TCGA SARC -0.13; TCGA THCA -0.212; TCGA STAD -0.117; TCGA UCEC -0.112 |
hsa-miR-29b-3p | DENND1B | 9 cancers: BLCA; COAD; HNSC; KIRP; LGG; LIHC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.085; TCGA COAD -0.117; TCGA HNSC -0.271; TCGA KIRP -0.169; TCGA LGG -0.141; TCGA LIHC -0.143; TCGA PAAD -0.283; TCGA PRAD -0.352; TCGA THCA -0.236 |
hsa-miR-29b-3p | KDM6B | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; OV; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.077; TCGA BRCA -0.129; TCGA COAD -0.08; TCGA ESCA -0.102; TCGA HNSC -0.211; TCGA KIRC -0.368; TCGA KIRP -0.176; TCGA LGG -0.249; TCGA OV -0.084; TCGA SARC -0.152; TCGA THCA -0.115; TCGA UCEC -0.073 |
hsa-miR-29b-3p | ZNF469 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LGG; PAAD; PRAD; SARC | miRNATAP | TCGA BLCA -0.284; TCGA BRCA -0.332; TCGA COAD -0.581; TCGA ESCA -0.392; TCGA HNSC -0.538; TCGA KIRC -0.202; TCGA LGG -0.14; TCGA PAAD -0.623; TCGA PRAD -0.273; TCGA SARC -0.167 |
hsa-miR-29b-3p | ATXN1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.192; TCGA BRCA -0.183; TCGA CESC -0.152; TCGA COAD -0.149; TCGA ESCA -0.148; TCGA HNSC -0.226; TCGA KIRC -0.178; TCGA KIRP -0.118; TCGA LIHC -0.093; TCGA LUAD -0.094; TCGA PAAD -0.367; TCGA PRAD -0.271; TCGA SARC -0.15; TCGA THCA -0.065; TCGA STAD -0.24 |
hsa-miR-29b-3p | ADAM22 | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.362; TCGA BRCA -0.371; TCGA CESC -0.527; TCGA COAD -0.35; TCGA HNSC -0.198; TCGA LGG -0.206; TCGA LIHC -0.298; TCGA LUAD -0.23; TCGA LUSC -0.26; TCGA OV -0.203; TCGA PAAD -0.636; TCGA PRAD -0.783; TCGA SARC -0.673; TCGA THCA -1.249; TCGA STAD -0.319; TCGA UCEC -0.218 |
hsa-miR-29b-3p | KPNA4 | 10 cancers: BLCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.077; TCGA HNSC -0.116; TCGA LUAD -0.087; TCGA LUSC -0.098; TCGA OV -0.081; TCGA PAAD -0.13; TCGA PRAD -0.101; TCGA THCA -0.098; TCGA STAD -0.131; TCGA UCEC -0.072 |
hsa-miR-29b-3p | TRIM9 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.244; TCGA CESC -0.466; TCGA COAD -0.509; TCGA ESCA -0.457; TCGA HNSC -0.469; TCGA KIRC -0.287; TCGA KIRP -0.31; TCGA LGG -0.241; TCGA LUSC -0.373; TCGA OV -0.318; TCGA SARC -0.231; TCGA THCA -0.227; TCGA STAD -0.462; TCGA UCEC -0.346 |
hsa-miR-29b-3p | KDM5A | 10 cancers: BLCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.09; TCGA HNSC -0.21; TCGA KIRP -0.065; TCGA LGG -0.16; TCGA LIHC -0.062; TCGA LUAD -0.086; TCGA LUSC -0.098; TCGA PRAD -0.201; TCGA SARC -0.071; TCGA THCA -0.113 |
hsa-miR-29b-3p | RAB6B | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.12; TCGA BRCA -0.124; TCGA CESC -0.295; TCGA COAD -0.287; TCGA ESCA -0.349; TCGA HNSC -0.169; TCGA KIRP -0.296; TCGA SARC -0.12; TCGA THCA -0.314; TCGA STAD -0.393 |
hsa-miR-29b-3p | SDK1 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.193; TCGA BRCA -0.181; TCGA CESC -0.4; TCGA COAD -0.665; TCGA ESCA -0.772; TCGA HNSC -0.305; TCGA KIRP -0.282; TCGA LUSC -0.2; TCGA OV -0.376; TCGA SARC -0.472; TCGA STAD -0.29; TCGA UCEC -0.268 |
hsa-miR-29b-3p | BRD3 | 17 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.176; TCGA BRCA -0.099; TCGA CESC -0.134; TCGA ESCA -0.13; TCGA HNSC -0.158; TCGA KIRC -0.131; TCGA KIRP -0.257; TCGA LGG -0.208; TCGA LIHC -0.2; TCGA LUAD -0.079; TCGA LUSC -0.197; TCGA OV -0.098; TCGA PRAD -0.147; TCGA SARC -0.211; TCGA THCA -0.157; TCGA STAD -0.189; TCGA UCEC -0.132 |
hsa-miR-29b-3p | GPAM | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.109; TCGA BRCA -0.27; TCGA CESC -0.079; TCGA HNSC -0.052; TCGA KIRP -0.109; TCGA LUSC -0.097; TCGA OV -0.139; TCGA PAAD -0.17; TCGA PRAD -0.087; TCGA SARC -0.153; TCGA THCA -0.35; TCGA STAD -0.173; TCGA UCEC -0.176 |
hsa-miR-29b-3p | RCOR1 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.104; TCGA HNSC -0.177; TCGA KIRC -0.125; TCGA KIRP -0.057; TCGA LGG -0.162; TCGA LIHC -0.066; TCGA LUAD -0.081; TCGA PRAD -0.169; TCGA SARC -0.123; TCGA THCA -0.109 |
hsa-miR-29b-3p | FEM1B | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.166; TCGA COAD -0.121; TCGA ESCA -0.23; TCGA HNSC -0.127; TCGA KIRP -0.058; TCGA LIHC -0.139; TCGA LUAD -0.127; TCGA LUSC -0.117; TCGA PAAD -0.171; TCGA PRAD -0.235; TCGA SARC -0.187; TCGA THCA -0.111; TCGA STAD -0.261 |
hsa-miR-29b-3p | HLF | 9 cancers: BLCA; BRCA; COAD; KIRC; KIRP; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.699; TCGA BRCA -0.469; TCGA COAD -0.23; TCGA KIRC -0.286; TCGA KIRP -0.169; TCGA PRAD -0.289; TCGA SARC -0.852; TCGA THCA -0.617; TCGA STAD -0.842 |
hsa-miR-29b-3p | PTP4A1 | 10 cancers: BLCA; HNSC; LGG; LIHC; OV; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.12; TCGA HNSC -0.107; TCGA LGG -0.083; TCGA LIHC -0.102; TCGA OV -0.091; TCGA PAAD -0.154; TCGA PRAD -0.143; TCGA SARC -0.08; TCGA THCA -0.133; TCGA STAD -0.123 |
hsa-miR-29b-3p | RHOBTB1 | 11 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.169; TCGA BRCA -0.163; TCGA CESC -0.253; TCGA HNSC -0.347; TCGA KIRC -0.182; TCGA LUSC -0.163; TCGA OV -0.228; TCGA PAAD -0.345; TCGA SARC -0.111; TCGA THCA -0.258; TCGA UCEC -0.225 |
hsa-miR-29b-3p | ATP7A | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.16; TCGA BRCA -0.106; TCGA CESC -0.182; TCGA COAD -0.099; TCGA HNSC -0.239; TCGA LGG -0.119; TCGA LUAD -0.07; TCGA LUSC -0.133; TCGA PAAD -0.121; TCGA PRAD -0.191; TCGA SARC -0.143; TCGA THCA -0.137; TCGA STAD -0.077 |
hsa-miR-29b-3p | MXI1 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.199; TCGA BRCA -0.071; TCGA CESC -0.114; TCGA ESCA -0.196; TCGA HNSC -0.072; TCGA KIRC -0.197; TCGA SARC -0.092; TCGA STAD -0.26; TCGA UCEC -0.078 |
hsa-miR-29b-3p | ROR1 | 12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.645; TCGA BRCA -0.534; TCGA CESC -0.323; TCGA COAD -0.784; TCGA HNSC -0.423; TCGA KIRC -0.238; TCGA KIRP -0.489; TCGA LUAD -0.357; TCGA PAAD -0.643; TCGA PRAD -0.811; TCGA SARC -0.463; TCGA STAD -0.355 |
hsa-miR-29b-3p | KIAA1549 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.21; TCGA BRCA -0.071; TCGA CESC -0.553; TCGA HNSC -0.354; TCGA KIRC -0.272; TCGA KIRP -0.108; TCGA LGG -0.266; TCGA LUSC -0.358; TCGA OV -0.246; TCGA PRAD -0.175; TCGA SARC -0.448; TCGA THCA -0.103; TCGA STAD -0.15; TCGA UCEC -0.258 |
hsa-miR-29b-3p | ELOVL4 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.478; TCGA BRCA -0.142; TCGA CESC -0.355; TCGA COAD -0.731; TCGA ESCA -0.867; TCGA HNSC -0.264; TCGA LUAD -0.23; TCGA LUSC -0.416; TCGA OV -0.338; TCGA PRAD -0.199; TCGA SARC -0.164; TCGA STAD -0.688; TCGA UCEC -0.199 |
hsa-miR-29b-3p | BTBD7 | 17 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.088; TCGA BRCA -0.109; TCGA CESC -0.147; TCGA COAD -0.08; TCGA HNSC -0.19; TCGA KIRC -0.151; TCGA KIRP -0.263; TCGA LGG -0.121; TCGA LIHC -0.091; TCGA LUAD -0.086; TCGA LUSC -0.075; TCGA PAAD -0.161; TCGA PRAD -0.208; TCGA SARC -0.168; TCGA THCA -0.169; TCGA STAD -0.105; TCGA UCEC -0.058 |
hsa-miR-29b-3p | TANC1 | 13 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.175; TCGA BRCA -0.131; TCGA CESC -0.085; TCGA ESCA -0.23; TCGA HNSC -0.165; TCGA KIRC -0.256; TCGA LGG -0.166; TCGA LUAD -0.059; TCGA LUSC -0.144; TCGA PAAD -0.29; TCGA PRAD -0.292; TCGA SARC -0.299; TCGA STAD -0.201 |
hsa-miR-29b-3p | WWTR1 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.33; TCGA BRCA -0.27; TCGA CESC -0.274; TCGA COAD -0.7; TCGA ESCA -0.342; TCGA HNSC -0.316; TCGA KIRC -0.295; TCGA KIRP -0.245; TCGA LUAD -0.182; TCGA LUSC -0.183; TCGA PAAD -0.553; TCGA PRAD -0.444; TCGA SARC -0.21; TCGA THCA -0.412; TCGA STAD -0.515 |
hsa-miR-29b-3p | ZDHHC15 | 16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.63; TCGA BRCA -0.198; TCGA CESC -0.456; TCGA COAD -0.866; TCGA HNSC -0.245; TCGA KIRC -0.396; TCGA KIRP -0.327; TCGA LGG -0.093; TCGA LUAD -0.225; TCGA OV -0.184; TCGA PAAD -0.208; TCGA PRAD -0.374; TCGA SARC -0.571; TCGA THCA -0.131; TCGA STAD -0.734; TCGA UCEC -0.206 |
hsa-miR-29b-3p | ANK3 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.152; TCGA BRCA -0.088; TCGA CESC -0.333; TCGA ESCA -0.181; TCGA HNSC -0.224; TCGA LUAD -0.117; TCGA PRAD -0.205; TCGA THCA -0.354; TCGA STAD -0.107 |
hsa-miR-29b-3p | PLEKHA1 | 13 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.094; TCGA CESC -0.131; TCGA HNSC -0.143; TCGA KIRC -0.132; TCGA KIRP -0.104; TCGA LIHC -0.13; TCGA LUAD -0.143; TCGA OV -0.064; TCGA PRAD -0.179; TCGA SARC -0.145; TCGA THCA -0.217; TCGA STAD -0.11; TCGA UCEC -0.074 |
hsa-miR-29b-3p | SCHIP1 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.191; TCGA BRCA -0.106; TCGA CESC -0.153; TCGA COAD -0.504; TCGA ESCA -0.568; TCGA KIRC -0.17; TCGA KIRP -0.619; TCGA LUAD -0.145; TCGA LUSC -0.148; TCGA OV -0.175; TCGA PAAD -0.156; TCGA PRAD -0.197; TCGA SARC -0.151; TCGA UCEC -0.183 |
hsa-miR-29b-3p | RNF169 | 14 cancers: BLCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.206; TCGA CESC -0.147; TCGA COAD -0.057; TCGA HNSC -0.238; TCGA KIRP -0.167; TCGA LGG -0.147; TCGA LIHC -0.158; TCGA LUAD -0.077; TCGA LUSC -0.099; TCGA PAAD -0.208; TCGA PRAD -0.366; TCGA SARC -0.185; TCGA THCA -0.209; TCGA STAD -0.118 |
hsa-miR-29b-3p | NDRG4 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.199; TCGA BRCA -0.116; TCGA CESC -0.462; TCGA COAD -0.347; TCGA ESCA -1.039; TCGA HNSC -0.4; TCGA LUAD -0.292; TCGA LUSC -0.264; TCGA OV -0.1; TCGA THCA -0.258; TCGA STAD -0.501; TCGA UCEC -0.126 |
hsa-miR-29b-3p | DICER1 | 9 cancers: BLCA; CESC; HNSC; KIRP; LIHC; LUAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.073; TCGA CESC -0.088; TCGA HNSC -0.182; TCGA KIRP -0.078; TCGA LIHC -0.081; TCGA LUAD -0.066; TCGA SARC -0.077; TCGA THCA -0.197; TCGA STAD -0.088 |
hsa-miR-29b-3p | PALM | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; PAAD; SARC; STAD | miRNATAP | TCGA BLCA -0.399; TCGA BRCA -0.284; TCGA COAD -0.532; TCGA ESCA -0.351; TCGA HNSC -0.148; TCGA LIHC -0.21; TCGA PAAD -0.18; TCGA SARC -0.315; TCGA STAD -0.556 |
hsa-miR-29b-3p | SLC16A2 | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.323; TCGA BRCA -0.193; TCGA COAD -0.659; TCGA HNSC -0.163; TCGA KIRC -0.343; TCGA LGG -0.145; TCGA LUAD -0.149; TCGA PAAD -0.323; TCGA PRAD -0.262; TCGA SARC -0.201; TCGA THCA -0.455; TCGA STAD -0.264; TCGA UCEC -0.122 |
hsa-miR-29b-3p | SLC16A14 | 10 cancers: BLCA; BRCA; CESC; ESCA; KIRC; OV; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.217; TCGA BRCA -0.141; TCGA CESC -0.206; TCGA ESCA -0.334; TCGA KIRC -0.191; TCGA OV -0.15; TCGA PAAD -0.309; TCGA PRAD -0.119; TCGA SARC -0.28; TCGA STAD -0.333 |
hsa-miR-29b-3p | SKI | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.135; TCGA BRCA -0.093; TCGA HNSC -0.141; TCGA KIRC -0.312; TCGA KIRP -0.1; TCGA LUAD -0.092; TCGA PAAD -0.154; TCGA PRAD -0.093; TCGA SARC -0.097; TCGA THCA -0.053; TCGA STAD -0.187; TCGA UCEC -0.06 |
hsa-miR-29b-3p | AQP4 | 9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.329; TCGA BRCA -0.226; TCGA CESC -0.449; TCGA KIRC -0.614; TCGA KIRP -0.628; TCGA LUAD -0.298; TCGA PRAD -0.264; TCGA SARC -0.549; TCGA THCA -0.45 |
hsa-miR-29b-3p | TNRC18 | 11 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.075; TCGA HNSC -0.181; TCGA KIRC -0.106; TCGA KIRP -0.198; TCGA LGG -0.195; TCGA LIHC -0.151; TCGA LUSC -0.104; TCGA SARC -0.191; TCGA STAD -0.105; TCGA UCEC -0.067 |
hsa-miR-29b-3p | DDX6 | 9 cancers: BLCA; HNSC; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.092; TCGA HNSC -0.11; TCGA LGG -0.077; TCGA LUAD -0.063; TCGA LUSC -0.051; TCGA PRAD -0.139; TCGA SARC -0.115; TCGA THCA -0.076; TCGA STAD -0.149 |
hsa-miR-29b-3p | SVIL | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.306; TCGA BRCA -0.214; TCGA CESC -0.183; TCGA COAD -0.318; TCGA ESCA -0.351; TCGA HNSC -0.156; TCGA KIRC -0.295; TCGA KIRP -0.402; TCGA LIHC -0.155; TCGA LUAD -0.123; TCGA LUSC -0.189; TCGA PAAD -0.495; TCGA PRAD -0.352; TCGA SARC -0.426; TCGA STAD -0.722; TCGA UCEC -0.175 |
hsa-miR-29b-3p | CAPN6 | 9 cancers: BLCA; BRCA; CESC; COAD; OV; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.809; TCGA BRCA -0.477; TCGA CESC -0.905; TCGA COAD -0.771; TCGA OV -0.519; TCGA PAAD -0.59; TCGA PRAD -0.635; TCGA SARC -1.23; TCGA STAD -0.598 |
hsa-miR-29b-3p | MTSS1L | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.148; TCGA BRCA -0.106; TCGA CESC -0.163; TCGA COAD -0.132; TCGA ESCA -0.526; TCGA HNSC -0.1; TCGA LGG -0.097; TCGA PRAD -0.122; TCGA SARC -0.231; TCGA STAD -0.4; TCGA UCEC -0.097 |
hsa-miR-29b-3p | ZNF532 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.256; TCGA BRCA -0.188; TCGA CESC -0.135; TCGA COAD -0.424; TCGA ESCA -0.381; TCGA HNSC -0.193; TCGA KIRC -0.28; TCGA KIRP -0.216; TCGA LGG -0.117; TCGA LUSC -0.197; TCGA PAAD -0.384; TCGA PRAD -0.212; TCGA SARC -0.276; TCGA STAD -0.39; TCGA UCEC -0.099 |
hsa-miR-29b-3p | LGI2 | 10 cancers: BLCA; BRCA; COAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.372; TCGA BRCA -0.19; TCGA COAD -0.733; TCGA OV -0.345; TCGA PAAD -0.314; TCGA PRAD -0.207; TCGA SARC -0.299; TCGA THCA -0.568; TCGA STAD -0.638; TCGA UCEC -0.235 |
hsa-miR-29b-3p | ZFP36L1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.096; TCGA BRCA -0.184; TCGA CESC -0.221; TCGA COAD -0.224; TCGA ESCA -0.288; TCGA HNSC -0.151; TCGA LUSC -0.085; TCGA PAAD -0.41; TCGA PRAD -0.217; TCGA STAD -0.105 |
hsa-miR-29b-3p | KIF26A | 11 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.397; TCGA BRCA -0.396; TCGA HNSC -0.341; TCGA KIRC -0.583; TCGA LGG -0.538; TCGA LUAD -0.188; TCGA LUSC -0.19; TCGA OV -0.306; TCGA SARC -0.594; TCGA THCA -0.359; TCGA STAD -0.231 |
hsa-miR-29b-3p | APPBP2 | 12 cancers: BLCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.1; TCGA CESC -0.157; TCGA COAD -0.103; TCGA HNSC -0.108; TCGA LIHC -0.065; TCGA LUAD -0.095; TCGA LUSC -0.121; TCGA OV -0.055; TCGA PRAD -0.179; TCGA SARC -0.131; TCGA THCA -0.165; TCGA STAD -0.138 |
hsa-miR-29b-3p | TRIM37 | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.124; TCGA CESC -0.158; TCGA ESCA -0.158; TCGA HNSC -0.059; TCGA KIRP -0.136; TCGA LIHC -0.147; TCGA LUSC -0.127; TCGA OV -0.056; TCGA PRAD -0.122; TCGA SARC -0.092; TCGA THCA -0.22; TCGA STAD -0.119; TCGA UCEC -0.085 |
hsa-miR-29b-3p | DIP2B | 13 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.103; TCGA CESC -0.157; TCGA ESCA -0.252; TCGA HNSC -0.275; TCGA KIRC -0.11; TCGA KIRP -0.122; TCGA LGG -0.074; TCGA LIHC -0.122; TCGA LUAD -0.111; TCGA LUSC -0.194; TCGA PRAD -0.261; TCGA SARC -0.102; TCGA THCA -0.236 |
hsa-miR-29b-3p | KCTD3 | 12 cancers: BLCA; CESC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.161; TCGA CESC -0.134; TCGA KIRP -0.106; TCGA LGG -0.146; TCGA LIHC -0.181; TCGA LUAD -0.102; TCGA LUSC -0.149; TCGA PAAD -0.128; TCGA PRAD -0.113; TCGA SARC -0.167; TCGA THCA -0.16; TCGA STAD -0.09 |
hsa-miR-29b-3p | RERE | 9 cancers: BLCA; CESC; HNSC; KIRC; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.148; TCGA CESC -0.174; TCGA HNSC -0.08; TCGA KIRC -0.125; TCGA LUAD -0.062; TCGA PRAD -0.097; TCGA SARC -0.08; TCGA STAD -0.211; TCGA UCEC -0.065 |
hsa-miR-29b-3p | SPTY2D1 | 9 cancers: BLCA; CESC; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.11; TCGA CESC -0.08; TCGA HNSC -0.162; TCGA KIRP -0.103; TCGA LUAD -0.087; TCGA LUSC -0.077; TCGA PAAD -0.241; TCGA PRAD -0.193; TCGA THCA -0.179 |
hsa-miR-29b-3p | PTPRD | 14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.61; TCGA BRCA -0.415; TCGA CESC -0.426; TCGA ESCA -1.022; TCGA HNSC -0.516; TCGA KIRP -0.726; TCGA LUAD -0.239; TCGA LUSC -0.335; TCGA OV -0.297; TCGA PAAD -0.461; TCGA PRAD -0.181; TCGA SARC -0.599; TCGA STAD -0.433; TCGA UCEC -0.523 |
hsa-miR-29b-3p | PKNOX2 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; OV; PAAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.379; TCGA BRCA -0.269; TCGA CESC -0.346; TCGA COAD -0.749; TCGA ESCA -0.322; TCGA HNSC -0.177; TCGA LUAD -0.264; TCGA OV -0.154; TCGA PAAD -0.271; TCGA SARC -0.42; TCGA THCA -0.752; TCGA STAD -0.479 |
hsa-miR-29b-3p | USP42 | 10 cancers: BLCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.061; TCGA HNSC -0.108; TCGA KIRP -0.202; TCGA LGG -0.148; TCGA LIHC -0.132; TCGA LUSC -0.1; TCGA OV -0.077; TCGA SARC -0.093; TCGA THCA -0.1; TCGA UCEC -0.056 |
hsa-miR-29b-3p | N4BP2 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.368; TCGA BRCA -0.165; TCGA CESC -0.305; TCGA COAD -0.247; TCGA HNSC -0.383; TCGA KIRP -0.381; TCGA LGG -0.36; TCGA LIHC -0.339; TCGA LUAD -0.142; TCGA LUSC -0.184; TCGA OV -0.118; TCGA PAAD -0.223; TCGA PRAD -0.602; TCGA SARC -0.394; TCGA THCA -0.512 |
hsa-miR-29b-3p | GSTA4 | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.397; TCGA CESC -0.421; TCGA ESCA -0.683; TCGA HNSC -0.237; TCGA KIRC -0.197; TCGA KIRP -0.203; TCGA LGG -0.15; TCGA LIHC -0.225; TCGA LUAD -0.14; TCGA LUSC -0.208; TCGA OV -0.138; TCGA SARC -0.211; TCGA STAD -0.282; TCGA UCEC -0.273 |
hsa-miR-29b-3p | HNRNPUL1 | 10 cancers: BLCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; UCEC | miRNATAP | TCGA BLCA -0.094; TCGA HNSC -0.063; TCGA KIRC -0.071; TCGA LGG -0.109; TCGA LIHC -0.134; TCGA LUAD -0.055; TCGA LUSC -0.062; TCGA OV -0.052; TCGA PRAD -0.112; TCGA UCEC -0.06 |
hsa-miR-29b-3p | SBF2 | 14 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.146; TCGA BRCA -0.135; TCGA CESC -0.17; TCGA HNSC -0.208; TCGA KIRC -0.126; TCGA KIRP -0.199; TCGA LGG -0.166; TCGA LUAD -0.179; TCGA LUSC -0.17; TCGA PAAD -0.199; TCGA PRAD -0.312; TCGA SARC -0.144; TCGA THCA -0.124; TCGA STAD -0.205 |
hsa-miR-29b-3p | KCNJ12 | 10 cancers: BLCA; BRCA; ESCA; LUAD; OV; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.558; TCGA BRCA -0.567; TCGA ESCA -0.399; TCGA LUAD -0.16; TCGA OV -0.192; TCGA PAAD -0.497; TCGA PRAD -0.205; TCGA SARC -0.429; TCGA THCA -0.15; TCGA UCEC -0.288 |
hsa-miR-29b-3p | SCN3B | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.459; TCGA BRCA -0.505; TCGA COAD -0.73; TCGA ESCA -0.418; TCGA HNSC -0.251; TCGA LUAD -0.281; TCGA PRAD -0.23; TCGA SARC -0.246; TCGA THCA -0.312; TCGA STAD -0.665 |
hsa-miR-29b-3p | WDFY3 | 15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.102; TCGA BRCA -0.058; TCGA CESC -0.222; TCGA COAD -0.134; TCGA ESCA -0.129; TCGA HNSC -0.223; TCGA KIRC -0.13; TCGA KIRP -0.156; TCGA LUAD -0.085; TCGA LUSC -0.129; TCGA PAAD -0.148; TCGA PRAD -0.254; TCGA SARC -0.079; TCGA THCA -0.186; TCGA STAD -0.234 |
hsa-miR-29b-3p | TCF4 | 17 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.403; TCGA BRCA -0.324; TCGA CESC -0.361; TCGA COAD -0.633; TCGA ESCA -0.316; TCGA HNSC -0.293; TCGA KIRC -0.513; TCGA LGG -0.205; TCGA LUAD -0.22; TCGA LUSC -0.221; TCGA OV -0.093; TCGA PAAD -0.487; TCGA PRAD -0.232; TCGA SARC -0.177; TCGA THCA -0.272; TCGA STAD -0.312; TCGA UCEC -0.105 |
hsa-miR-29b-3p | CSGALNACT2 | 9 cancers: BLCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.162; TCGA COAD -0.325; TCGA HNSC -0.17; TCGA KIRC -0.091; TCGA LGG -0.088; TCGA LUAD -0.09; TCGA PAAD -0.402; TCGA PRAD -0.113; TCGA STAD -0.237 |
hsa-miR-29b-3p | CAMK1D | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.168; TCGA BRCA -0.078; TCGA CESC -0.285; TCGA ESCA -0.688; TCGA HNSC -0.132; TCGA KIRC -0.209; TCGA KIRP -0.287; TCGA LUSC -0.163; TCGA PAAD -0.246; TCGA PRAD -0.435; TCGA THCA -0.237; TCGA STAD -0.374 |
hsa-miR-29b-3p | C5orf24 | 13 cancers: BLCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.159; TCGA CESC -0.157; TCGA COAD -0.092; TCGA HNSC -0.109; TCGA LGG -0.067; TCGA LUAD -0.112; TCGA LUSC -0.081; TCGA PAAD -0.169; TCGA PRAD -0.249; TCGA SARC -0.189; TCGA THCA -0.129; TCGA STAD -0.179; TCGA UCEC -0.071 |
hsa-miR-29b-3p | CBX2 | 9 cancers: BLCA; ESCA; HNSC; KIRC; LGG; LUSC; OV; SARC; UCEC | miRNATAP | TCGA BLCA -0.165; TCGA ESCA -0.805; TCGA HNSC -0.195; TCGA KIRC -0.253; TCGA LGG -0.434; TCGA LUSC -0.383; TCGA OV -0.304; TCGA SARC -0.342; TCGA UCEC -0.377 |
hsa-miR-29b-3p | KDELC1 | 19 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.228; TCGA BRCA -0.231; TCGA CESC -0.265; TCGA COAD -0.285; TCGA ESCA -0.379; TCGA HNSC -0.214; TCGA KIRC -0.161; TCGA KIRP -0.536; TCGA LGG -0.285; TCGA LIHC -0.324; TCGA LUAD -0.214; TCGA LUSC -0.293; TCGA OV -0.207; TCGA PAAD -0.494; TCGA PRAD -0.196; TCGA SARC -0.183; TCGA THCA -0.128; TCGA STAD -0.254; TCGA UCEC -0.293 |
hsa-miR-29b-3p | ZNF641 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.221; TCGA BRCA -0.114; TCGA CESC -0.189; TCGA COAD -0.148; TCGA HNSC -0.22; TCGA KIRC -0.204; TCGA KIRP -0.166; TCGA LGG -0.076; TCGA LUAD -0.124; TCGA LUSC -0.106; TCGA PAAD -0.15; TCGA PRAD -0.46; TCGA SARC -0.341; TCGA THCA -0.336; TCGA STAD -0.15 |
hsa-miR-29b-3p | ZNF362 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; OV; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.078; TCGA BRCA -0.073; TCGA CESC -0.131; TCGA COAD -0.134; TCGA ESCA -0.267; TCGA HNSC -0.057; TCGA KIRC -0.195; TCGA LIHC -0.085; TCGA LUSC -0.153; TCGA OV -0.067; TCGA SARC -0.087; TCGA STAD -0.224; TCGA UCEC -0.114 |
hsa-miR-29b-3p | MFAP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.188; TCGA BRCA -0.335; TCGA CESC -0.364; TCGA COAD -0.557; TCGA ESCA -0.796; TCGA HNSC -0.249; TCGA KIRP -0.338; TCGA LGG -0.209; TCGA LUAD -0.093; TCGA LUSC -0.25; TCGA OV -0.373; TCGA PAAD -0.879; TCGA STAD -0.29; TCGA UCEC -0.566 |
hsa-miR-29b-3p | GLIS3 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; PAAD; PRAD; THCA | miRNATAP | TCGA BLCA -0.154; TCGA BRCA -0.37; TCGA CESC -0.313; TCGA COAD -0.686; TCGA HNSC -0.369; TCGA KIRC -0.133; TCGA KIRP -0.234; TCGA PAAD -0.443; TCGA PRAD -0.142; TCGA THCA -0.314 |
hsa-miR-29b-3p | RARB | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.451; TCGA CESC -0.271; TCGA COAD -0.449; TCGA ESCA -0.494; TCGA HNSC -0.165; TCGA KIRC -0.289; TCGA LUAD -0.189; TCGA PAAD -0.366; TCGA PRAD -0.198; TCGA SARC -0.296; TCGA THCA -0.352; TCGA STAD -0.305; TCGA UCEC -0.154 |
hsa-miR-29b-3p | AP4E1 | 12 cancers: BLCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.106; TCGA COAD -0.068; TCGA ESCA -0.116; TCGA HNSC -0.128; TCGA LGG -0.056; TCGA LIHC -0.098; TCGA LUAD -0.067; TCGA LUSC -0.063; TCGA PAAD -0.127; TCGA PRAD -0.18; TCGA THCA -0.072; TCGA STAD -0.103 |
hsa-miR-29b-3p | SLITRK4 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.484; TCGA BRCA -0.214; TCGA HNSC -0.513; TCGA KIRP -0.536; TCGA LUAD -0.282; TCGA PAAD -0.761; TCGA PRAD -0.28; TCGA SARC -0.257; TCGA STAD -0.539 |
hsa-miR-29b-3p | TPM1 | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.354; TCGA BRCA -0.119; TCGA CESC -0.204; TCGA COAD -0.307; TCGA HNSC -0.168; TCGA KIRC -0.265; TCGA KIRP -0.202; TCGA LUAD -0.131; TCGA LUSC -0.12; TCGA PAAD -0.601; TCGA PRAD -0.221; TCGA SARC -0.302; TCGA STAD -0.465 |
hsa-miR-29b-3p | VCL | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.183; TCGA BRCA -0.169; TCGA CESC -0.119; TCGA COAD -0.254; TCGA ESCA -0.145; TCGA HNSC -0.229; TCGA KIRC -0.107; TCGA LUAD -0.163; TCGA LUSC -0.126; TCGA PAAD -0.354; TCGA PRAD -0.421; TCGA SARC -0.248; TCGA STAD -0.344; TCGA UCEC -0.075 |
hsa-miR-29b-3p | TTYH2 | 10 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.153; TCGA BRCA -0.071; TCGA COAD -0.34; TCGA ESCA -0.385; TCGA HNSC -0.17; TCGA KIRC -0.299; TCGA PRAD -0.179; TCGA SARC -0.223; TCGA THCA -0.356; TCGA STAD -0.275 |
hsa-miR-29b-3p | NEGR1 | 11 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.681; TCGA BRCA -0.328; TCGA COAD -0.941; TCGA HNSC -0.382; TCGA LUAD -0.293; TCGA LUSC -0.26; TCGA PAAD -0.441; TCGA PRAD -0.326; TCGA SARC -0.262; TCGA THCA -0.284; TCGA STAD -0.737 |
hsa-miR-29b-3p | ABL1 | 14 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.226; TCGA BRCA -0.15; TCGA ESCA -0.112; TCGA HNSC -0.146; TCGA KIRC -0.119; TCGA LGG -0.184; TCGA LUSC -0.112; TCGA OV -0.09; TCGA PAAD -0.186; TCGA PRAD -0.089; TCGA SARC -0.17; TCGA THCA -0.086; TCGA STAD -0.241; TCGA UCEC -0.08 |
hsa-miR-29b-3p | SPSB4 | 12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.672; TCGA BRCA -0.42; TCGA CESC -0.626; TCGA ESCA -1.035; TCGA HNSC -0.344; TCGA LGG -0.433; TCGA LUAD -0.348; TCGA LUSC -0.551; TCGA OV -0.569; TCGA PAAD -0.486; TCGA SARC -0.494; TCGA UCEC -0.384 |
hsa-miR-29b-3p | EHD2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.131; TCGA BRCA -0.297; TCGA COAD -0.621; TCGA ESCA -0.377; TCGA HNSC -0.184; TCGA KIRC -0.455; TCGA KIRP -0.336; TCGA LUAD -0.151; TCGA PAAD -0.245; TCGA PRAD -0.202; TCGA STAD -0.372 |
hsa-miR-29b-3p | FBN1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.47; TCGA BRCA -0.434; TCGA CESC -0.217; TCGA COAD -0.831; TCGA ESCA -0.338; TCGA HNSC -0.572; TCGA KIRC -0.218; TCGA LUAD -0.227; TCGA LUSC -0.271; TCGA PAAD -0.901; TCGA PRAD -0.371; TCGA THCA -0.437; TCGA STAD -0.417 |
hsa-miR-29b-3p | SENP1 | 14 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BLCA -0.132; TCGA CESC -0.113; TCGA ESCA -0.138; TCGA HNSC -0.075; TCGA KIRP -0.095; TCGA LGG -0.19; TCGA LIHC -0.165; TCGA LUAD -0.098; TCGA LUSC -0.137; TCGA OV -0.076; TCGA PRAD -0.191; TCGA SARC -0.108; TCGA THCA -0.05; TCGA UCEC -0.082 |
hsa-miR-29b-3p | EPHA3 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.582; TCGA BRCA -0.25; TCGA CESC -0.338; TCGA COAD -0.688; TCGA HNSC -0.455; TCGA KIRC -0.497; TCGA LUAD -0.232; TCGA PAAD -0.745; TCGA PRAD -0.494; TCGA THCA -0.379; TCGA STAD -0.645 |
hsa-miR-29b-3p | EPHB3 | 9 cancers: BLCA; ESCA; HNSC; LGG; LUSC; OV; PAAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.306; TCGA ESCA -0.455; TCGA HNSC -0.309; TCGA LGG -0.291; TCGA LUSC -0.266; TCGA OV -0.152; TCGA PAAD -0.253; TCGA SARC -0.249; TCGA UCEC -0.229 |
hsa-miR-29b-3p | PRRT4 | 10 cancers: BLCA; BRCA; ESCA; LGG; LUAD; OV; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.267; TCGA BRCA -0.39; TCGA ESCA -0.541; TCGA LGG -0.26; TCGA LUAD -0.196; TCGA OV -0.266; TCGA SARC -0.45; TCGA THCA -0.332; TCGA STAD -0.675; TCGA UCEC -0.36 |
hsa-miR-29b-3p | CFL2 | 9 cancers: BLCA; CESC; COAD; ESCA; LUAD; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.355; TCGA CESC -0.143; TCGA COAD -0.557; TCGA ESCA -0.249; TCGA LUAD -0.186; TCGA PAAD -0.187; TCGA PRAD -0.226; TCGA THCA -0.174; TCGA STAD -0.615 |
hsa-miR-29b-3p | HMGCR | 11 cancers: BLCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.069; TCGA CESC -0.147; TCGA HNSC -0.085; TCGA LGG -0.105; TCGA LIHC -0.207; TCGA LUAD -0.141; TCGA LUSC -0.165; TCGA OV -0.086; TCGA PRAD -0.223; TCGA THCA -0.316; TCGA UCEC -0.142 |
hsa-miR-29b-3p | PRELP | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.641; TCGA BRCA -0.302; TCGA CESC -0.252; TCGA COAD -1.146; TCGA HNSC -0.303; TCGA LUAD -0.223; TCGA PAAD -0.676; TCGA PRAD -0.269; TCGA SARC -0.438; TCGA STAD -0.955 |
hsa-miR-29b-3p | IDE | 10 cancers: BLCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.16; TCGA HNSC -0.257; TCGA LGG -0.09; TCGA LUAD -0.069; TCGA LUSC -0.077; TCGA PAAD -0.333; TCGA PRAD -0.368; TCGA SARC -0.078; TCGA THCA -0.281; TCGA STAD -0.058 |
hsa-miR-29b-3p | BIRC6 | 9 cancers: BLCA; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA BLCA -0.114; TCGA HNSC -0.196; TCGA KIRP -0.081; TCGA LGG -0.127; TCGA LIHC -0.129; TCGA LUSC -0.075; TCGA PRAD -0.288; TCGA SARC -0.106; TCGA THCA -0.151 |
hsa-miR-29b-3p | DNM3 | 11 cancers: BLCA; BRCA; CESC; COAD; KIRC; LIHC; LUAD; PAAD; PRAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.273; TCGA BRCA -0.274; TCGA CESC -0.287; TCGA COAD -0.27; TCGA KIRC -0.295; TCGA LIHC -0.143; TCGA LUAD -0.132; TCGA PAAD -0.258; TCGA PRAD -0.127; TCGA SARC -0.376; TCGA UCEC -0.194 |
hsa-miR-29b-3p | SLK | 13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.089; TCGA BRCA -0.093; TCGA COAD -0.071; TCGA HNSC -0.105; TCGA KIRC -0.154; TCGA KIRP -0.223; TCGA LIHC -0.09; TCGA LUAD -0.083; TCGA PAAD -0.215; TCGA PRAD -0.2; TCGA SARC -0.084; TCGA THCA -0.286; TCGA STAD -0.124 |
hsa-miR-29b-3p | PDGFRB | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.293; TCGA BRCA -0.374; TCGA COAD -0.586; TCGA ESCA -0.26; TCGA HNSC -0.382; TCGA KIRC -0.473; TCGA LUAD -0.101; TCGA LUSC -0.139; TCGA PAAD -0.594; TCGA PRAD -0.18; TCGA THCA -0.195; TCGA STAD -0.31 |
hsa-miR-29b-3p | CBX1 | 14 cancers: BLCA; CESC; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.136; TCGA CESC -0.201; TCGA ESCA -0.399; TCGA KIRP -0.213; TCGA LGG -0.094; TCGA LIHC -0.214; TCGA LUAD -0.087; TCGA LUSC -0.216; TCGA OV -0.137; TCGA PRAD -0.056; TCGA SARC -0.137; TCGA THCA -0.125; TCGA STAD -0.164; TCGA UCEC -0.201 |
hsa-miR-29b-3p | SPRY1 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUAD; PAAD; PRAD; SARC; STAD | miRNATAP | TCGA BLCA -0.242; TCGA BRCA -0.326; TCGA CESC -0.311; TCGA COAD -0.082; TCGA HNSC -0.147; TCGA KIRC -0.507; TCGA LUAD -0.147; TCGA PAAD -0.284; TCGA PRAD -0.23; TCGA SARC -0.228; TCGA STAD -0.228 |
hsa-miR-29b-3p | CPNE8 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BLCA -0.23; TCGA BRCA -0.19; TCGA COAD -0.34; TCGA ESCA -0.407; TCGA HNSC -0.144; TCGA KIRC -0.108; TCGA KIRP -0.201; TCGA PAAD -0.273; TCGA PRAD -0.286; TCGA THCA -0.253; TCGA STAD -0.331 |
hsa-miR-29b-3p | CAPN7 | 9 cancers: BLCA; CESC; KIRP; LGG; LIHC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BLCA -0.076; TCGA CESC -0.125; TCGA KIRP -0.112; TCGA LGG -0.081; TCGA LIHC -0.126; TCGA PRAD -0.116; TCGA SARC -0.12; TCGA THCA -0.112; TCGA STAD -0.128 |
hsa-miR-29b-3p | BMP1 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; PAAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA BRCA -0.231; TCGA COAD -0.216; TCGA ESCA -0.349; TCGA HNSC -0.129; TCGA KIRC -0.195; TCGA KIRP -0.227; TCGA LGG -0.216; TCGA PAAD -0.284; TCGA UCEC -0.166 |
hsa-miR-29b-3p | CECR2 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; OV; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.191; TCGA ESCA -0.882; TCGA HNSC -0.628; TCGA LGG -0.364; TCGA LUAD -0.175; TCGA OV -0.354; TCGA PRAD -0.281; TCGA SARC -0.35; TCGA THCA -0.727; TCGA STAD -0.425 |
hsa-miR-29b-3p | MYCN | 10 cancers: BRCA; CESC; KIRC; LGG; LIHC; LUSC; OV; SARC; THCA; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.238; TCGA CESC -0.53; TCGA KIRC -0.495; TCGA LGG -0.386; TCGA LIHC -0.272; TCGA LUSC -0.356; TCGA OV -0.319; TCGA SARC -0.194; TCGA THCA -0.556; TCGA UCEC -0.358 |
hsa-miR-29b-3p | PTEN | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LUAD; PAAD; THCA; STAD | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BRCA -0.062; TCGA COAD -0.119; TCGA HNSC -0.104; TCGA KIRC -0.1; TCGA KIRP -0.052; TCGA LUAD -0.093; TCGA PAAD -0.169; TCGA THCA -0.108; TCGA STAD -0.065 |
hsa-miR-29b-3p | AMMECR1L | 13 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.051; TCGA HNSC -0.064; TCGA KIRC -0.107; TCGA KIRP -0.077; TCGA LGG -0.173; TCGA LIHC -0.104; TCGA LUSC -0.092; TCGA PAAD -0.109; TCGA PRAD -0.114; TCGA SARC -0.077; TCGA THCA -0.103; TCGA STAD -0.079; TCGA UCEC -0.071 |
hsa-miR-29b-3p | PDPN | 9 cancers: BRCA; COAD; ESCA; LUAD; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.375; TCGA COAD -0.694; TCGA ESCA -0.537; TCGA LUAD -0.257; TCGA OV -0.176; TCGA PAAD -1.035; TCGA PRAD -0.198; TCGA STAD -0.126; TCGA UCEC -0.201 |
hsa-miR-29b-3p | MEST | 13 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.257; TCGA HNSC -0.131; TCGA KIRP -0.419; TCGA LGG -0.313; TCGA LIHC -0.368; TCGA LUAD -0.076; TCGA LUSC -0.209; TCGA OV -0.295; TCGA PAAD -0.126; TCGA PRAD -0.132; TCGA SARC -0.525; TCGA THCA -0.181; TCGA UCEC -0.196 |
hsa-miR-29b-3p | NCKAP5 | 10 cancers: BRCA; ESCA; HNSC; LGG; LUAD; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.172; TCGA ESCA -0.454; TCGA HNSC -0.301; TCGA LGG -0.08; TCGA LUAD -0.44; TCGA PAAD -0.277; TCGA PRAD -0.265; TCGA SARC -0.193; TCGA THCA -0.452; TCGA UCEC -0.214 |
hsa-miR-29b-3p | B4GALT6 | 10 cancers: BRCA; CESC; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BRCA -0.118; TCGA CESC -0.253; TCGA LIHC -0.13; TCGA LUAD -0.241; TCGA LUSC -0.315; TCGA OV -0.129; TCGA PRAD -0.294; TCGA SARC -0.199; TCGA STAD -0.199; TCGA UCEC -0.137 |
hsa-miR-29b-3p | CILP2 | 10 cancers: BRCA; CESC; COAD; HNSC; OV; PAAD; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.325; TCGA CESC -0.236; TCGA COAD -0.359; TCGA HNSC -0.29; TCGA OV -0.147; TCGA PAAD -1.007; TCGA PRAD -0.163; TCGA SARC -0.527; TCGA STAD -0.456; TCGA UCEC -0.221 |
hsa-miR-29b-3p | IL1RAP | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD | MirTarget; miRNATAP | TCGA BRCA -0.164; TCGA COAD -0.208; TCGA ESCA -0.388; TCGA HNSC -0.19; TCGA KIRC -0.171; TCGA LIHC -0.239; TCGA LUAD -0.205; TCGA PAAD -0.528; TCGA PRAD -0.321 |
hsa-miR-29b-3p | NEDD9 | 10 cancers: BRCA; COAD; KIRC; LUAD; OV; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.281; TCGA COAD -0.347; TCGA KIRC -0.417; TCGA LUAD -0.183; TCGA OV -0.213; TCGA PAAD -0.265; TCGA PRAD -0.144; TCGA SARC -0.193; TCGA THCA -0.131; TCGA UCEC -0.316 |
hsa-miR-29b-3p | BMF | 9 cancers: BRCA; CESC; COAD; LGG; LIHC; OV; PAAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.066; TCGA CESC -0.253; TCGA COAD -0.293; TCGA LGG -0.262; TCGA LIHC -0.369; TCGA OV -0.194; TCGA PAAD -0.189; TCGA SARC -0.162; TCGA UCEC -0.271 |
hsa-miR-29b-3p | CCNJ | 10 cancers: BRCA; CESC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; UCEC | MirTarget | TCGA BRCA -0.053; TCGA CESC -0.112; TCGA KIRP -0.154; TCGA LGG -0.245; TCGA LIHC -0.16; TCGA LUSC -0.136; TCGA OV -0.161; TCGA PAAD -0.112; TCGA PRAD -0.176; TCGA UCEC -0.211 |
hsa-miR-29b-3p | ADAMTS7 | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PAAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.284; TCGA CESC -0.334; TCGA COAD -0.438; TCGA ESCA -0.235; TCGA HNSC -0.402; TCGA KIRC -0.62; TCGA KIRP -0.3; TCGA LGG -0.231; TCGA LUSC -0.278; TCGA OV -0.197; TCGA PAAD -0.385; TCGA SARC -0.124; TCGA THCA -0.117; TCGA UCEC -0.479 |
hsa-miR-29b-3p | FREM2 | 14 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.451; TCGA CESC -1.154; TCGA HNSC -0.518; TCGA KIRC -0.569; TCGA KIRP -0.409; TCGA LUAD -0.302; TCGA LUSC -0.624; TCGA OV -0.647; TCGA PAAD -0.903; TCGA PRAD -0.565; TCGA SARC -0.414; TCGA THCA -0.438; TCGA STAD -0.699; TCGA UCEC -0.578 |
hsa-miR-29b-3p | FREM1 | 9 cancers: BRCA; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.66; TCGA LUAD -0.238; TCGA OV -0.185; TCGA PAAD -0.884; TCGA PRAD -0.169; TCGA SARC -0.57; TCGA THCA -0.345; TCGA STAD -0.698; TCGA UCEC -0.209 |
hsa-miR-29b-3p | COL2A1 | 11 cancers: BRCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.288; TCGA CESC -0.614; TCGA HNSC -0.269; TCGA LGG -0.319; TCGA LIHC -0.951; TCGA LUAD -0.403; TCGA LUSC -0.539; TCGA OV -0.669; TCGA PRAD -1.099; TCGA SARC -0.825; TCGA UCEC -0.406 |
hsa-miR-29b-3p | ATRN | 14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.076; TCGA CESC -0.19; TCGA COAD -0.168; TCGA ESCA -0.165; TCGA HNSC -0.198; TCGA KIRP -0.108; TCGA LIHC -0.28; TCGA LUAD -0.088; TCGA LUSC -0.19; TCGA OV -0.073; TCGA PRAD -0.166; TCGA SARC -0.079; TCGA THCA -0.25; TCGA UCEC -0.085 |
hsa-miR-29b-3p | TRIB2 | 9 cancers: BRCA; COAD; KIRC; LGG; LUAD; PAAD; PRAD; SARC; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.118; TCGA COAD -0.441; TCGA KIRC -0.457; TCGA LGG -0.227; TCGA LUAD -0.082; TCGA PAAD -0.181; TCGA PRAD -0.099; TCGA SARC -0.195; TCGA UCEC -0.176 |
hsa-miR-29b-3p | MTMR3 | 12 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.056; TCGA CESC -0.09; TCGA HNSC -0.146; TCGA KIRC -0.086; TCGA KIRP -0.094; TCGA LGG -0.116; TCGA LIHC -0.065; TCGA LUSC -0.084; TCGA PRAD -0.076; TCGA SARC -0.086; TCGA THCA -0.11; TCGA STAD -0.082 |
hsa-miR-29b-3p | UNC5B | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; UCEC | mirMAP | TCGA BRCA -0.138; TCGA COAD -0.462; TCGA ESCA -0.419; TCGA HNSC -0.229; TCGA KIRC -0.457; TCGA LUAD -0.129; TCGA LUSC -0.174; TCGA PAAD -0.331; TCGA PRAD -0.182; TCGA UCEC -0.104 |
hsa-miR-29b-3p | TSPAN11 | 9 cancers: BRCA; COAD; LGG; OV; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BRCA -0.444; TCGA COAD -0.562; TCGA LGG -0.382; TCGA OV -0.25; TCGA PAAD -0.335; TCGA PRAD -0.285; TCGA SARC -0.3; TCGA THCA -0.289; TCGA STAD -0.21 |
hsa-miR-29b-3p | SEMA5A | 13 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LUAD; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BRCA -0.47; TCGA HNSC -0.258; TCGA KIRC -0.191; TCGA KIRP -0.176; TCGA LGG -0.233; TCGA LUAD -0.333; TCGA OV -0.183; TCGA PAAD -0.206; TCGA PRAD -0.498; TCGA SARC -0.397; TCGA THCA -0.152; TCGA STAD -0.145; TCGA UCEC -0.234 |
hsa-miR-29b-3p | RAB3B | 11 cancers: BRCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; OV; PRAD; SARC; STAD | mirMAP | TCGA BRCA -0.299; TCGA CESC -0.343; TCGA COAD -0.488; TCGA HNSC -0.246; TCGA KIRP -0.735; TCGA LUAD -0.239; TCGA LUSC -0.386; TCGA OV -0.404; TCGA PRAD -0.611; TCGA SARC -0.313; TCGA STAD -0.198 |
hsa-miR-29b-3p | KREMEN1 | 9 cancers: BRCA; ESCA; HNSC; LUSC; OV; PAAD; PRAD; THCA; STAD | mirMAP | TCGA BRCA -0.206; TCGA ESCA -0.617; TCGA HNSC -0.142; TCGA LUSC -0.321; TCGA OV -0.078; TCGA PAAD -0.165; TCGA PRAD -0.108; TCGA THCA -0.128; TCGA STAD -0.173 |
hsa-miR-29b-3p | GPR173 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.175; TCGA CESC -0.414; TCGA COAD -0.488; TCGA HNSC -0.247; TCGA KIRC -0.204; TCGA KIRP -0.663; TCGA LGG -0.252; TCGA LUSC -0.152; TCGA PRAD -0.422; TCGA SARC -0.238; TCGA STAD -0.421; TCGA UCEC -0.226 |
hsa-miR-29b-3p | C1QTNF6 | 9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD | miRNATAP | TCGA BRCA -0.225; TCGA COAD -0.292; TCGA ESCA -0.28; TCGA HNSC -0.257; TCGA KIRC -0.209; TCGA KIRP -0.24; TCGA LGG -0.263; TCGA LIHC -0.213; TCGA PAAD -0.302 |
hsa-miR-29b-3p | COL4A5 | 13 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.371; TCGA COAD -0.36; TCGA ESCA -0.859; TCGA HNSC -0.195; TCGA LUAD -0.243; TCGA LUSC -0.235; TCGA OV -0.18; TCGA PAAD -0.673; TCGA PRAD -0.108; TCGA SARC -0.911; TCGA THCA -0.27; TCGA STAD -0.639; TCGA UCEC -0.387 |
hsa-miR-29b-3p | DCAF5 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.062; TCGA CESC -0.084; TCGA COAD -0.098; TCGA HNSC -0.116; TCGA KIRC -0.102; TCGA KIRP -0.102; TCGA LGG -0.103; TCGA PRAD -0.122; TCGA SARC -0.074; TCGA THCA -0.059; TCGA STAD -0.112 |
hsa-miR-29b-3p | NCKAP5L | 9 cancers: BRCA; COAD; ESCA; HNSC; LGG; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.105; TCGA COAD -0.191; TCGA ESCA -0.236; TCGA HNSC -0.143; TCGA LGG -0.14; TCGA PRAD -0.134; TCGA THCA -0.066; TCGA STAD -0.241; TCGA UCEC -0.051 |
hsa-miR-29b-3p | COL4A6 | 12 cancers: BRCA; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.551; TCGA ESCA -0.88; TCGA HNSC -0.318; TCGA LUAD -0.357; TCGA LUSC -0.314; TCGA OV -0.251; TCGA PAAD -0.516; TCGA PRAD -0.336; TCGA SARC -0.82; TCGA THCA -0.564; TCGA STAD -0.727; TCGA UCEC -0.274 |
hsa-miR-29b-3p | KIF26B | 11 cancers: BRCA; COAD; ESCA; HNSC; LGG; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.262; TCGA COAD -0.531; TCGA ESCA -0.287; TCGA HNSC -0.533; TCGA LGG -0.143; TCGA LUSC -0.241; TCGA PAAD -0.601; TCGA PRAD -0.171; TCGA SARC -0.366; TCGA THCA -0.53; TCGA UCEC -0.198 |
hsa-miR-29b-3p | ATP2B1 | 10 cancers: BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; PRAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.163; TCGA CESC -0.203; TCGA COAD -0.072; TCGA HNSC -0.186; TCGA KIRP -0.162; TCGA LIHC -0.24; TCGA LUAD -0.221; TCGA PRAD -0.181; TCGA THCA -0.11; TCGA UCEC -0.073 |
hsa-miR-29b-3p | FRAS1 | 14 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.41; TCGA CESC -0.8; TCGA COAD -0.607; TCGA HNSC -0.226; TCGA KIRC -0.426; TCGA KIRP -0.378; TCGA LUAD -0.491; TCGA LUSC -0.401; TCGA OV -0.281; TCGA PAAD -0.549; TCGA PRAD -0.459; TCGA THCA -0.631; TCGA STAD -0.427; TCGA UCEC -0.473 |
hsa-miR-29b-3p | SERPINH1 | 13 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.23; TCGA COAD -0.239; TCGA ESCA -0.228; TCGA HNSC -0.216; TCGA KIRP -0.116; TCGA LGG -0.162; TCGA LIHC -0.21; TCGA LUSC -0.142; TCGA OV -0.096; TCGA PAAD -0.436; TCGA PRAD -0.095; TCGA STAD -0.11; TCGA UCEC -0.209 |
hsa-miR-29b-3p | DGKH | 12 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | miRNATAP | TCGA BRCA -0.159; TCGA CESC -0.167; TCGA HNSC -0.261; TCGA KIRC -0.431; TCGA KIRP -0.242; TCGA LUAD -0.099; TCGA LUSC -0.197; TCGA PAAD -0.348; TCGA PRAD -0.373; TCGA SARC -0.103; TCGA THCA -0.249; TCGA STAD -0.297 |
hsa-miR-29b-3p | FRMD4A | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUAD; PAAD; PRAD; THCA; STAD | miRNATAP | TCGA BRCA -0.067; TCGA COAD -0.209; TCGA ESCA -0.225; TCGA KIRC -0.242; TCGA KIRP -0.208; TCGA LUAD -0.145; TCGA PAAD -0.256; TCGA PRAD -0.072; TCGA THCA -0.167; TCGA STAD -0.26 |
hsa-miR-29b-3p | ZC4H2 | 10 cancers: BRCA; KIRC; KIRP; LGG; LUAD; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.19; TCGA KIRC -0.117; TCGA KIRP -0.091; TCGA LGG -0.213; TCGA LUAD -0.088; TCGA OV -0.234; TCGA PRAD -0.184; TCGA SARC -0.287; TCGA THCA -0.174; TCGA UCEC -0.329 |
hsa-miR-29b-3p | MAPK10 | 11 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LUAD; OV; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.215; TCGA COAD -0.761; TCGA ESCA -0.602; TCGA KIRC -0.196; TCGA KIRP -0.144; TCGA LUAD -0.172; TCGA OV -0.306; TCGA SARC -0.608; TCGA THCA -0.191; TCGA STAD -0.592; TCGA UCEC -0.202 |
hsa-miR-29b-3p | DNMT3A | 11 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA CESC -0.148; TCGA HNSC -0.08; TCGA KIRP -0.196; TCGA LGG -0.117; TCGA LIHC -0.375; TCGA LUSC -0.154; TCGA OV -0.198; TCGA PRAD -0.081; TCGA SARC -0.181; TCGA STAD -0.198; TCGA UCEC -0.203 |
hsa-miR-29b-3p | DNMT3B | 10 cancers: CESC; ESCA; HNSC; LGG; LIHC; LUSC; OV; SARC; THCA; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA CESC -0.205; TCGA ESCA -0.431; TCGA HNSC -0.141; TCGA LGG -0.261; TCGA LIHC -0.41; TCGA LUSC -0.266; TCGA OV -0.117; TCGA SARC -0.141; TCGA THCA -0.101; TCGA UCEC -0.171 |
hsa-miR-29b-3p | NKIRAS2 | 13 cancers: CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; SARC; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; miRNATAP | TCGA CESC -0.063; TCGA ESCA -0.184; TCGA HNSC -0.064; TCGA KIRC -0.092; TCGA KIRP -0.167; TCGA LGG -0.256; TCGA LIHC -0.142; TCGA LUSC -0.132; TCGA OV -0.099; TCGA SARC -0.103; TCGA THCA -0.136; TCGA STAD -0.089; TCGA UCEC -0.095 |
hsa-miR-29b-3p | PIGN | 11 cancers: CESC; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA CESC -0.162; TCGA HNSC -0.08; TCGA KIRP -0.071; TCGA LGG -0.057; TCGA LUAD -0.057; TCGA LUSC -0.149; TCGA PAAD -0.116; TCGA PRAD -0.209; TCGA SARC -0.068; TCGA THCA -0.294; TCGA UCEC -0.073 |
hsa-miR-29b-3p | GPATCH2 | 10 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUSC; OV; PRAD; SARC; UCEC | MirTarget | TCGA CESC -0.138; TCGA HNSC -0.09; TCGA KIRP -0.088; TCGA LGG -0.133; TCGA LIHC -0.131; TCGA LUSC -0.108; TCGA OV -0.078; TCGA PRAD -0.118; TCGA SARC -0.131; TCGA UCEC -0.094 |
hsa-miR-29b-3p | ZMYM2 | 11 cancers: CESC; HNSC; LGG; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.13; TCGA HNSC -0.108; TCGA LGG -0.071; TCGA LIHC -0.1; TCGA LUSC -0.115; TCGA OV -0.1; TCGA PRAD -0.114; TCGA SARC -0.132; TCGA THCA -0.074; TCGA STAD -0.153; TCGA UCEC -0.072 |
hsa-miR-29b-3p | ZBTB34 | 11 cancers: CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.123; TCGA HNSC -0.068; TCGA KIRC -0.139; TCGA KIRP -0.134; TCGA LIHC -0.182; TCGA LUAD -0.056; TCGA LUSC -0.081; TCGA OV -0.071; TCGA SARC -0.134; TCGA STAD -0.157; TCGA UCEC -0.094 |
hsa-miR-29b-3p | SWAP70 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.1; TCGA COAD -0.193; TCGA ESCA -0.114; TCGA HNSC -0.092; TCGA KIRC -0.212; TCGA LUAD -0.059; TCGA PAAD -0.284; TCGA PRAD -0.108; TCGA THCA -0.066; TCGA STAD -0.076 |
hsa-miR-29b-3p | BLMH | 14 cancers: CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.144; TCGA COAD -0.101; TCGA ESCA -0.255; TCGA KIRC -0.13; TCGA KIRP -0.173; TCGA LGG -0.168; TCGA LIHC -0.142; TCGA LUAD -0.189; TCGA LUSC -0.185; TCGA OV -0.114; TCGA SARC -0.063; TCGA THCA -0.071; TCGA STAD -0.112; TCGA UCEC -0.176 |
hsa-miR-29b-3p | OXR1 | 9 cancers: CESC; HNSC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget; miRNATAP | TCGA CESC -0.203; TCGA HNSC -0.117; TCGA KIRP -0.57; TCGA LUAD -0.075; TCGA LUSC -0.076; TCGA PAAD -0.257; TCGA PRAD -0.165; TCGA SARC -0.169; TCGA STAD -0.136 |
hsa-miR-29b-3p | SETDB1 | 9 cancers: CESC; HNSC; KIRC; LGG; LIHC; LUSC; OV; SARC; UCEC | MirTarget; miRNATAP | TCGA CESC -0.06; TCGA HNSC -0.053; TCGA KIRC -0.103; TCGA LGG -0.217; TCGA LIHC -0.197; TCGA LUSC -0.107; TCGA OV -0.065; TCGA SARC -0.07; TCGA UCEC -0.081 |
hsa-miR-29b-3p | PHC1 | 9 cancers: CESC; KIRC; KIRP; LGG; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA CESC -0.207; TCGA KIRC -0.28; TCGA KIRP -0.252; TCGA LGG -0.246; TCGA LUSC -0.097; TCGA OV -0.124; TCGA SARC -0.178; TCGA STAD -0.074; TCGA UCEC -0.124 |
hsa-miR-29b-3p | MAPRE1 | 10 cancers: CESC; LGG; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.083; TCGA LGG -0.173; TCGA LIHC -0.138; TCGA LUAD -0.07; TCGA LUSC -0.067; TCGA OV -0.085; TCGA PRAD -0.08; TCGA THCA -0.133; TCGA STAD -0.083; TCGA UCEC -0.085 |
hsa-miR-29b-3p | EML4 | 9 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.123; TCGA HNSC -0.062; TCGA KIRP -0.129; TCGA LGG -0.146; TCGA LIHC -0.135; TCGA LUAD -0.052; TCGA PAAD -0.122; TCGA PRAD -0.172; TCGA UCEC -0.061 |
hsa-miR-29b-3p | TAF11 | 11 cancers: CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; SARC; THCA; UCEC | MirTarget | TCGA CESC -0.098; TCGA ESCA -0.1; TCGA KIRC -0.147; TCGA KIRP -0.1; TCGA LGG -0.074; TCGA LIHC -0.217; TCGA LUSC -0.075; TCGA OV -0.116; TCGA SARC -0.054; TCGA THCA -0.087; TCGA UCEC -0.133 |
hsa-miR-29b-3p | CBFA2T2 | 10 cancers: CESC; KIRP; LIHC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.246; TCGA KIRP -0.173; TCGA LIHC -0.295; TCGA LUSC -0.101; TCGA OV -0.073; TCGA PRAD -0.087; TCGA SARC -0.147; TCGA THCA -0.107; TCGA STAD -0.186; TCGA UCEC -0.067 |
hsa-miR-29b-3p | GOSR1 | 9 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA | mirMAP | TCGA CESC -0.067; TCGA HNSC -0.053; TCGA KIRP -0.09; TCGA LGG -0.09; TCGA LIHC -0.077; TCGA LUSC -0.104; TCGA PRAD -0.125; TCGA SARC -0.058; TCGA THCA -0.117 |
hsa-miR-29b-3p | C16orf87 | 10 cancers: CESC; ESCA; HNSC; LGG; OV; PAAD; PRAD; SARC; THCA; UCEC | mirMAP; miRNATAP | TCGA CESC -0.136; TCGA ESCA -0.153; TCGA HNSC -0.086; TCGA LGG -0.193; TCGA OV -0.111; TCGA PAAD -0.129; TCGA PRAD -0.09; TCGA SARC -0.118; TCGA THCA -0.162; TCGA UCEC -0.131 |
hsa-miR-29b-3p | NUFIP2 | 9 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; THCA | miRNATAP | TCGA CESC -0.05; TCGA HNSC -0.108; TCGA KIRP -0.135; TCGA LGG -0.051; TCGA LIHC -0.053; TCGA LUSC -0.06; TCGA PRAD -0.123; TCGA SARC -0.065; TCGA THCA -0.085 |
hsa-miR-29b-3p | E2F7 | 9 cancers: CESC; ESCA; LGG; LIHC; LUSC; OV; PAAD; SARC; UCEC | miRNATAP | TCGA CESC -0.272; TCGA ESCA -0.287; TCGA LGG -0.387; TCGA LIHC -0.603; TCGA LUSC -0.297; TCGA OV -0.125; TCGA PAAD -0.306; TCGA SARC -0.17; TCGA UCEC -0.149 |
hsa-miR-29b-3p | NRAS | 12 cancers: CESC; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA CESC -0.071; TCGA HNSC -0.115; TCGA KIRC -0.095; TCGA LGG -0.075; TCGA LIHC -0.163; TCGA LUAD -0.13; TCGA LUSC -0.094; TCGA OV -0.075; TCGA PAAD -0.195; TCGA PRAD -0.146; TCGA THCA -0.156; TCGA UCEC -0.073 |
hsa-miR-29b-3p | TIAM1 | 9 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA CESC -0.224; TCGA COAD -0.455; TCGA ESCA -0.591; TCGA HNSC -0.097; TCGA LUAD -0.165; TCGA LUSC -0.152; TCGA PRAD -0.284; TCGA STAD -0.199; TCGA UCEC -0.108 |
hsa-miR-29b-3p | GOPC | 11 cancers: CESC; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA CESC -0.12; TCGA HNSC -0.121; TCGA KIRC -0.081; TCGA KIRP -0.099; TCGA LGG -0.066; TCGA LUAD -0.07; TCGA LUSC -0.084; TCGA PAAD -0.144; TCGA PRAD -0.142; TCGA SARC -0.073; TCGA THCA -0.102 |
hsa-miR-29b-3p | DAG1 | 11 cancers: CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA CESC -0.073; TCGA HNSC -0.104; TCGA KIRP -0.105; TCGA LGG -0.085; TCGA LIHC -0.062; TCGA LUAD -0.104; TCGA LUSC -0.134; TCGA PRAD -0.181; TCGA THCA -0.063; TCGA STAD -0.073; TCGA UCEC -0.069 |
hsa-miR-29b-3p | RNF152 | 12 cancers: COAD; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA COAD -0.441; TCGA ESCA -0.39; TCGA HNSC -0.235; TCGA KIRC -0.355; TCGA LGG -0.088; TCGA LUAD -0.179; TCGA LUSC -0.314; TCGA PAAD -0.325; TCGA PRAD -0.317; TCGA SARC -0.393; TCGA THCA -0.38; TCGA UCEC -0.226 |
hsa-miR-29b-3p | ZNF512B | 10 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; SARC; THCA; STAD | MirTarget; miRNATAP | TCGA COAD -0.267; TCGA ESCA -0.508; TCGA HNSC -0.073; TCGA KIRC -0.154; TCGA KIRP -0.064; TCGA LGG -0.131; TCGA LIHC -0.164; TCGA SARC -0.253; TCGA THCA -0.093; TCGA STAD -0.333 |
hsa-miR-29b-3p | NOS1 | 9 cancers: COAD; ESCA; HNSC; LUAD; PAAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.895; TCGA ESCA -1.657; TCGA HNSC -0.454; TCGA LUAD -0.521; TCGA PAAD -0.59; TCGA PRAD -0.99; TCGA SARC -0.302; TCGA THCA -0.793; TCGA STAD -1.197 |
hsa-miR-29b-3p | ZNF346 | 9 cancers: ESCA; KIRC; LGG; LIHC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA ESCA -0.088; TCGA KIRC -0.096; TCGA LGG -0.099; TCGA LIHC -0.068; TCGA OV -0.055; TCGA SARC -0.104; TCGA THCA -0.133; TCGA STAD -0.111; TCGA UCEC -0.086 |
hsa-miR-29b-3p | TUBD1 | 10 cancers: ESCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA ESCA -0.154; TCGA KIRC -0.138; TCGA KIRP -0.228; TCGA LGG -0.063; TCGA LIHC -0.187; TCGA LUSC -0.104; TCGA OV -0.112; TCGA SARC -0.119; TCGA STAD -0.108; TCGA UCEC -0.074 |
hsa-miR-29b-3p | JARID2 | 10 cancers: ESCA; HNSC; KIRC; LGG; LIHC; LUAD; OV; PRAD; THCA; UCEC | MirTarget; miRNATAP | TCGA ESCA -0.323; TCGA HNSC -0.142; TCGA KIRC -0.159; TCGA LGG -0.124; TCGA LIHC -0.146; TCGA LUAD -0.084; TCGA OV -0.144; TCGA PRAD -0.094; TCGA THCA -0.058; TCGA UCEC -0.122 |
hsa-miR-29b-3p | ERCC6 | 9 cancers: ESCA; HNSC; KIRP; LGG; LIHC; LUAD; PRAD; SARC; STAD | MirTarget | TCGA ESCA -0.142; TCGA HNSC -0.151; TCGA KIRP -0.143; TCGA LGG -0.073; TCGA LIHC -0.166; TCGA LUAD -0.052; TCGA PRAD -0.249; TCGA SARC -0.108; TCGA STAD -0.097 |
hsa-miR-29b-3p | IGF1R | 10 cancers: ESCA; HNSC; KIRC; KIRP; LGG; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA ESCA -0.286; TCGA HNSC -0.255; TCGA KIRC -0.181; TCGA KIRP -0.166; TCGA LGG -0.115; TCGA LUSC -0.233; TCGA PAAD -0.135; TCGA PRAD -0.243; TCGA SARC -0.205; TCGA STAD -0.24 |
hsa-miR-29b-3p | CCNYL1 | 10 cancers: HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; PRAD; THCA; STAD | MirTarget | TCGA HNSC -0.148; TCGA KIRC -0.09; TCGA KIRP -0.132; TCGA LIHC -0.221; TCGA LUAD -0.086; TCGA OV -0.067; TCGA PAAD -0.207; TCGA PRAD -0.064; TCGA THCA -0.168; TCGA STAD -0.098 |
hsa-miR-29b-3p | ZNF28 | 10 cancers: HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | MirTarget | TCGA HNSC -0.145; TCGA KIRP -0.188; TCGA LIHC -0.275; TCGA LUAD -0.087; TCGA LUSC -0.14; TCGA OV -0.062; TCGA PRAD -0.241; TCGA SARC -0.116; TCGA THCA -0.199; TCGA UCEC -0.074 |
hsa-miR-29b-3p | ZNF264 | 9 cancers: HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA HNSC -0.07; TCGA KIRC -0.126; TCGA KIRP -0.16; TCGA LIHC -0.091; TCGA LUAD -0.062; TCGA PRAD -0.154; TCGA SARC -0.065; TCGA THCA -0.053; TCGA STAD -0.208 |
hsa-miR-29b-3p | UBN2 | 9 cancers: HNSC; KIRC; KIRP; LGG; LIHC; PRAD; SARC; THCA; STAD | miRNATAP | TCGA HNSC -0.093; TCGA KIRC -0.081; TCGA KIRP -0.311; TCGA LGG -0.158; TCGA LIHC -0.129; TCGA PRAD -0.066; TCGA SARC -0.1; TCGA THCA -0.08; TCGA STAD -0.082 |
hsa-miR-29b-3p | CTNND1 | 10 cancers: HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; THCA | miRNATAP | TCGA HNSC -0.165; TCGA KIRC -0.116; TCGA KIRP -0.099; TCGA LGG -0.127; TCGA LIHC -0.068; TCGA LUSC -0.074; TCGA PAAD -0.175; TCGA PRAD -0.184; TCGA SARC -0.111; TCGA THCA -0.153 |
Enriched cancer pathways of putative targets